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„Manchmal hat man eine sehr lange Straße 
vor sich. Man denkt, die ist so schrecklich 
lang; das kann man niemals schaffen, denkt 
man [...] Und dann fängt man an, sich zu 
beeilen. Und man eilt sich immer mehr. 
Jedes Mal, wenn man aufblickt, sieht man, 
dass es gar nicht weniger wird, was noch vor 
einem liegt. Und man strengt sich noch mehr 
an, man kriegt es mit der Angst, und zum 
Schluss ist man ganz außer Puste und kann 
nicht mehr. Und die Straße liegt immer noch 
vor einem. So darf man es nicht machen. 
[...] Man darf nie an die ganze Straße auf 
einmal denken. Man muss nur an den 
nächsten Schritt denken, an den nächsten 
Atemzug, an den nächsten Besenstrich. Und 
immer wieder nur an den nächsten. [...] Auf 
einmal merkt man, dass man Schritt für 
Schritt die ganze Straße gemacht hat.“ 
(Beppo der Straßenkehrer, aus Momo, 
Michael Ende
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I SUMMARY 
NG2-glia - also known as oligodendrocyte progenitor cells - constitute a fraction of around 5% 
of the adult cells in the rodent brain. NG2-glia are the only proliferating cells in the adult brain 
parenchyma and are additionally able to generate mature and myelinating oligodendrocytes 
throughout lifetime. Despite their high number and substantial characterization, their functional 
role both in the intact and injured adult brain remains unclear. To address this question, this 
thesis exploited the conditional genetic deletion of the Esco2 protein in the inducible 
Sox10iCreERT2xCAG-eGFPxEsco2fl/fl mouse line to specifically trigger apoptosis in dividing 
NG2-glia during M-phase. Using this mouse line, it could be shown in this work that deletion 
of the Esco2 protein in NG2-glia in the adult brain induced progressive cell death in the dividing 
recombined cells. This process is compensated by enhanced proliferation of the non-
recombined subpopulation, so that no change in the overall NG2-glia numbers could be 
observed. Specifically in the white matter of the cerebral cortex, the continuous loss of NG2-
glia resulted in a decreased number of newly generated oligodendrocytes that was followed 
by structural as well as functional changes in the nodes of Ranvier. As a consequence, a 
deceleration in the nerve conduction velocity of myelinated WM fibers could be measured. 
These animals – in contrast to control littermates – developed progressive motor deficits both 
in general as well as in the fine-coordinated movements.  
As NG2-glia after acute brain injury strongly react to this insult by increasing their proliferation 
rate more than 15-fold, the function of these proliferating NG2-glia was also analyzed by 
ablating them after an acute stab wound lesion using the above mentioned genetic model. The 
fast ablation of proliferating recombined NG2-glia resulted in a transient but significant 
diminishment of the overall NG2-glia population in close proximity to the lesion site. As a 
consequence of this cell number reduction, the wound closure capacity was significantly 
delayed. Furthermore, the transient reduction of these cells resulted in a severely disturbed 
reaction of both the microglial and astrocyte population.  
Taken together, the findings obtained in this work strongly suggest that proliferating NG2-glia 
and newly generated oligodendrocytes in the adult brain are: (I) crucial for the maintenance of 
myelin-associated structures and the underlying physiological function in the healthy mouse, 
as well as (II) for proper tissue repair and the injury-related glial reaction in the pathological 
brain. 
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II ZUSAMMENFASSUNG 
NG2-glia – auch bekannt als Oligodendrozyten-Vorläuferzellen – bilden mit etwa 5% eine 
Hauptfraktion der Zellen im erwachsenen Gehirn von Nagetieren und sind dort die einzigen 
sich teilenden Zellen außerhalb der neurogenen Nischen. Zudem sind sie während des ganzen 
Lebens fähig, reife und myelinisierende Oligodendrozyten zu bilden. Trotz ihres hohen 
Vorkommens sowie ihrer umfangreichen Charakterisierung ist ihre eigentliche Funktion sowohl 
im intakten als auch im verletzten erwachsenen Gehirn größtenteils unbekannt. Um dieses Feld 
näher zu untersuchen, wurde in der vorliegenden Arbeit die genetische Entfernung des Esco2-
Proteins in der induzierbaren Sox10iCreERT2xCAG-eGFPxEsco2fl/fl-Mauslinie verwendet, um 
spezifisch den apoptotischen Zelltod während der M-Phase in proliferierenden NG2-glia 
auszulösen. Mit dieser Mauslinie konnte gezeigt werden, dass der Verlust des Esco2-Proteins 
in NG2-Glia im erwachsenen Gehirn einen fortschreitenden Zelltod in sich teilenden, 
rekombinierten Zellen auslöst, der von nicht rekombinierten Zellen durch eine erhöhte 
Teilungsrate kompensiert wird. Besonders in der weißen Substanz führte der kontinuierliche 
Verlust von NG2-glia zu einer reduzierten Anzahl an neu gebildeten Oligodendrozyten. Dieser 
Beobachtung folgten weiterhin sowohl strukturelle als auch funktionale Veränderungen in den 
Ranvierschen Schnürringen. Diese Veränderungen führten wiederum zu einer Verlangsamung 
in der Geschwindigkeit der Nervenleitung. Im Gegensatz zu den Kontrolltieren entwickelten 
diese Mäuse zunehmende motorische Störungen - sowohl in den generellen als auch im 
feinmotorischen Bewegungsablauf. 
NG2-glia erhöhen ihre Proliferationsrate nach einer Verletzung mehr als 15-fach und reagiren 
auch anderweitig sehr stark auf pathologische Einflüsse. Daher wurde in dieser Arbeit mit dem 
gleichen Mechanismus zusätzlich die Funktion von proliferierenden NG2-Glia nach akuter 
Gehirnverletzung untersucht. Der schnelle Zelltod der rekombinierten NG2-Glia führte in 
diesem Fall zu einer erheblichen, vorübergehenden Reduktion der NG2-Glia-Population in 
unmittelbarer Umgebung der Verletzung. Als Konsequenz dieses Zellverlustes resultierte eine 
Verspätung im Wundverschluss. Zusätzlich führte der vorübergehende Zellverlust ebenso zu 
einer stark veränderten Reaktion der Mikroglia- als auch der Astroglia-Populationen. 
Zusammenfassend suggerieren diese Ergebnisse, dass sich im physiologischen Maße teilende 
NG2-Glia sowie eine korrekte Anzahl neu gebildeter Oligodendroglia einen beträchtlichen 
Einfluss auf die Erhaltung der Ranvierschen Schnürringe, auf deren grundliegende 
physiologische Funktionen im gesunden Gehirn sowie auf eine angemessene Reparatur und 
die damit verbundene allgemeine Gliazellen-Reaktion im verletzten Gehirn haben. 
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1 INTRODUCTION 
1.1 GLIAL CELLS IN THE ADULT MAMMALIAN BRAIN 
Beside neurons, glial cells constitute a major fraction of the total brain mass ranging from 33% 
up to 66% within different mammalian species. The mouse brain only consists of 35% glial 
cells and is therefore located near the lower border, whereas the human brain with 50% glial 
cells is situated towards the upper border of this range (Herculano-Houzel 2014; Azevedo et 
al. 2009). Glial cells have already been identified in the 19th century by many famous 
neuroscientists. At that time they were suggested to function as the so-called ‘Nervenkitt’ 
(German for nerve glue); meaning that their inherent function was meant to provide a 
foundation for the neurons in the brain. However, with the progression of time, scientists 
started to ask questions about possible and additional functions of these cells. Although these 
questions have already been asked decades ago, many of them remain unanswered until today 
(Somjen 1988). At least, it became increasingly clear that glial cells are more than just brain 
glue; nowadays, they attract a lot of scientific interest. 
Traditionally glial cells in the adult mammalian central nervous system (CNS) can be subdivided 
into three major groups according to their inherent functions as illustrated in Figure 1: 
microglia, astrocytes and oligodendrocytes, with the latter two forming together the macroglia 
(reviewed in Barres 2008; He and Sun 2007). 
 
Astrocytes
Microglia
Neurons
Oligodendrocytes
Blood vessels
Oligodendrocyte
progenitor cell (OPC)
NG2-glia
 
Figure 1: Cell types in the adult central nervous system (CNS). Microglia (blue) are the immune-surveilling 
cells in the CNS, although they developmentally derive from another origin. Astrocytes (green) extend their endfeet 
to blood vessels and to neuronal nodes of Ranvier located at myelinated axons. Oligodendrocytes (orange) form 
myelin sheaths that enwrap neuronal axons (brown) allowing saltatory nerve conduction and hence increase the 
conduction velocity and information processing. Oligodendrocyte progenitor cells (OPCs) – also named NG2-glia 
(red) – are a fourth glial cell population in the adult CNS with a possible yet unknown function (besides being the 
progenitors for mature oligodendrocytes) which only came into the focus in the last decades. 
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In a simplified view microglia – that are developmentally not glial cells but migrate into the 
brain from the mesoderm at neonatal stages – are the immunocompetent and phagocyting 
cells of the brain parenchyma (Kim and Vellis 2005; Santambrogio et al. 2001; Kettenmann et 
al. 2011) They are not only constantly sensing their environment with their highly motile 
filopodia during healthy conditions, but also react rapidly as a response to changes in the 
environment and to extrinsic insults (Nimmerjahn et al. 2005). Macroglial astrocytes constitute 
the major fraction of glial cells in the brain. They have many different pivotal functions, also 
depending on their location in the brain. The most prominent astrocytic functions are: the 
maintenance of the fluid and ion concentration homeostasis, their functional and modulatory 
role in the tripartite synapse (presynaptic membrane, postsynaptic membrane and glial cell), 
as well as their contribution to the formation of the blood-brain-barrier (BBB) (Halassa et al. 
2009; Kimelberg 2010; Kimelberg and Nedergaard 2010). The third glial cell population – the 
oligodendrocytes – produces myelin sheaths that enwrap neuronal axons and therefore both 
allow and increase the nerve impulse conduction (Baumann and Pham-Dinh 2001). In the late 
1980’s another cell type was identified that can be distinguished in the brain by the expression 
of the proteoglycan neuron-glia antigen 2 (NG2) (Ffrench-Constant and Raff 1986; Stallcup 
and Beasley 1987). This discovery was the starting point of a further macroglial cell population 
– the nowadays so called NG2-glia – the cell type this thesis is focused on and that is described 
in more detail below. 
 
1.2 ORIGIN AND PERSISTENCE OF THE OLIGODENDROCYTE LINEAGE 
Progenitors of the oligodendrocyte lineage (oligodendrocyte progenitor cells, OPCs), located 
in the developing spinal cord and brain stem, start to develop at embryonic day 12.5 (E12.5) 
in the ventral progenitor zone together with motor neurons from a common source of precursor 
motoneuron (pMN) progenitor cells that express the oligodendrocyte transcription factor 2 
(Olig2) (Lu et al. 2002; Takebayashi et al. 2002). A second source of these progenitor cells in 
the neural tube starts to emerge at E15.5 from more dorsal regions. However, the latter ones 
are generally outnumbered and suppressed by their ventrally-derived counterparts (Calver et 
al. 1998; Vallstedt et al. 2005; Cai et al. 2005; Richardson et al. 2006). 
Like in the spinal cord, OPCs in the forebrain pass through different stages and derive from 
multiple sources, starting from ventral to more dorsal regions, as depicted in Figure 2. The 
first wave of precursors that express and can therefore be identified by the transcription factor 
Nkx2.1 starts to emerge at E12.5 from the medial ganglionic eminence (MGE) and the anterior 
entopeduncular area (AEP). Subsequently these cells migrate into other parts of the developing 
brain.  
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Figure 2: Waves of oligodendrocyte progenitor cells (OPCs) in the developing brain. The first wave of 
OPCs that are expressing Nkx2.1+ (red) emerge at E12.5 from the medial ganglionic eminence (MGE). At E15.5 a 
second wave of Gsh2-expressing progenitors (blue) starts to populate the brain from the medial and the caudal 
ganglionic eminence (LGE/CGE). At P0 a third wave of Emx1-expressing OPCs (green) derive directly from the 
cortex. During postnatal stages, Nkx2.1-expressing OPCs disappear, whereas those from the second and third wave 
persist into adulthood (adapted from Kessaris et al. 2006). 
 
Most interestingly, Nkx2.1+ OPCs are eliminated during the further development and do not 
persist into adulthood (Kessaris et al. 2006). A second wave of precursors starts to develop at 
E15.5 from the lateral and caudal ganglionic eminence (LGE and CGE). Unlike cells of the first 
wave, they can be identified by the expression of Gsh2. These cells migrate from their place 
of origin into the whole brain and although many of these cells are also eliminated, some 
persist into adulthood. A third wave of Emx1+ precursor cells can be found right after birth at 
the first postnatal day zero (P0) deriving directly from the cortex (Kessaris et al. 2006; 
Richardson et al. 2006). Like the Gsh2+ precursor population, Emx1+ precursors migrate within 
the brain, both populations together form the oligodendrocyte progenitor pool in the brain at 
postnatal stages. So far, no clear evidence was found indicating any functional differences 
between the cells deriving from the different origins. The fact that the ventrally and dorsally-
derived progenitors have very similar electrophysiological properties suggests a high degree 
of redundancy (Tripathi et al. 2011). Genetic ablation studies of both populations showed that 
the cells are fully replaced by progenitors of the other origin, however, detailed functional 
analysis of the different populations, including the influence of the same environment in which 
they are located has not been performed (Kessaris et al. 2006; Ventura and Goldman 2006; 
Mitew et al. 2014). After populating the brain, the majority of the OPCs start to differentiate 
into mature and myelinating oligodendrocytes; both differentiation and myelination is peaking 
in the second postnatal week (Sturrock 1980; Greenwood 2003). Although oligodendrogenesis 
and myelination decline thereafter, OPCs are still persistent in the adult brain in high numbers 
(Pringle et al. 1992).  
MGE
LGE/CGE Nkx2.1
Gsh2
Emx1
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As OPCs differentiate into oligodendrocytes along the oligodendrocyte lineage, they do not 
only undergo morphological and functional changes (e.g. myelination), but also express 
different markers, as depicted in Figure 3. Some transcription factors (Olig2 and sex 
determining region Y-related high mobility group box protein, Sox10) are commonly expressed 
during all differentiation stages, hence using Olig2 and Sox10 as markers, cells of the 
oligodendrocyte lineage can be distinguished from other cell types in the brain (Kuhlbrodt et 
al. 1998; Takebayashi et al. 2002). OPCs additionally express characteristic surface markers 
like the platelet-derived growth factor receptor α (PDGFRα) and NG2, that is encoded by the 
chondroitin sulfate protein 4 gene (cspg4) (Nishiyama et al. 1997; Dawson 2003). When these 
cells differentiate further into mature and myelinating oligodendrocytes, they stop to express 
the precursor markers and become postmitotic. It is proposed that they subsequently 
differentiate via a stage of premyelinating oligodendrocytes. In this phase they are thought to 
acquire a more complex morphology with additional ramified processes. Boda et al. (2011) 
suggested this stage to be distinguishable by the expression of the G-protein coupled receptor 
17 (GPR17). A very recent study from our lab in which the GPR17+ cell population was 
genetically labelled, however disproved this marker to be specific for this stage (Viganò and 
Schneider et al. in press). 
 
NG2-
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NG2- NG2+
PDGFRa+
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Sox10+
NG2+
PDGFRa+
Olig2+
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MBP-
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Figure 3: Oligodendrocyte lineage during differentiation. As soon as lineage-specific stem cells differentiate, 
they start to express progenitor markers like NG2 and PDGFRα. These oligodendrocyte progenitor cells (OPCs) still 
have the capacity to proliferate (indicated with a loop arrow). Alongside the differentiation they lose their precursor 
markers and also their ability to proliferate. Mature oligodendrocytes express markers like adenomatous polyposis 
coli (APC or CC1), 2’, 3’-cyclic nucleotide 3’-phosphodiesterase (CNPase) or the Glutathione S-transferase π (GSTπ). 
Myelinating oligodendrocytes additionally express typically myelin-associated markers like the proteolipid protein 
(PLP), the myelin associated glycoprotein (MAG) and the myelin basic protein (MBP). The transcription factors 
OLIG2 and Sox10 are expressed throughout the lineage (modified after Nishiyama et al. 2009). 
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Along with their differentiation and maturation, oligodendrocytes start to express proteins like 
adenomatous polyposis coli (APC, better known as CC1), 2’, 3’-cyclic nucleotide 3’-
phosphodiesterase (CNPase) or the Glutathione S-transferase π (GSTπ). In the final step of 
differentiation when the oligodendrocytes start to myelinate axons, they express markers that 
are typically located in the myelin sheaths: the myelin basic protein (MBP) and its isoforms, 
proteolipid protein (PLP) as well as the myelin associated glycoprotein (MAG) (Pfeiffer et al. 
1993; Baumann and Pham-Dinh 2001; Nishiyama et al. 2009; Fulton et al. 2010). As the 
differentiation of OPCs to fully mature oligodendrocytes is a continuous process, there might 
be intermediate stages where specific markers could overlap.  
 
1.3 NG2-GLIA – THE FOURTH GLIAL CELL POPULATION 
OPCs are progenitors that produce mature and myelinating oligodendrocytes during 
development, but although most of oligodendrocyte and myelin production occurs during the 
first postnatal weeks (Sturrock 1980; Greenwood 2003), these cells are persistent in the adult 
brain where they make up 5-8% of the rodent’s adult CNS (Pringle et al. 1992; Dawson 2003). 
Due to their specific cellular characteristics, OPCs have been drawing a lot of attention by 
neuroscientists. The fact that they are not only progenitors of the oligodendrocyte lineage, but 
also comprise additional physiological functions cannot be argued any more. OPCs can already 
be found in lower vertebrates which do not have myelinated axons (Banerjee et al. 2006; 
Banerjee and Bhat 2008), supporting the idea of the functional importance of these cells as a 
separate cell type. The idea that they comprise a fourth glial cell population in the CNS is more 
and more established within the research community. Due to the novelty of this specific field, 
not only their function is extensively discussed, but also a number of different denominations 
is associated with them. In the beginning, this cell type was named O-2A progenitors, due to 
the fact that it was identified to be in vitro the precursor of oligodendrocytes and type 2 
astrocytes (Raff et al. 1983). However, after type 2 astrocytes could not be detected in vivo, 
as they turned out to be a cell culture artefact, this term was replaced by the current 
expression: OPCs. Polydendrocytes is another common term for OPCs, used to emphasize the 
fact that they are different from other glial cell types, including oligodendrocytes, and to refer 
to their specific morphology (Nishiyama et al. 2002). NG2-expressing cells that form synapses 
together with neurons and contact the nodes of Ranvier have been referred to as synantocytes 
(Butt et al. 2002). Other names like NG2+ cells, or simply NG2 cells are also commonly used, 
as they are characterized by the expression of the proteoglycan NG2. In order to separate 
them from their embryonic counterparts which majorly create mature and myelinating 
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oligodendrocytes and to stress the fact that they represent a distinct glial cell population, the 
term NG2-glia is used throughout this thesis. 
The proliferative character and abundance of NG2-glia in both the developmental and the adult 
CNS created the idea that they are not only lineage-committed progenitors, but also 
multipotent stem cells that can be exploited for tissue repair after injury. After scientists 
showed that postnatal, optic nerve-originated NG2-glia are multipotent and able to give rise 
to neurons, astrocytes and oligodendrocytes in vitro (Kondo and Raff 2000), scientific interest 
noticeably increased. In order to clarify the multipotency of NG2-glia in vivo, a high number 
of fate mapping analyses with recombinant mouse lines have been used allowing specific 
labelling of NG2-glia to determine their cellular fate.  
 
 
Figure 4: Lineage specificity of NG2-glia in health and disease. In the healthy brain (upper part) NG2-glia 
give mainly rise to NG2-glia, oligodendrocytes and some astrocytes during development. However, upon some 
specific pathological conditions (like e.g. non-inflammatory and inflammatory demyelination, neurodegeneration or 
traumatic injury), NG2-glia were shown to generate astrocytes as well as myelinating Schwann cells. Lineage 
plasticity into neurons is however still controversially discussed (adapted from Dimou and Gallo 2015). 
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Although some of the studies demonstrated controversial results, it is now generally accepted 
that during health NG2-glia give rise to oligodendrocyte lineage cells as well as to a low number 
of astrocytes during development (Guo et al. 2009; Zhu et al. 2011; Huang et al. 2014b), while 
they remain committed to their own lineage in the adult brain (Dimou et al. 2008; Rivers et 
al. 2008; Kang et al. 2010; Simon et al. 2012). In contrast, during disease the lineage-
commitment in the adult brain changes: upon different pathological insults (e.g. non-
inflammatory and inflammatory demyelination, neurodegeneration and traumatic injury), NG2-
glia can be reactivated to give rise to astrocytes or Schwann cells (Figure 4, Alonso 2005; 
Cassiani-Ingoni et al. 2006; Magnus et al. 2007; Zhao et al. 2009; Tripathi et al. 2010; 
Komitova et al. 2011). The fate switch of NG2-glia into neurons that was observed in vitro 
could on the contrary not be verified in vivo yet, indicating that these cells do not carry a full 
multipotent potential in comparison with neural stem cells (Richardson et al. 2011; Dimou and 
Götz 2014; Dimou and Gallo 2015). 
1.3.1 NG2-GLIA FORM A TIGHT HOMEOSTATIC NETWORK 
It has been shown that NG2-glia are evenly distributed throughout the whole brain (Nishiyama 
et al. 1999). They feature a stellate morphology with a very elaborate tree of processes evenly 
distributed around their central cell body. Utilizing a three dimensional (3D) reconstruction 
method, a total surface area of around 2000µm² was calculated for one single cell (Kukley et 
al. 2007). A recent study showed that NG2-glia processes are very motile and that even their 
whole cell body moves in the adult cortex in a non-directed manner, wherefore the net 
movement is hardly detectable (Hughes et al. 2013). Within this movement, they sense their 
environment using filopodia, with each cell keeping its own territory through self-repulsion of 
its filopodia from adjacent cells. As soon as one cell is lost, either through cell death or 
differentiation, neighboring cells are able to detect the emerged gap in the homeostatic 
network and fill it up (Hughes et al. 2013). Besides this intercellular network, NG2-glia (and 
the other cells of the oligodendrocyte lineage) form multiple heterologous networks and 
connections with astrocytes as well as with neurons that are mediated by connexins (Parenti 
et al. 2010; May et al. 2013). Additionally, they were shown to extend some of their processes 
into the nodes of Ranvier, suggesting interaction with neuronal axons (Butt et al. 1999; Wigley 
et al. 2007; Wigley and Butt 2009). 
1.3.2 NG2-GLIA ARE PROLIFERATIVE, SELF-RENEWING AND KEEP PRODUCING MATURE OLIGODENDROCYTES 
THROUGHOUT LIFETIME 
The most significant cellular property of NG2-glia is that they are the only cells being able to 
proliferate under physiological conditions in the adult brain parenchyma outside the neurogenic 
niches. Simon et al. (2011) showed that some of the NG2-glia can enter the cell cycle at least 
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twice, meaning that they are not only proliferative, but also self-renewing. A recent study using 
the Star Trek clonal analysis method demonstrated that even in the adult brain, one single 
NG2-glia can generate up to 400 progenies (García-Marqués et al. 2014). Although there is an 
age-dependent decline, proliferation of NG2-glia never stops throughout lifetime (Gensert and 
Greenwood 1997; Dimou et al. 2008; Psachoulia et al. 2009; Simon et al. 2011; Young et al. 
2013). Experiments using 5’-bromo-desoxyuridine (BrdU) and 5’-ethynyl-2’-deoxyuridine (EdU) 
labelling to follow cells that have proliferated, showed that almost all NG2-glia (80-98%, 
depending on the type of analysis) in the cortical gray matter (GM) and white matter (WM) do 
proliferate. Due to a comparatively long G1 resting phase, the average cell cycle length of NG2-
glia in the cortical GM accounts to 37 days in three months old mice (Simon et al. 2011). 
Region-dependent analysis showed that WM-derived NG2-glia cycle much faster. Notably, the 
cell cycle length of different WM tracts can also vary significantly from approximately ten days 
in the corpus callosum up to 20 days in the optic nerve. The cell cycle length also increases 
during aging (Kang et al. 2010; Young et al. 2013).  
NG2-glia do not only differentiate during development, but they also keep producing mature 
and myelinating oligodendrocytes throughout lifetime (Dimou et al. 2008; Simon et al. 2011; 
Young et al. 2013). BrdU label retaining experiments demonstrated that around 50% of BrdU 
incorporating NG2-glia have differentiated into mature oligodendrocytes during a time window 
of three months in young adult mice (Simon et al. 2011). Another study showed that 30% of 
all mature oligodendrocytes in the adult corpus callosum emerge after the age of eight weeks 
in rodents (Rivers et al. 2008). Comparable to proliferation, differentiation of NG2-glia is 
region-dependent: the proportion of differentiated cells is much higher in WM tracts compared 
with GM in the adult brain. In line with proliferation properties, differentiation has been shown 
to decline with age (Dimou et al. 2008; Young et al. 2013). However, the functional role of 
this adult oligodendrogenesis that will be discussed elsewhere in this discussion (chapter 1.4.3) 
remains highly debated. 
1.3.3 NEURON-NG2-GLIA SYNAPSES AND ACTIVITY-DEPENDENT REACTION OF NG2-GLIA  
As already mentioned above, NG2-glia in the adult brain highly interconnect with neurons 
(Wigley et al. 2007). Bergles and colleagues first demonstrated that hippocampal NG2-glia are 
not only connected, but also actively receive synaptic input from neurons. These synapses can 
be both glutamatergic, mediated by α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) or N-methyl-D-aspartic acid (NMDA) receptors, as well as ‘GABAergic’ via gamma-
aminobutyric acid (GABAA) receptors (Bergles et al. 2000; Lin and Bergles 2002, 2004). 
Although GABAA signaling is usually considered as inhibitory, this does not seem to be the case 
with NG2-glia where the glutamatergic and the GABAergic signals evoke an identical reaction 
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(Passlick et al. 2013). Subsequent studies identified a high number of additional 
neurotransmitter receptors in vitro: nicotinic and muscarinic acetylcholine, dopamine, 
cannabinoid, glycine and purinergic receptors, however their functionality in vivo has not been 
verified so far (Sun and Dietrich 2013). It became clear that neuron-NG2-glia synapses are not 
exclusively found on NG2-glia in the hippocampus, but throughout the CNS in both GM and 
WM tracts (Káradóttir et al. 2005; Mangin and Gallo 2011; in Sun and Dietrich 2013; Dimou 
and Gallo 2015). Most of these synapses are at least physically maintained during proliferation 
and are only being retracted during differentiation (Kukley et al. 2008; Ge et al. 2009; Kukley 
et al. 2010; Fröhlich et al. 2011). A very recent study from Sahel et al. (2015) however 
suggested for the first time that NG2-glia do not receive synaptic input during the process of 
proliferation, but that the connection has to be re-established afterwards. 
The neuron-NG2-glia synapses work via a classical vesicular release that is indistinguishable 
from the mechanism in neurons (Paukert and Bergles 2006; Maldonado et al. 2011). Although 
at least some NG2-glia express voltage-gated ion channels – both potassium (K+) and sodium 
(Na2+) channels – it is not clear whether NG2-glia are able to integrate and remit the electrical 
signal they receive from neurons (Steinhauser et al. 1994; De Biase et al. 2010; Kukley et al. 
2010; Sun and Dietrich 2013). Káradóttir et al. (2008) suggested that upon synaptic vesicular 
release some NG2-glia in the rat WM are able to fire axon potentials independently by opening 
voltage-gated Na2+ channels, however, this functionality could not be verified in mice (De Biase 
et al. 2010; Clarke et al. 2012).  
The synaptic transmission results in a local intracellular increase in calcium (Ca2+) in the 
processes of NG2-glia that could be important as a second messenger inducing functional 
changes (Bergles et al. 2000; Ge et al. 2006; Tanaka et al. 2009; Haberlandt et al. 2011; Sun 
and Dietrich 2013). Whether the observed Ca2+ elevation is caused by entry through ionotropic 
receptors or by release of intracellular Ca2+ storage is still being discussed (Sun and Dietrich 
2013). Another trigger to increase NG2-glial intracellular Ca2+ is the neuronal and astrocytic 
release of adenosine triphosphate (ATP) into the synaptic space that furthermore acts via 
metabotropic P2Y1 and ionotropic P2X7 receptors on NG2-glia (Hamilton et al. 2010; Butt et 
al. 2014). 
NG2-glia show a strong neural activity-dependent behavior with regard to proliferation, 
migration, differentiation and myelination both under physiological conditions as well as after 
injury that might be mediated via these described synapses between NG2-glia and neurons 
(Simon et al. 2011; Wake et al. 2011; Boscia et al. 2012; Mangin et al. 2012; Hill and Nishiyama 
2014; Gibson et al. 2014). On the other hand, it is becoming increasingly evident that neuronal 
activity is not only influencing NG2-glia, but that NG2-glia are also a potent modulator of the 
neuronal network themselves. Sakry et al. (2014) demonstrated that the proteoglycan NG2 
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expressed on NG2-glia can be shed from the cell and has then an effect on the NMDA-
dependent long-term potentiation (LTP) in pyramidal neurons as well as on their AMPA 
receptor composition. The same group recently reported that NG2-glia express the neuro-
modulatory proteins prostaglandin D2 synthase (PTGDS) and neuronal pentraxin 2 
(Nptx2/Narp). These findings suggest that NG2-glia have a higher influence on the neuronal 
network than previously expected (Sakry et al. 2015). 
1.3.4 REGIONAL AND CELL-INTRINSIC HETEROGENEITY OF NG2-GLIA 
Since NG2-glia in the adult CNS are homogeneously distributed and so far no further markers 
for specific subpopulations could be detected, they have been considered to be a 
homogeneous population. Nevertheless, they show a high variability with regard to their cell 
cycle length and differentiation properties throughout different brain regions, giving a body of 
evidence that a certain heterogeneity exists. A recent gene expression profile study where 
NG2-glia were isolated from adult humans suggests the existence of three different 
subpopulations of NG2-glia (Leong et al. 2014). However, the authors neither distinguished 
between GM or WM tracts, nor between cells that are in a different cell cycle status or in 
various differentiation stages. To further address the question of possible variability between 
cells of different origin, Viganò et al. (2013) transplanted NG2-glia from the cortical GM into 
the WM and vice versa. The authors demonstrated that the WM is in general a more supportive 
environment for differentiation, with cell-intrinsic factors being evenly important for regulating 
the cell fate of NG2-glia.  
Electrophysiological analysis revealed WM-derived NG2-glia to exhibit a different resting 
membrane potential than GM-derived cells. This is achieved through differential expression of 
voltage gated potassium (Kv1) and inward rectifying Kir channels as well as through a different 
ability to elicit immature action potentials (Chittajallu et al. 2004). However, no differences in 
cell-intrinsic signaling pathways between WM-derived and GM-derived NG2-glia were detected 
so far (Hill and Nishiyama 2014). In a study using organotypic slice culture explants from 
postnatal mice, the authors demonstrated that WM-derived NG2-glia show a significantly 
stronger response to PDGF-AA compared with their GM-derived counterparts (Hill et al. 2013), 
although PDGFRα expression and the intracellular transduction pathway of these two 
populations is not detectably different (Pringle et al. 1992; Nishiyama et al. 1996; Hill et al. 
2013). This finding suggests PDGF to be an extrinsic factor differentially regulating the 
proliferation of NG2-glia. Within these differing microenvironments, the extracellular matrix as 
well as paracrine signaling molecules from other cells could play an important role as well (Hill 
et al. 2013; Hill and Nishiyama 2014). Figure 5 is summarizing the heterogeneity of GM- and 
WM-derived NG2-glia, as far as it is known to date. 
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Figure 5: Heterogeneity of NG2-glia between gray and white matter. Top: White matter-derived NG2-glia 
(right) are reported to be less electrically polarized compared with those originating from gray matter (left), due to 
their different expression of Kir channels. Middle: Despite the expression of comparable amounts of PDGFRα on the 
cell surfaces and the availability of PDGF in the environment, WM-derived NG2-glia are increasingly activated due 
to different receptor activation mechanisms. Bottom: The intracellular and regional heterogeneity result in a 
variability in proliferation and differentiation rates between WM and GM-derived NG2-glia (modified after Hill and 
Nishiyama 2014). 
 
Besides the regional heterogeneity, in the last years many studies aimed to assess the topic 
of intracellular heterogeneity within the same cortical region as well as the cellular factors 
driving NG2-glia to proliferate or to differentiate. At least in the telencephalon, a subpopulation 
of NG2-glia was found to uniquely express the transcription factor mammalian achaete scute 
homolog 1 (Mash1), indicating some intra-regional heterogeneity. However, the factor’s 
functional role within this subpopulation has not been ascertained yet (Parras et al. 2007).  
One proposed possibility that could be the driving force for an intraregional heterogeneity 
could be a different cellular origin. Indeed, it was demonstrated that in the adult corpus 
callosum there is a continuous addition of new NG2-glia deriving from progenitors in the 
subventricular zone (Menn et al. 2006; Ortega et al. 2013). Hence, as the NG2-glia population 
in the corpus callosum could derive from different origins, the cells could have variable cellular 
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characteristics and functions. Although this hypothesis attracted a great scientific interest, 
neither a specific marker for these two distinct populations from different origins could be 
found, nor could it completely be verified until now. One protein and possible candidate that 
is only expressed by a subset of NG2-glia in all regions throughout the brain is the G-protein-
coupled receptor 17 (GPR17) (Boda et al. 2011). Recent studies from our lab assessed the 
GPR17-expression heterogeneity using the novel GPR17iCreERT2 mouse line: especially in the 
GM, a specific subpopulation expressing GPR17 seems to serve as a reserve pool of NG2-glia 
that under physiological conditions differentiate slower compared to those not expressing the 
receptor. After lesion, this subpopulation reacts with an increase in differentiation, indicating 
that it represents a reservoir for brain repair. Cellular mechanistic pathways driving this 
heterogeneity have not been identified so far (Viganò and Schneider et al. in press).  
As the interest in heterogeneous subpopulations of NG2-glia is just evolving, there is a high 
demand for finding new markers that could possibly identify them. RNA-sequencing techniques 
for transcriptome analysis of single cells have recently been established and conducted in order 
to analyze the transcriptome of variably maturated cells within the oligodendrocyte lineage 
(Zhang et al. 2014). Using this technique for multiple regions or sub-regions could be a 
promising approach for disclosing the root of intracellular NG2-glia heterogeneity in the CNS. 
1.3.5 ABLATION ATTEMPTS OF NG2-GLIA 
Although only little is known about their elusive physiological functions, NG2-glia attracted the 
attention of many scientists in the last decades, leading to the identification and thorough 
description of many of their cellular characteristics. In order to address this point, many studies 
tried to analyze the CNS in the absence of NG2-glia by ablating them with irradiation, chemical 
agents like arabinofuranosyl cytidine (AraC) or diphtheria toxin (DT) and immunotoxins (Chari 
and Blakemore 2002; Chari et al. 2003; Irvine and Blakemore 2007; Robins et al. 2013; Leoni 
et al. 2014; Birey and Aguirre 2015). Most of these studies targeted the proliferative capacity 
of NG2-glia for the ablation approach, as they are vulnerable to agents that interfere with DNA 
synthesis (e.g. AraC) or to irradiation. Independent from the used method, NG2-glia could be 
ablated in the region of interest only for a short time period within those studies. Remaining 
NG2-glia from the same or neighboring regions quickly repopulated the ablated areas by 
increasing their rate of proliferation. The repopulation capacity is maintained throughout 
lifetime, although the proliferation rate and the therof resulting speed of repopulation is 
declining with age (Chari et al. 2003). As these approaches unspecifically depleted all 
proliferating cells including microglia and astrocytes, a serious conclusion cannot be drawn for 
the function of one specific cell type. Although no significant conclusions about the 
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physiological functions of NG2-glia in the adult could be drawn with these studies, the 
maintenance of the homeostatic network seems to play a key role in this context.  
 
1.4 MYELIN 
1.4.1 FUNCTION AND COMPOSITION OF MYELIN 
Myelin - originally referred to as the ‘fatty marrow’ - is an electrical insulator allowing faster 
velocity through saltatory conduction in axons that is required for higher organisms to achieve 
a better temporal resolution. It took several decades to understand that myelin is indeed a 
motile membrane produced by living cells (Virchow 1854; Geren and Raskind 1953; Rosenbluth 
1999). With the invention of electron microscopy (EM), it could be disclosed that myelin is 
formed by compacted plasma membrane extensions that are wrapped multiple times around 
the axons. Although it was thought to be a very simple structure, a recent proteomic analysis 
demonstrated that myelin is – besides its basic fatty component cholesterol – composed of 
342 different proteins. The major myelin associated proteins like proteolipid protein (PLP) and 
myelin basic protein (MBP) amount to only 17% and 8%, respectively (Jahn et al. 2009). In 
the same study, the authors showed that many of these proteins are important for the 
cytoskeleton, vesicular trafficking, cell adhesion and catalytic activities. The multilamellar 
wrappings around the axons that form the compact myelin and represent the internodes are 
interrupted by the myelin free nodes of Ranvier alongside the axons. In these structures, a lot 
of ion channels accumulate directly on the axon to generate action potentials, being the basis 
for saltatory nerve conduction (Nave 2010). Moreover, the node of Ranvier is a complex 
functional unit. It is subdivided into the node, the paranode being the axon-glia contact zone 
and separating the periaxonal space from the outside, as well as the juxtaparanode where 
many potassium channels are located (Salzer et al. 2008). As the myelin sheaths are strongly 
insulating the axons from their environment, it became clear that myelin is not only needed 
for faster nerve conduction, but also for long-term integrity of the tissue. Furthermore it is 
important for the survival of axons: myelin abnormalities are leading to thinner axon diameters, 
general axonal malformations like axonal swellings, as well as to long-term axonal 
degeneration (Griffiths et al. 1998; Edgar et al. 2009; Brady et al. 1999). The signals that are 
important for the interaction between the axon and the established myelin sheath are not well 
defined yet. Myelin associated glycoprotein (MAG) seems to play an important role, as mice 
that completely lack the MAG, do not show any perturbation in myelin but in axon diameters 
(Yin et al. 1998) as well as in exosome-mediated transport from oligodendrocytes to axons 
(Frühbeis et al. 2013). In proteolipid protein (Plp1)-null mice completely lacking the PLP 
protein, myelin formation and the physical development of the body occurs normally. During 
adulthood, however, these mice undergo neurodegeneration, indicating that this axon-glia 
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interdependence is not only based on myelin ensheathment but also that glia may give other 
support to axons (Griffiths et al. 1998). Indeed, some studies suggested that oligodendrocytes 
that are capable of anaerobic glycolysis, provide lactate to axons mediated via the 
monocarboxylate transporter 1 (MCT1) in case that other energy sources are limited 
(Fünfschilling et al. 2012; Lee et al. 2012b). These new insights in the oligodendrocyte-neuron 
interactions yield a deeper understanding of myelin diseases like multiple sclerosis (MS) or 
leukodystrophies that lead to long-term Wallerian degeneration (Nave 2010; Bercury and 
Macklin 2015). 
1.4.2 THE PROCESS AND KINETICS OF MYELIN FORMATION 
In different brain regions, a vast number of axons remains unmyelinated even in the adult 
(Sturrock 1980). Hence, there has been a long discussion about how oligodendrocytes are 
deciding on which axon to myelinate and which to leave unmyelinated. It was recently shown 
that both a neuronal activity-dependent as well as a neuronal activity-independent mode of 
myelination exists. The activity-dependent mode could be induced by neuronal action 
potentials and the thereby implemented synaptic vesicular release of glutamate or GABA 
(Lundgaard et al. 2013; Mensch et al. 2015). The activity-independent mode on the other 
hand is based on the axon calibers, confirmed by another study showing that oligodendrocytes 
in culture are able to myelinate nanofibers but just with a certain caliber (Lee et al. 2012a). 
The number of myelin sheaths on a single axon, expressed in the g-ratio (ratio of the inner 
axonal diameter to the total outer diameter), was shown to be individually regulated by the 
axon caliber itself. The same oligodendrocyte is able to myelinate both large as well as small 
diameters properly (Almeida et al. 2011). However, the sheath length on a myelinated axon 
was shown to be regulated by the oligodendrocyte itself (Bechler et al. 2015). 
The molecular axonal signaling pathways involved in the process of myelin encasement are 
not fully understood. Axonal neuregulin-1/ErbB signaling was shown to regulate myelination 
in the PNS (Nave and Salzer 2006), these factors could however not be verified to play the 
same role in CNS myelination, wherefore it was suggested that oligodendrocytes developed 
an alternative mechanism for axonal interactions compared with Schwann cells (Brinkmann et 
al. 2008). 
Besides the search for factors regulating myelination, there was a long debate about how the 
myelin sheath is wrapped around the axon during the myelination process. Over the years 
several mechanisms for this process  have been suggested. The most accepted ones that have 
long been accepted in the field are: (I) the so called ‘rolled up carpet’ model where the initial 
wrap is elongating and moving underneath itself to form multiple layers that was adapted from 
the model for PNS myelination (Geren and Schmitt 1954), and (II) an initial wrap that is moving 
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around the axons in spirals. After a sufficient amount of wraps have been formed, the myelin 
is flattening and moving laterally to finally form the sheaths (Robertis et al. 1958; Bauer et al. 
2009; Bercury and Macklin 2015). As imaging techniques have become better over time, these 
models were refined, suggesting the ‘liquid croissant’ model of myelination where myelin is 
‘poured out’ in a triangular shape and concurrently moving sidewards (Sobottka et al. 2011). 
In this model, new myelin wraps are proposed to be added on top of the former ones. By 
using a combination of different high resolution imaging techniques, it was demonstrated that 
the originally proposed ‘rolled up carpet’ model is indeed the appropriate one. Myelin is 
extending as an inner tongue underneath existing sheaths and moving laterally along the 
axons, where the paranodal loops are then formed (Snaidero et al. 2014; Snaidero and Simons 
2014). A recent study from Kerman et al. (2015) exploiting the oligodendrocytes’ capacity to 
myelinate in vitro now additionally unraveled the early mechanisms of the myelin initiation. 
The authors demonstrated that the oligodendrocyte process surveys the axons before it 
anchors and that after the anchoring the unanchored part of the oligodendrocyte process starts 
to wrap the axon. Together with the late stage mechanisms from older studies they suggested 
the ‘SARAPE’ mechanism: survey, anchor, wrap and expand. 
Regarding the kinetics of myelination, live-imaging in a transgenic zebrafish model showed 
that it is a very fast and dynamic process. Individual oligodendrocytes produce stable myelin 
sheaths within a time window of only five hours (Czopka et al. 2013). Whether this time 
window also applies to rodents and other mammalian species still needs to be investigated.  
1.4.3 OLIGODENDROCYTE AND MYELIN PLASTICITY DURING ADULTHOOD 
The dynamics of adult oligodendrogenesis in a few brain regions are well characterized, 
however we are just at the beginning of understanding the functional role of these adult-born 
oligodendrocytes. Recent studies demonstrated that under physiological conditions myelin is 
continuously generated and remodeled in the adult CNS, even without any injury, explaining 
the high amount of newly generated oligodendrocytes (Young et al. 2013; Yeung et al. 2014). 
It is not clear whether the newly generated oligodendrocytes and the resulting myelin are 
required to replace already existing oligodendrocytes and myelin sheaths, or if it is added into 
already existing structures. Several arguments support the case of de-novo myelination: (I) 
already years ago different studies demonstrated that both the number of oligodendrocytes 
and myelinated fibers in the adult rodent brain are accumulating over time and do not seem 
to be replaced by others (McCarthy and Leblond 1988; Yates and Juraska 2007). (II) As about 
two thirds of the callosal axons remain unmyelinated in the adult mouse, de-novo myelination 
of previously unmyelinated fibers is possible (Sturrock 1980). (III) Tomassy et al. (2014) 
reported also in the GM about an uneven distribution of myelin thickness along the axonal 
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length and that axons can be only partially myelinated, allowing additional space for de-novo 
myelination. Additionally, for other brain areas – and hence supporting the myelin remodeling 
thesis – newly generated myelin can also be found in highly myelinated WM tracts, e.g. in the 
optic nerve where ~98% of the axons are myelinated (Honjin et al. 1977; Young et al. 2013). 
The authors showed that in this area pre-exiting myelin is remodeled by inserting new myelin 
sheaths into the node of Ranvier (Young et al. 2013). The fact that during aging internodes 
are increasing in numbers while their length is decreasing, supports this later finding (Lasiene 
et al. 2009). Summarizing these data, de-novo myelination and myelin remodeling are most 
likely happening concurrently in the CNS. The question about the underlying physiological 
function of this remodeling, however, remains at least partially unanswered.  
With the myelination of previously unmyelinated fiber tracts or partially myelinated axons, new 
neuronal circuits, e.g. after learning a new skill, could be established and strengthened in the 
brain. This hypothesis was not only based on rodents, but also human functional magnetic 
resonance imaging (fMRI) studies indeed demonstrated long-term myelin remodeling in WM 
tracts of the brain after motor training, juggling, playing the piano and learning a second 
language (Bengtsson et al. 2005; Scholz et al. 2009; Schlegel et al. 2012; Sampaio-Baptista 
et al. 2013). The structural changes are reported to be visible within hours after training by 
measuring the fractional anisotropy (FA) of water in WM tracts, suggesting a very high 
remodeling rate of myelin (Pierpaoli and Basser 1996; Yamasaki et al. 2005; Hayashida et al. 
2006). However, to which extent these observations in the FA represent myelin remodeling or 
other changes, has still to be clarified (Pierpaoli and Basser 1996; Yamasaki et al. 2005; 
Hayashida et al. 2006; Zatorre et al. 2012). Along the same line, Gibson et al. (2014) reported 
that artificial stimulation of neurons by optogenetics results in higher myelin production of 
adjacent oligodendrocytes and improved motor performance in mice. Using a transgenic 
mouse line that blocks the generation of new oligodendrocytes and therefore myelin, another 
study suggested that myelin remodeling is not only beneficial, but even required for learning 
new complex motor skills (McKenzie et al. 2014; Bercury and Macklin 2015, Figure 6). 
Besides the involvement of myelin remodeling in motor skills, white matter and myelin volumes 
including intracortical myelin are thought to also be correlated to cognitive functions, as the 
volume of white matter tracts drastically decreases during aging and other cognitive 
impairments (Lebel et al. 2012; Sala et al. 2012; Haroutunian et al. 2014). As this decline is 
going hand in hand with a reduced oligodendrogenesis and myelin production, myelin 
remodeling could be a physiological mechanism for maintaining cognitive functions. Thus, 
keeping up NG2-glia proliferation and differentiation into old age could be a useful tool for 
medical applications in the treatment of cognitive impairment (Richardson et al. 2011; Bercury 
and Macklin 2015). 
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Figure 6: Neuronal activity and motor learning influences myelin plasticity. Optogenetic-induced 
activation in neurons increases adult oligodendrogenesis that results in enhanced motor performance on the catwalk 
in mice that is itself correlated with myelin plasticity (left side). Motor learning on a complex wheel was shown to 
require oligodendrogenesis and myelin plasticity (adapted from Bercury and Macklin 2015). 
 
1.5 TRAUMATIC BRAIN INJURY 
According to the Brain Association of America, traumatic, also classified as acquired brain injury 
is defined as: ‘Alteration of the brain function, or other evidence of brain pathology, caused 
by an external force, which is not hereditary, congenital, degenerative or induced by birth 
trauma.’ As this is a very broad definition, traumatic brain injuries (TBI) include a big variety 
of insults that can either be focused on the site of the primary insult or diffused with damages 
at more remote sides from the origin of the injury. Brain injuries can furthermore be closed 
(most of the time resulting from a crash), meaning that both the skull and the underlying dura 
mater remain intact, or open with an object penetrating these physical barriers. Besides the 
original insult, a secondary injury caused by the opening of the blood-brain-barrier (BBB), 
inflammation and other biochemical processes worsen the outcome of the original insult (Park 
et al. 2008; Maas et al. 2008; O´Connor et al. 2011). TBI is a major cause of death and 
disability all over the world, especially in children and young adults (Clark and Kochanek 2001). 
Hence, a deep understanding of brain-intrinsic mechanisms following TBI that cause severe 
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deficits is important to foster repair and improvement for affected patients. In order to address 
this issue, scientists developed a number of animal models to mimic and systemically study 
TBI. 
1.5.1 MODELS OF TRAUMATIC BRAIN INJURY 
TBI is a multifaceted injury that cannot be mimicked in a single model, and hence a lot of 
different injury models are required to observe the full spectrum of TBI. As deformations of 
the brain tissue are commonly found, many different models to mimic this insult exist: (I) the 
controlled cortical impact (CCI) model, where mechanical energy from a pneumatic cylinder is 
applied directly to the dura mater, (II) the weight drop model, where a weight is dropped 
either on the dura mater or the cranium in a controlled manner and (III) the vacuum 
deformation model, where the exposed brain is rapidly deformed by a vacuum pulse applied 
through the meninges (O´Connor et al. 2011). 
Besides the typical deformation models, a variety of models to mimic different brain injuries 
exist, but although not emphasized specifically, deformation of the brain tissue as a 
consequence of tissue reaction and swelling is included in those models as well. Applying 
cryolesions is another commonly used method to produce long lasting, inflammatory brain 
damage with an eventual opening of the BBB depending on the severity of the lesion. To 
achieve this, a steel rod that was cooled in liquid nitrogen is directly applied to the dura mater 
(Sun et al. 2000). A relatively new method to induce and study a rather small lesion in which 
cells are locally destroyed is to apply a high energy laser pulse to the tissue that is sometimes 
referred to as focal laser lesion. This method is often used in combination with bi-photon in 
vivo live imaging techniques. The advantage therof is the controllability of both size and 
location of the lesion (Nimmerjahn et al. 2005; Hughes et al. 2013). Open brain injuries are 
often mimicked by a stab wound injury (SWI): after a craniotomy above the region of interest, 
the brain tissue is deeply cut with a knife, resulting in the opening of the BBB, inflammation 
and local tissue damage causing a reaction of different cell types like the resident glial cells as 
well as infiltrating cells from the periphery. This injury can easily be controlled in size as well 
as in location (Buffo et al. 2005; Bardehle et al. 2013). 
1.5.2 TISSUE REACTION AND FOLLOWING SCAR FORMATION AFTER BRAIN INJURY 
The immediate reaction of the CNS tissue resulting in scar formation are the hallmarks of TBI 
in the mammalian brain that can persist for weeks or even months. However, the tissue 
reaction in the CNS is highly variable between injuries with an intact or an open BBB, as in the 
latter ones infiltrating peripheral immune cells and other factors play an additional role, mostly 
leading to increased cellular reactions. (Dimou and Götz 2014). Moreover, a lot of studies 
addressing this point have been performed in the spinal cord of rodents, and yet it is not clear 
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whether the findings from there can directly be translated to brain injuries or if other 
mechanisms also apply in the brain. 
Following brain injury with an open BBB, three different stages of tissue reaction can be 
distinguished (Figure 7): (I) cell death and inflammation, (II) tissue replacement and (III) 
tissue remodeling (Burda and Sofroniew 2014). The first stage starts already within seconds 
after the injury and includes rapid cell death, blood coagulation, and the release of signaling 
molecules for attracting inflammatory cells to clear out the debris (Pineau and Lacroix 2009). 
Although immediate inflammatory signals are crucial to initiate these responses, a sensitive 
regulation between pro- and anti-inflammatory signals is required, as excessive inflammation 
can also be detrimental for tissue repair (Sofroniew 2015). This first stage is also accompanied 
by the deposition of additional extracellular matrix proteins (e.g. fibrinogen, collagen), and the 
immediate reaction of brain intrinsic microglia and NG2-glia (Nimmerjahn et al. 2005; Hughes 
et al. 2013; Burda and Sofroniew 2014; von Streitberg and Schneider et al. submitted;).  
In the second stage where the BBB is still leaky, a massive proliferation and migration of cells 
- including endothelial lineage, fibroblast-like and glial cells - can be observed to regenerate 
and repopulate the damaged tissue. Astrocytes start to elongate around the lesion to corral 
the lesion core and the inflammatory response from the healthy tissue (Wanner et al. 2013). 
Recent studies demonstrated that within the corralled lesion core a high number of reactive 
microglia and NG2-glia can be found trapping dystrophic axons (Cregg et al. 2014). 
In the tissue remodeling stage, the astrocytic scar is tightened and forms a sticky physical 
barrier while the cells in the peri-lesion already start to go back to normal. This is generally a 
chronic stage with gradual, continuous changes in the lesion core and its surroundings (Silver 
and Miller 2004). The glial scar has been shown to be beneficial shortly after injury by 
hampering the spreading of the lesion and by closure of the BBB, in the long-term, however, 
it is detrimental to complete tissue regeneration. Secreted molecules like proteoglycans, 
semaphorins as well as phosphatase and tensin homolog (PTEN) accumulate in the lesion core 
and seem to block the regrowth of neurons. Therefore, the lesion core cannot be functionally 
recovered (Silver and Miller 2004; Zukor et al. 2013; Dimou and Götz 2014; Burda and 
Sofroniew 2014). Indeed, mouse models with limited scar formation showed to allow the 
integration and long-time survival of neurons in the lesion core (Magavi et al. 2000; Chen et 
al. 2004). 
From a historical point of view, the glial scar was thought to be exclusively formed by 
astrocytes and contributing to closing the lesion (Wanner et al. 2013). However, as high-
resolution techniques evolved during the last decades, it became possible to study glial scar 
formation in more detail. Many studies elucidated the glial scar to be a complex and highly 
regulated composition of various cell types (reviewed in Cregg et al. 2014). 
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Figure 7: Stages and time line of different cellular responses after acute brain injury. After a focal lesion 
at least in rodents, three stages of scar formation can be observed: (I) cell death and inflammation, (II) tissue 
replacement and (III) tissue remodeling. During these stages multiple cellular responses over a long time frame 
are happening, including the vasculature, the immune system, glial cells as well as neurons. BBB: blood-brain-
barrier, ECM: extracellular matrix, wpl: weeks post lesion, mpl: months post lesion, ypl: years post lesion (adapted 
from Burda and Sofroniew 2014). 
 
Besides astrocytes, the glial scar contains high numbers of functional glial cells, fibromeningeal 
cells, endothelial cells, pericytes and a dense collagenous matrix that all have an important 
contribution to the functional tissue remodeling of the scar (Sofroniew and Vinters 2010; Cregg 
et al. 2014). 
1.5.3 SEPARATE REACTION OF MAJOR GLIAL CELL TYPES 
In this chapter the individual reaction of microglia, NG2-glia and astrocytes toward acute brain 
injury will be discussed. Microglia immediately respond and strongly proliferate very shortly 
after the injury. NG2-glia start to proliferate and respond after. The last glial cell type that is 
reacting to injury are astrocytes having their proliferative peak even later with the number of 
proliferating astrocytes being rather low compared with microglia and NG2-glia (Buffo et al. 
2005; Simon et al. 2011; Robel et al. 2011b; Bardehle et al. 2013). This exemplary time course 
is strongly dependent on the type of lesion and on the cortical brain area it occured in. In 
general, bigger lesions elicit a stronger reaction of glial cells (at least as shown for astrocytes 
and NG2-glia) compared to smaller lesions (Bardehle et al. 2013; von Streitberg and Schneider 
et al. submitted). In addition, stab wound injuries that are touching the WM, induce a stronger 
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reaction than those locally restricted to the GM (Mattugini and Götz unpublished observations). 
Most of the numerous studies that tried to unravel the detailed mechanisms and functions of 
glial cell reaction after injury only looked at the glial populations in a very isolated way. As 
these cell types already functionally interact in the intact brain, there is evidence that they also 
communicate with each other after injury and that their individual reactions are dependent on 
each other. However, as this is an emerging field, there are only few studies so far addressing 
this point. Wu et al. (2010b) suggested that the tissue inhibitor of metalloproteinase 1 (TIMP 
1) amongst others plays an important role in the signaling between microglia and NG2-glia. 
Another study could show that this very same factor is also influencing astrocyte reaction after 
injury (Welser-Alves et al. 2011) and macrophage-derived osteopontin was shown to be 
important for activating astrocytes (Gliem et al. 2015).  
1.5.3.1 REACTION OF MICROGLIA AND MACROPHAGES TO BRAIN INJURY 
Microglia, the tissue-surveilling cells of the immune-privileged CNS, are the environmental 
sensor to injury and react after any kind of injury with a fast and long-lasting immune reaction 
(Silver et al. 2014; Zhou et al. 2014). Activated microglia retract their ramified processes to 
become amoeboid-shaped and are actively phagocyting to clear the tissue from debris, 
damaged cells or even microbes. Hence, activated microglia are often denoted as macrophages 
(Kettenmann et al. 2011). Moreover resident microglia increase their cell numbers by 
proliferation in close proximity to the lesion site, chemo-tactically polarize and migrate towards 
the lesion site and were even shown to contribute to scar formation (Davalos et al. 2005; Dibaj 
et al. 2010). Activated macrophages can be distinguished from their surveilling counterparts 
by the up-regulation of the ionized calcium binding adaptor 1 (Iba1), leucocyte common 
antigen, LCA (CD45) and macrosialin (CD68) amongst others (Kettenmann et al. 2011). 
Starting from around 2dpl, monocytes from the blood are recruited into the lesion site via pro-
inflammatory signals mainly derived from astrocytes (Pineau et al. 2010). They locally 
differentiate into macrophages afterwards. As these infiltrating bone marrow-derived 
macrophages (BMDMs) share the same developmental origin, no reliable markers could be 
identified until recently to distinguish these two populations. Additionally, they cannot be 
discriminated by their morphology from resident microglia, hence the term ‘macrophages’ 
referring to the time after lesion, is commonly used for both the resident macrophages as well 
as the BMDMs (Silver et al. 2014). Several studies already addressed the differences between 
resident and bone marrow-derived macrophages, and suggested that low CX3C chemokine 
receptor 1 and high macrophage 1 antigen expressing BMDMs (CX3CR1low/Mac-2high) 
predominantly migrate into the lesion core, while the CX3CR1high/Mac-2low resident 
macrophages predominantly stay in the peri-lesion (Zhou et al. 2014). Therefore, macrophages 
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in the peri-lesion seem to block the tissue damage (Hines et al. 2009), whereas the BMDMs 
are devoted the clear the cell debris in the lesion core (David and Kroner 2011). Another recent 
study could show that macrophages support the short-term clearance of cell debris, while 
BMDMs are important for the less efficient long-term phagocytosis; they are moreover 
responsible for the protracted axonal dieback (Greenhalgh and David 2014; Evans et al. 2014). 
Along the same line of ambiguity, it cannot clearly be determined if the inflammatory effect of 
macrophages and their released cytokines are beneficial or detrimental to tissue repair after 
TBI (Hohlfeld et al. 2007; Kerschensteiner et al. 2009). The idea of two different types of 
macrophages is becoming increasingly accepted: classified into the traditionally activated M1 
and the alternatively activated M2 macrophages. M1 macrophages – that are colloquially called 
the ‘bad’ macrophages – secrete high levels of pro-inflammatory factors, e.g. interleukine 6 
(IL-6) and interferone gamma (INF-γ), as well as proteolytic enzymes, like metalloproteinases 
that are degrading the ECM and other proteins. Moreover the secretion of the inducible nitric 
oxide synthase (iNOS) directly induces neuronal death and secondary tissue damage (Kigerl 
et al. 2009; Zhou et al. 2014). M2 macrophages on the other hand secrete anti-inflammatory 
factors (e.g. IL-4, IL-10) to support neuroprotection, tissue regeneration and even the 
differentiation of neural stem cells and re-myelination in the injury core (Varnum and Ikezu 
2012; Zhou et al. 2014). Whether M2 macrophages are derived from a fate switch of M1 
macrophages to resolve the inflammation, or from an alternative subgroup of immature cells, 
and when this occurs, is still being controversially discussed (Varnum and Ikezu 2012; Weisser 
et al. 2013). Many studies, including a clinical trial in phase 2, tried to exploit M2-primed 
macrophages for a better clinical outcome after injury. However, especially the phase 2 study 
was not successful, as the efficacy could not be established and the adverse effects were too 
high (Lammertse et al. 2012). The limits for this application could be that not enough is known 
about the internal and external cues inducing this fate switch and about the maintenance of 
M2 macrophages (reviewed in Silver et al. 2014). For this reason, some scientists already start 
to retract the simple idea about this ‘good’ and ‘bad’ microglia populations. 
1.5.3.2 REACTION OF NG2-GLIA TO BRAIN INJURY 
NG2-glia are another cell type reacting within a quite short time window to different kinds of 
brain insults: within three days following the injury, they significantly increase their 
proliferation rate resulting in an increase in cell numbers in the proximity of the lesion site 
(Tan et al. 2005; Buffo et al. 2005; Simon et al. 2011). Moreover, NG2-glia are becoming 
hypertrophic what is accompanied by morphological changes including a shortening and a 
thickening of their processes as well as the up-regulation of NG2 (Levine 1994). Post mortem 
analysis as well as recent in vivo imaging studies demonstrated that these cells polarize and 
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even migrate towards and into the lesion core, suggesting that they are involved in the wound 
closure and also in the formation of the glial scar (Levine et al. 2001; Hughes et al. 2013; von 
Streitberg and Schneider et al. submitted). 
NG2-glia do not only have a cellular function, they can also provide signals to the surrounding 
matrix and other cells. As the proteoglycan NG2 is a transmembrane spanning protein, its 
extracellular domain can be cleaved in the extracellular space by proteases that are present in 
the lesion (Nishiyama et al. 2009; Trotter et al. 2010). The functions of this shed NG2 are not 
fully understood yet. It could be active in cell-to-cell signaling and activation of other cells, as 
the proteoglycan is involved in cell migration (Karram et al. 2005; Binamé et al. 2013). Several 
studies demonstrated that NG2 – or better said the chondroitin sulfate proteoglycan – is 
inhibiting neuronal regrowth inside the lesion (Levine et al. 2001; Tan et al. 2005; Galtrey and 
Fawcett 2007). In vivo injections of chondroitinases indeed improve axonal regeneration after 
injury (Bradbury et al. 2002). Other studies, however, contradictorily demonstrated that the 
unshed NG2 proteoglycan is supportive to axonal survival (Busch et al. 2010), and that even 
the shed proteoglycan enhances axonal regrowth for some neurons at least after spinal cord 
injury (Castro et al. 2005). These data suggest that NG2 could be both supportive and repulsive 
to neuronal regrowth, depending on the type of neurons or the type of lesion as well as on 
the area (reviewed in Karram et al. 2005).  
While bi-photon in vivo imaging is giving new ways to follow individual NG2-glia for longer 
time periods after the lesion in order to answer the questions of migration, it also enabled 
scientists to observe the heterogeneity of the cell population. The reaction of NG2-glia close 
to the lesion site is highly heterogeneous (Figure 8): some NG2-glia migrate, some proliferate, 
some become hypertrophic and others remain stable; a combination of these reactions can 
also be observed (von Streitberg and Schneider et al. submitted). 
 
 
Figure 8: Heterogeneous reaction of NG2-glia after cortical stab wound injury. In the non-lesioned 
condition, NG2-glia are homogeneously distributed in the cortical GM. Upon injury, some NG2-glia start to migrate 
(gray) towards the lesion, some become hypertrophic (orange), some proliferate (blue), some polarize toward the 
lesion (purple) and some few cells remain stable (green). Whether these heterogeneous reactions are due to 
intrinsic or external cue differences is still unknown (adapted from Dimou and Götz 2014). 
non-lesioned lesioned
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However, to which extent these cellular differences occur and whether intrinsic or local external 
cues are involved still needs to be clarified. 
NG2-glia reaction is also highly dependent on the lesion paradigm. Although they react in a 
comparable manner to viral injections, demyelinating and other inflammatory diseases (Levine 
et al. 1998; Levine et al. 2001; Zawadzka et al. 2010), they do not become reactive in lesions 
where the BBB remains closed, although a reaction of both microglia and astrocytes can be 
observed. Indeed, other studies suggest that platelets, macrophages and other inflammation-
associated cytokines derived from the blood are needed to elicit a reaction in NG2-glia (Rhodes 
et al. 2006; Wang and He 2009; Sirko et al. 2013; Dimou and Götz 2014). 
1.5.3.3 REACTION OF ASTROCYTES TO BRAIN INJURY 
Astrocytes are showing a heterogeneous reaction to any kind of damage to the CNS and the 
process of combined astrocyte reactions is commonly termed astrogliosis. As this term has 
been used unequally by different scientists, a common definition was suggested (Sofroniew 
and Vinters 2010). In order to term some astrocyte reaction as astrogliosis, the reaction needs 
to include: (I) a spectrum of changes occurring to all kinds of insults, (II) a variation in the 
reaction according to the severity of the insult, (III) a context-specific reaction induced by 
signaling molecules, (IV) the alteration of physiological astrocyte function and most recently, 
(V) the identification of gradations in different diseases (Sofroniew 2009; Sofroniew and 
Vinters 2010). The initiation of astrogliosis occurs by pro-inflammatory cytokines like the 
transforming growth factor α (TGFα) or IL-6, that are released from the injured environment 
or other cells (Pekny and Pekna 2014). 
Although astrogliosis is subdivided into different grades of severity – depending on the type of 
insult – the hallmarks thereof are the up-regulation of intermediate filaments like the glial 
fibrillary acidic protein (GFAP), nestin and vimentin, as well as the hypertrophy of both the cell 
body and the processes. (Wilhelmsson et al. 2006; Sofroniew and Vinters 2010). When 
astrocytes in the healthy tissue and even after a mild injury become hypertrophic, they occupy 
separate distinct and non-overlapping domains (Bushong et al. 2002; Wilhelmsson et al. 2006). 
However, this feature is abrogated after severe injury and scar formation (Sofroniew 2009). 
In addition to their increase in size, astrocytes that are quiescent in a healthy situation also 
increase in number due to proliferation in close proximity to the lesion site (Buffo et al. 2005; 
Robel et al. 2011b). However, this increase in number was now shown to be much lower as 
previously thought. Most likely, the GFAP upregulation and the hypertrophy was misinterpreted 
as an increase in numbers, although it is apparently mostly an increase in cell size. Compared 
with the other glial cell types, less astrocytes re-enter the cell cycle, proliferation starts later, 
and the proliferating cells are found in great numbers amongst the juxtavascular astrocytes 
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that contact the blood-vessels not only with their endfeet but with the whole cell soma 
(Bardehle et al. 2013). As in vitro scratch wound models demonstrated, astrocytes were 
previously thought to migrate into the lesion core to close the lesion (Robel et al. 2011a). 
However, a recent in vivo study proved that their processes polarize toward the lesion, while 
the cell body remains stable (Bardehle et al. 2013).  
From a historical point of view, the astrocytic glial scar and the therein included molecules like 
chondroitin sulfate proteoglycans or ephrins was seen as a detrimental border for the long-
term axonal regrowth and functional improvement after TBI for more than 100 years (Ramón 
y Cajal, Santiago 1928). Indeed, GFAP/vimentin double knockout mice, in which the dense 
astrocytic scar formation is limited, exhibit an initially negative but on the long-term better 
neuroregenerative potential after injury (Wilhelmsson et al. 2004). Recent findings on the 
other hand using different loss-of-function approaches give evidence that astrocytes have a 
protective role for the tissue surrounding the lesioned area and that they are an important 
player in the regulation of CNS inflammation (Sofroniew 2015). Rothstein et al. (1996) 
demonstrated that astrocytes take up free, diffusing glutamate from the lesion to protect 
neurons from degeneration. As astrocytes are additionally a key player in the BBB-formation, 
their proper function is also required for the BBB-closure after injury (Sofroniew and Vinters 
2010).  
Besides their cellular properties, astrocytes tightly regulate CNS inflammation by secretion of 
several both anti-inflammatory, e.g. sonic hedgehoc (SHH), IL-6 and retinoic acid, as well as 
pro-inflammatory signals, e.g. the chemokine (C-C motif) ligand 2 (CCL2), the tumor necrosis 
factor α (TNFα) and the vascular endothelial growth factor (VEGF). Hence, an excessive 
astrocyte reaction can also lead to a detrimental outcome due to an excessive inflammation 
(reviewed in Sofroniew 2015). 
 
Table 1: Positive and negative effects of reactive astrogliosis (modified after Pekny and Pekna 2014). 
Positive effects Negative effects 
Physical barrier formation to restrict inflammation Block of axonal regrowth
Restriction of injury size 
Limitation of regenerative response & functional 
Recovery after spinal cord injury 
Blood-brain barrier repair Limitation of synaptic regeneration 
Limitation of neuronal loss by uptake of glutamate & 
release of neuroprotective factors 
Negative influence on integration of transplanted 
neurons/stem cells  
Protection from long-term neurodegeneration
Reduction of synaptic loss
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Taken together, a well-balanced astrocyte reaction after TBI requires a complex regulation by 
intrinsic and extrinsic signals and is furthermore of high importance for the regulation of tissue 
reaction itself (Pekny and Pekna 2014; Sofroniew 2015).  
Besides their general reaction following brain injury, mature parenchymal astrocytes acquire 
properties that make them similar to adult neural stem cells (NSCs) in the subventricular zone 
(SVZ) and radial glia during development, from which they developmentally originate, although 
they only give rise to neurons in vitro but not in vivo (Robel et al. 2011b; Sirko et al. 2013). 
These properties are e.g. the upregulation of GFAP, vimentin, tenascin C (TNC) as well as the 
ability to proliferate. Whether these cells acquire their stem cell potential via de-differentiation 
from mature astrocytes, or if these neural stem cell-like cells are indeed stem cells migrating 
into the lesion site from neurogenic niches, is still not fully understood (Lang et al. 2004; Brill 
et al. 2009). Although these properties and the included mechanisms are only partially 
understood, they are very attractive to be utilized for endogenous neuronal repair after TBI 
(Robel et al. 2011b). 
 
1.6 TAMOXIFEN-INDUCIBLE TRANSGENIC MOUSE MODELS 
Transgenic inducible mouse lines are a tool to target, visualize and manipulate a specific cell 
type of interest at a defined stage in the lifetime of a mouse. Although several mechanisms to 
achieve that goal have been developed, most of the mouse lines employ the CreER/LoxP 
technology (reviewed in Bockamp et al. 2002). In this system, the cyclization recombination 
(Cre) site-specific DNA recombinase of the bacteriophage P1 is fused with a modified estrogen 
receptor (ER) binding domain that has a high affinity to the artificial estrogen tamoxifen (TAM) 
and the 4-hydroxy-tamoxifen (OHT) derivative, but not to mouse endogenous estrogens. This 
fusion protein can be placed into the mouse genome under the control of a specific promoter 
of interest, therefore only cells that are actively expressing the gene of the targeted promoter 
of interest do translate the CreER fusion protein. By choosing the promotor of interest, the 
specificity of the targeted cell type can be controlled to a high extent. As the modified ER 
follows the localization of the endogenous ones without ligand binding, it remains in the 
cytoplasm and also keeps the Cre recombinase there (Jaisser 2000). Upon TAM induction, the 
CreER fusion protein is translocated into the nucleus where the Cre recombinase is becoming 
active. However, the recombination does not occur randomly, but at specific locus of crossover 
phage (LoxP) sites that have been inserted into the mouse genome. This can be used to 
specifically delete or activate – by removing a stop cassette – the gene of interest (Sauer 
2002), dependent on the localization of the LoxP sites. So-called reporter lines carry a reporter, 
e.g. the green fluorescent protein (GFP), or β-galactosidase (lacZ), with an upstream stop 
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cassette that is flanked by LoxP sites. As this system modifies the genome, the induced 
changes are stable and the reporter remains active until the death of the cells independent 
from further activity of the promoter, making this system highly favorable for fate-mapping 
analysis. The advantages hereof compared with constitutively active reporter, or knock-out 
lines is the increased controllability of the tamoxifen dose (and recombination) as well as the 
timing of the induction, e.g. when comparing mice at embryonic, postnatal and adult stages, 
or after injury.  
Three types of CreER mouse lines exist: (I) knock-in, (II) transgenic, and (III) bacterial/phage 
artificial chromosome (BAC/PAC)-transgenic mouse lines. In the knock-in line, the CreER is 
placed downstream the endogenous promoter, replacing at least parts of the endogenous 
gene. Although these mice are generally bred heterozygous to maintain the endogenous gene 
expression, the partial loss can already influence cellular or even behavioral characteristics and 
can result in a phenotype, as e.g. observed in mice with a heterogeneous paired box 6 (Pax6) 
mutation (Baulmann et al. 2002). However, using these knock-in lines homozygous serves as 
a good tool to knock out any gene of interest and to analyze its function. In transgenic and 
BAC/PAC transgenic mouse lines, the CreER fusion protein is randomly inserted into the 
genome together with the endogenous promoter sequence and its corresponding regulatory 
elements, therefore maintaining the endogenous expression levels of the targeted gene.  
 
Table 2: Tamoxifen-inducible mouse lines to target NG2-glia.  
Name Type Efficiency Targeted cell types Reference 
GPR17iCreERT2 BAC-transgene high 
Subsets of NG2-glia expressing 
GPR17 
Viganò and 
Schneider et al. in 
press 
NG2CreERT2* Knock-in medium NG2-glia, few neurons 
Huang et al. 
2014b 
NG2CreERTM BAC-transgene low NG2-glia, mature oligodendrocytes Zhu et al. 2008 
Olig2::CreERTM Knock-in low 
Total oligodendrocyte lineage,    
few astrocytes, few neurons 
Dimou et al. 2008 
PDGFRαCreERT2 PAC-transgene high 
NG2-glia, mature oligodendrocytes, 
few neurons 
Rivers et al. 2008 
PDGFRαCreERTM BAC-transgene medium 
NG2-glia, few neurons, few 
pericytes 
Kang et al. 2010 
Plp1CreERT transgene low 
NG2-glia, mature and myelinating 
oligodendrocytes, astrocytes, 
neurons 
Doerflinger et al. 
2003 
Sox10iCreERT2* BAC-transgene high Total oligodendrocyte lineage Simon et al. 2012
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*These mouse lines were used within the presented work. 
Compared to conventional transgenes, the BAC/PAC plasmid is bigger, being of advantage, as 
the promotor region of a gene can be very big and small vectors can only carry parts of it. 
Moreover, BACs/PACs where shown to insert into the genome multiple times, resulting in a 
higher recombination efficiency (Chandler et al. 2007). 
A second modulatory factor that can influence the outcome of a transgenic mouse is the use 
of different estrogen receptors. Some mouse lines carry a modified mouse ER (ERTM), whereas 
others use the later on developed human ERT or its improved ERT2 version (Metzger et al. 
1995; Indra et al. 1999; Vasioukhin et al. 1999). Apart from modulating the estrogen receptor, 
Shimshek et al. (2002) developed a novel improved form of the Cre recombinase (iCre) that 
allows a more stable and efficient recombination also improving the outcome. 
Although NG2-glia only came into the focus in the last decades, already several mouse lines 
exist using the above described systems to target and analyze these cells. Table 2 gives a 
summary of the existing inducible mouse lines for NG2-glia. Within the work presented in this 
thesis, both the Sox10iCreERT2 as well as the NG2CreERT2 line were used. 
 
1.7 THE CELL CYCLE REGULATOR ESCO2 
Mitosis is a complicated cellular process that requires a high number of control mechanisms in 
order to be completed accurately. Especially during S-phase, dividing cells have to ensure that 
the sister chromatids are symmetrically passed to the two daughter cells in the telophase. 
Before the separation, the chromatids need to be actively held together. This so called 
cohesion is mainly mediated by the cohesin: a protein complex consisting of four major 
subunits as well as many different additional regulatory proteins. The formation of the cohesion 
machinery that is necessary to provide proper sister chromatid separation can be divided into 
four major stages: (I) loading, in which the non-cohesive cohesin binds to chromatin, (II) 
establishment, where cohesin becomes cohesive, (III) maintenance, to keep the chromatids 
together, and (IV) dissolution, where the chromatids are finally separated. Each of these 
stages require individual regulatory proteins. The acetyl-transferase establishment of cohesion 
1 homologue 2 (Esco2) is one of the most important regulatory proteins in the second stage 
(reviewed in Onn et al. 2008). This protein was originally discovered in saccharomyces 
cervisiae (Eco1), where it is essential for cell viability, but it was also found to be highly 
conserved in other mammalian as well as non-mammalian species (Uhlmann and Nasmyth 
1998; Onn et al. 2008). At least in humans and rodents the Esco2 gene is located on the short 
arm of chromosome eight. Mammalian genomes encode two orthologues: Esco2 and Esco1 
that are variable in their N-termini. Esco1 has been suggested to be partially redundant, but 
cannot completely replace the function of Esco2 (Hou and Zou 2005; Whelan et al. 2012b; 
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Rahman et al. 2015). Loss-of function studies demonstrated that Esco2 is only required for the 
establishment of the cohesion, but dispensable for the loading as well as the maintenance 
(Unal et al. 2007). Esco2 mutations in humans are associated with the Roberts syndrome in 
which patients suffer from mild to severe congenital disorders and their chromatogram shows 
a typical form of ‘railroad-track’ chromosomes (Vega et al. 2005). 
Hence Esco2 is an efficient regulator for proper cohesion and therefore the whole cell cycle. 
The loss of the gene function was exploited to systemically drive proliferating cells in culture 
into apoptosis as it causes severe chromatid defects (Whelan et al. 2012a). The same group 
demonstrated a very efficient use of the Esco2 loss-of-function using an Emx1CrexEsco2fl/fl 
mouse line recombining in cortical neuronal progenitors, in which the knockout mice in 
postnatal stages completely lack the cortex and half of the hippocampus as cortical 
neurogenesis does not take place (Whelan et al. 2012b; Hammerschmidt et al. 2015).  
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2 AIM OF THE STUDY 
The cellular characteristics of NG2-glia in the adult brain are well characterized, however still 
very much remains unknown about their physiological functions in the homeostatic brain 
network as well as after traumatic brain injury. 
Thus, the main objective of my PhD thesis was to address the physiological function of NG2-
glia both under physiological conditions as well as after brain injury. Therefore I used a novel 
approach to deplete proliferating NG2-glia in the adult mouse brain. The depletion was 
achieved with the tamoxifen-inducible Sox10iCreERT2xCAG-eGFPxEsco2fl/fl mouse line, in which 
targeted proliferating NG2-glia are driven into apoptosis during M-phase and are therefore 
depleted as soon as they try to finish their cell cycle. 
Using this novel tool that induces a reduction in the pool of proliferating NG2-glia, I tried to 
disclose the following more specific questions: 
 Does the lack of proliferating NG2-glia alter the tightly regulated homeostatic network? 
 Does the depletion influence other cell types in the brain? 
 Does the intervention in the physiological lineage progression elicit changes in the cell 
distribution within the oligodendrocyte lineage? 
 Does the depletion of NG2-glia influence the behavioral phenotype in living mice? 
Moreover, I used the cortical stab wound injury model in the Sox10iCreERT2xCAG-
eGFPxEsco2fl/fl mouse line to specifically answer those questions: 
 Does the fast depletion of individual NG2-glia affect the total NG2-glia population and 
its reaction upon brain injury? 
 Does the lack of NG2-glia in the injury site modify the reaction of other cell types after 
brain lesion? 
 Does the lack of NG2-glia influence the wound healing capacity of the brain? 
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3 RESULTS 
This chapter summarizes the results that were obtained from the genetic ablation of 
proliferating NG2-glia using the Sox10iCreERT2xCAG-eGFPxEsco2fl/fl mouse line. The first part 
addresses the inducible NG2-glia ablation, its long-term cellular as well as functional 
consequences for the mice under physiological conditions. In the second part, this mouse line 
was used to analyze the cellular function and consequences of the ablation of proliferating 
NG2-glia after acute traumatic brain injury. 
 
3.1 NG2-GLIA ABLATION IN THE HEALTHY BRAIN 
3.1.1 ESCO2 DELETION CAUSES SLOW BUT PROGRESSIVE LOSS OF PROLIFERATIVE RECOMBINED NG2-GLIA 
To ablate proliferating NG2-glia in the adult brain we used the inducible Sox10iCreERT2xCAG-
eGFPxEsco2fl/fl mouse line. In all cells with an active Sox10 promoter, tamoxifen induction 
resulted in a permanent expression of the green fluorescent protein (GFP) as well as in a 
deletion of the acetyl transferase Esco2 (Figure 9-A), whose permanent loss is detrimental for 
the assembly of the cohesion apparatus during mitosis.  
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Figure 9: Genetic ablation of proliferating NG2-glia in the adult brain. (A) Schematic drawing of the 
inducible Sox10iCreERT2xCAG-eGFPxEsco2fl/fl mouse model. (B) Examples of apoptotically dying 
TUNEL+/GFP+/NG2+ cells in the cortical GM (upper panel) and WM (lower panel) at 6wpi. Scale bars represent 
25µm. 
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Consequently, cycling cells that were lacking the Esco2 protein in this mouse model were not 
able to complete their cycle and were thus driven into apoptosis by cell cycle checkpoints 
during M-phase. The Sox10 promoter that was used as a driver for this mouse line is active 
throughout the oligodendrocyte lineage, therefore also mature and myelinating 
oligodendrocytes were recombined. However, as mature cells are postmitotic and further 
functions of Esco2 in posmitotic cells are not known, no obvious effects of the Esco2 depletion 
were expected. Hence, this mouse model represents a novel tool that specifically allows the 
ablation of cycling NG2-glia in the adult brain. 
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Figure 10: NG2-glia ablation in different cerebral areas. (A) GFP staining in a saggital section of an Esco2fl 
mouse at 16wpi. Blow-ups show NG2+ (red) and NG2+/GFP+ (yellow) NG2-glia in the visual (a, a’), somatosensory 
(b, b’) and motor cortex (c, c’). (B) Quantification of GFP+ cells in the GM of the whole cerebral cortex. (C) 
Quantification of GFP+ cells in the WM underlying the whole cerebral cortex. Scale bars represent 50µm. Number 
of animals: n=3 for each bar. Data are presented as mean±sem. Statistical analysis: One-way ANOVA, nsp>0.05, 
*p<0.05. 
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To analyze the loss of NG2-glia in the adult brain, we induced adult mice at the age of eight 
to ten weeks and investigated coronal brain sections for dying cells by terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining at six weeks post 
induction (wpi). TUNEL+/NG2+/GFP+ cells could be found both in the GM and the WM 
throughout the cerebral cortex of Esco2fl mice, meaning that recombined NG2-glia in our 
mouse model were indeed diminished by apoptotic cell death (Figure 9-B).  
In order to see if the loss of recombined cells occurred evenly distributed or preferentially in 
distinct areas of the cortical WM, saggital sections to better compare different cortical areas 
within one section were immunohistochemically analyzed at 16wpi (Figure 10-A). These data 
revealed that despite the same recombination rate, the loss of recombined (GFP+/NG2+) NG2-
glia was higher in the GM of the somatosensory cortex compared with the GM of the visual 
and motor cortex, indicating that the proliferation rate and therefore the death of NG2-glia did 
not occur equally in different cortical areas. However, it cannot be ruled out that in some 
cortical areas the loss of Esco2 was more easily compensated, and hence more cells could 
escape and still be able to proliferate. For the WM on the other hand, no region-specific 
differences between rostral and caudal areas could be observed (data not shown).  
To determine the dimension of the loss of recombined cells, the total number of GFP+ cells 
(including NG2-glia as well as mature and myelinating oligodendrocytes) was analyzed at 1wpi 
and 16wpi both in the GM and the WM of the cerebral cortex as an average of all cortical areas 
(Figure 10-B and C). At 1wpi, the total number of GFP+ cells was observed to be similar in 
Esco2wt and Esco2fl mice, both in the GM as well as in the WM. However, while the cell number 
during the 16 weeks of analysis in the Esco2wt group significantly increased in both cortical 
areas – most likely due to the expansion of the proliferative NG2-glia pool – it even decreased 
in the Esco2fl (Table 8 in supplementary tables). 
To investigate whether the above described reduction in the GFP+ cell pool specifically derived 
from the ablation of recombined NG2-glia and to address the time course of their death, 
immunohistochemical analysis in coronal sections of the GM and the WM of the cerebral cortex 
was performed at 1wpi, 6wpi, 11wpi and 16wpi after tamoxifen induction (Figure 11-B). 
Initially, the recombination rate at 1wpi reached 76.03±0.46% of the total NG2-glia in Esco2wt 
and 74.67±0.57% in Esco2fl animals in the GM (Figure 11-C, Table 9 and Table 10 in 
supplementary tables). For the WM, the recombination rate was even significantly higher with 
85.2±2.3% of all NG2-glia in the Esco2wt and 83.3±3.1% of all NG2-glia in the Esco2fl mice 
(Figure 11-D, Table 9 and Table 10 in supplementary tables). As recombined NG2-glia were 
apoptotically lost after proliferation in Esco2fl mice, a progressive decrease in the absolute 
number of NG2+GFP+ cells could be observed, both in the GM as well as in the WM. As 
expected, the loss of these cells was much more prominent in the WM compared with the GM 
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(Table 9 in supplementary tables), due to the shorter cell cycle length of NG2-glia in the WM. 
In contrast, in the wildtype control group the total number of recombined NG2-glia remained 
almost stable in the GM and decreased – although significant – only little in the WM. Notably, 
the absolute number of cells in the NG2-glia population (GFP+ and GFP-) in Esco2fl mice was 
never reduced over the whole analysis time compared with the Esco2wt group, neither in the 
GM nor in the WM of the cerebral cortex (Figure 11, Table 10 in supplementary tables). 
To test whether the stability of the total NG2-glia numbers derived from a compensatory 
proliferation of non-recombined NG2-glia, Ki67 staining to label actively proliferating cells was 
performed at 11wpi in coronal sections of the GM and the WM (Figure 12). 
 
 
Figure 11: Long term analysis of recombined NG2-glia. (A) Images of recombined and non-recombined NG2-
glia in the cortical gray and white matter at 1wpi and 16wpi. Non-recombined NG2-glia are indicated with an 
asterisk. (B) Scheme of the experimental procedure. (C) Absolute numbers/mm² of recombined (yellow) and non-
recombined (red) NG2-glia in the cortical GM at different timepoints after induction. (D) Absolute numbers/mm² of 
recombined (yellow) and non-recombined (red) NG2-glia in the cortical WM at different timepoints after induction. 
Scale bars represent 25µm. Data are presented as mean±sem. Number of animals: n=3 for each bar (n=4 for 
Esco2fl GM 11wpi). Statistical analysis: One-way ANOVA, *p<0.05, **p<0.001, ***p<0.0001. 
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Figure 12: Proliferating NG2-glia in the cortical GM and WM. (A) Proliferating (Ki67+) recombined (yellow 
arrows) and non-recombined (white arrows) NG2-glia in the cortical GM and WM. (B) Scheme of experimental 
procedure. Absolute numbers/mm² of recombined (yellow) and non-recombined (red) Ki67+ NG2-glia in the cortical 
(C) GM and (D) WM at 11 weeks after induction. Scale bars represent 25µm. Data are presented as mean±sem. 
Number of animals: n=3 for each bar. Statistical analysis: unpaired students t-test, nsp>0.05, ***p<0.0001. 
 
Indeed, we found that the number of the non-recombined, actively cycling NG2+/Ki67+/GFP- 
cells was significantly higher in Esco2fl (2.9±1.1 cells/mm2 in the GM and 20.3±6.7 cells/mm2 
in the WM) than in Esco2wt animals (0.6±0.2 cells/mm2 in the GM, 3.7±1.8 cells/mm2 in the 
WM), demonstrating a compensatory increase in the proliferation of non-recombiend NG2-glia. 
 In order to analyze whether the progressive apoptotic loss and subsequent change in 
the proliferative behavior of NG2-glia induced any changes or even activation in other major 
brain cell populations, microglia/macrophages, astrocytes as well as neurons were 
immunohistochemically analyzed in coronal sections of the cerebral GM at 16wpi (Figure 13). 
As the apoptotic loss of NG2-glia occurred progressively and was widely distributed in the used 
mouse model, we did not observe a significant infiltration of blood-derived (CD45+/Iba1-) 
macrophages (data not shown) that would display a strong sign of inflammation. Furthermore 
Iba1/CD45-activated microglia were not significantly augmented in the Esco2fl mice (2.7±0.5 
cells/mm²) compared with the wildtype controls (8.6±2.4 cells/mm²), although the number of 
actively cycling microglia (Iba1+/Ki67+) was increased in the Esco2fl (0.2±0.2 cells/mm²), 
compared with the Esco2wt mice (1.7±0.2 cells/mm², Figure 13-A and B). However, the 
proliferation rate was still low and therefore the absolute cell number of microglia in the cortex 
was not affected (data not shown), meaning that the overall cell population did not change. 
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Analysis of the astrocyte population showed that some of the cells upregulated GFAP in the 
GM, that is usually only expressed by activated protoplasmic astrocytes in Esco2fl mice 
(91.5±3.2 cells/mm2), but only little under physiological conditions in control animals 
(13.3±1.5 cells/mm2). Actively cycling, reactive astrocytes (GFAP+/Ki67+) on the other hand 
were not present (data not shown), meaning that the Esco2fl mice did not develop a full 
astrogliosis, as the hallmark thereof is both activation and proliferation of astrocytes. 
Additionally, neuronal cresylviolet staining did not reveal any observable modifications in the 
neuronal population that could have been induced by the cumulative changes in the NG2-glia 
population (Figure 13-C). 
In summary, successful Sox10-promoter-driven ablation of proliferating NG2-glia was achieved 
both in the GM as well as in the WM of the cerebral cortex. The progressive loss of proliferating 
recombined NG2-glia resulted in an increased proliferation of non-recombined cells, without 
inducing any changes in numbers and morphology of GM neuronal cell bodies. Only minor 
changes in cell numbers or reaction of the other major glial cell populations in the GM were 
observed. 
 
 
Figure 13: Reaction of other cell types in the cortical gray matter at 16wpi. (A) Examples and absolute 
numbers/mm² of CD45/Iba1-activated microglia (white arrows) in the cortical gray matter. (B) Proliferating (Ki67+, 
white arrows) and non-proliferating Iba1+ microglia/mm² in the cortical gray matter. Yellow arrows indicate 
Ki67+Iba1- proliferating cells. (C) Cortical neuronal cell bodies stained with cresylviolet. (D) Examples and absolute 
numbers/mm² of GFAP-reactive astrocytes in the cerebral gray matter. Scale bars represent 50µm, 25µm in inlays 
in D. Data are presented as mean±sem. Number of animals: n=3 for each bar. Statistical analysis: unpaired 
student’s t-test, nsp>0.05, **p<0.001, ***p<0.0001. 
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3.1.2 NG2-GLIA ABLATION DECREASES OLIGODENDROGENESIS 
The NG2-glia network displays a tightly regulated system in which the homeostasis between 
proliferation and differentiation is strongly controlled. In order to analyze whether the altered 
proliferation characteristics of NG2-glia in the above described mouse model also affected their 
differentiation properties, we analyzed the oligodendrocyte turnover in coronal sections of 
adult animals. After tamoxifen induction the animals received the thymidine analog 5-Bromo-
2’-deoxyuridine (BrdU) for two weeks via the drinking water. BrdU is integrated into the newly 
synthesized DNA strand of dividing cells and can be identified by directing an antibody against 
it. After a nine week retaining period (11wpi in total) animals were sacrificed (Figure 14-B). 
During this retaining period, the mice received normal drinking water, however, BrdU has 
permanently been integrated into the DNA strand and therefore retained in the originally 
proliferating cells, allowing the determination of the fate of those cells. As CC1+ 
oligodendrocytes are postmitotic, potential BrdU+/CC1+ cells were originally proliferating NG2-
glia that incorporated BrdU, and subsequently differentiated into mature oligodendrocytes 
during the retaining period. Newly generated oligodendrocytes could therefore be identified 
by BrdU/CC1 double labeling at the end of the retaining period.  
In the GM, no obvious differences in the absolute number of newly generated oligodendrocytes 
could be found between the Esco2fl and control animals (64.6±3.3 cells/mm2 in the Esco2wt 
and 53.5±2.9 cells/mm2 in the Esco2fl mice, Figure 14-C). Only the amount of CC1+BrdU+GFP+ 
triple positive, newly generated oligodendrocytes was reduced (14.7±1.6 cells/mm2) compared 
with the wildtype group (32.5±2.6 cells/mm2), demonstrating that the differentiation capacity 
of recombined NG2-glia was decreased, as these cells were either depleted or forced to 
proliferate in the Esco2fl mice. However, this fraction was slightly compensated by the 
increased differentiation of non-recombined (CC1+/BrdU+/GFP-) cells (32.1±1.6 cells/mm2 in 
the Esco2wt and 38.8±2.1 cells/mm2 in the Esco2fl mice). Regarding the percentage of total 
BrdU cells in the cortical GM (Figure 14-D), the fraction of newly generated oligodendrocytes 
in total (CC1+/BrdU+/GFP+ and CC1+/BrdU+/GFP-) was significantly lower in the Esco2fl mice 
(29.4±1.1%) than in the wildtype controls (47.6±3.5%). Moreover, NG2-glia in the Esco2fl 
mice increased their proliferation at the expense of differentiation (57.9±1.1%), as their 
fraction within the BrdU (NG2+BrdU+) pool was highly increased compared with the controls 
(42.9±2.6%, Figure 14-E). 
In the WM on the other hand, the total number of newly generated oligodendrocytes that were 
BrdU+/CC1+-labelled was significantly lower in Esco2fl animals (49.6±12.9 cells/mm2), 
compared with their Esco2wt littermate controls (153.6±4.1 cells/mm2, Figure 14-D). 
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Figure 14: Newly generated oligodendrocytes in the cortical GM and WM. (A) Recombined (yellow arrows) 
and non-recombined (white arrows) newly generated oligodendrocytes (BrdU+/CC1+) in the cortical GM and WM at 
11wpi. (B) Scheme of the experimental procedure. Absolute numbers/mm² of recombined (orange) and non-
recombined (purple) BrdU+ oligodendrocytes in the cortical (C) GM and (D) WM at 11wpi. (E) Percentage 
distribution of different cell types amongst the total BrdU population in Esco2wt and Esco2fl mice at 11wpi. Scale 
bars represent 25µm. Data are presented as mean±sem. Number of animals: n=3 for each bar or pie. Statistical 
analysis: unpaired student’s t-test, nsp>0.05, **p<0.001, ***p<0.0001. 
 
The major reduction in the Esco2fl mice could again be observed in the CC1+/BrdU+/GFP+ 
recombined cell fraction (105.8±7.2 cells/mm2 in the Esco2wt and 5.8±3.2 cells/mm2 in the 
Esco2fl mice), whereas the non-recombined cells contributing to the newly generated 
oligodendrocytes CC1+/BrdU+/GFP- were similar in both groups (47.7±8.3 cells/mm2 in the 
Esco2wt and 43.8±10.8 cells/mm2 in the Esco2fl mice). Analysis of WM tracts in the cerebellum 
yielded similar results (data not shown), where newly generated oligodendrocytes of 
116.2±8.3 cells/mm2 in the Esco2wt, but only 30.4±9.9 cells/mm2 in the Esco2fl mice, were 
found. Also here, the reduction of the total number of oligodendrocytes was mainly derived 
from the loss of the recombined (GFP+) cell fraction.  
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In summary, this experiment revealed that the increased proliferation and the death of NG2-
glia resulted in a decreased differentiation into mature oligodendrocytes; predominantly in WM 
tracts of the cortex. 
3.1.3 NG2-GLIA ABLATED MICE SHOW DISRUPTIONS IN THE NODES OF RANVIER 
As the proliferation and differentiation capacities of NG2-glia in the cortical GM are known to 
be much lower compared with those in the WM, the progressive ablation of NG2-glia did not 
result in significant cellular changes in the cortical GM but only in the WM. Therefore, all further 
analysis was carried out in the cortical WM, where significant changes in proliferation as well 
as in differentiation properties of NG2-glia were identified in the Esco2fl mice. In recent years, 
many studies demonstrated – against the old dogma of solely postnatal myelin production – 
that new oligodendrocytes and consequently new myelin sheaths are produced throughout the 
whole lifespan. Therefore we hypothesized that the lack of adult oligodendrogenesis in our 
mouse model could affect the myelin turnover and subsequently lead to disruptions in the 
global myelin structure. Consequently, a global Sudan black myelin staining as well as an 
ultrastructural analysis was performed in the cortical WM of our animal model at 16wpi and 
12wpi, respectively.  
 
 
Figure 15: Myelin analysis in the white matter. (A) Sudan black staining in the white matter in Esco2wt and 
Esco2fl mice at 16wpi. (B) Gray value intensity measurement of myelin staining in in Esco2wt and Esco2fl mice at 
16wpi. (C) Ultrastructural analysis (electron microscopy) of saggital sections in the white matter in Esco2wt and 
Esco2fl animals at 12wpi. Scale bars represent 50µm (A) and 1250nm (B). Data are presented as mean±sem. 
Number of animals: n=3 for the Esco2wt and n=4 for the Esco2fl. Statistical analysis: unpaired student’s t-test, 
nsp>0.05. 
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Compared with the wildtype controls, the global myelination was not different in the Esco2fl 
mice: the Sudan black gray value intensity analysis in coronal WM sections did not reveal any 
differences between the two groups (544.7±43.4x10³ for the Esco2wt, 569.3±68.4x10³ for the 
Esco2fl, Figure 15-B), meaning that no obvious demyelinated areas were present that would 
appear white in the staining (and give a high gray value in the analysis, Figure 15-A).  
To additionally investigate the myelin integrity of single axons in the WM, electron microscopy 
was performed in saggital sections at 12wpi. In accordance with the myelin staining, Esco2fl 
mice did not show severe signs of demyelination (Figure 15-C). The number of myelinated 
axons did not seem to be different and the myelin sheaths around the axons also appeared 
normally wrapped and compacted. We found some myelin aberrations in the Esco2fl mice 
(multiply myelinated axons, myelin protrusions), but they were not significantly higher 
compared with the rarely appearing abberations in the Esco2wt mice (data not shown). 
Although the analysis of the global myelination did not yield any disturbances in the Esco2fl 
mice neither at 12wpi nor at 16wpi, we wanted to investigate the integrity of the nodal regions 
in these mice as the nodes of Ranvier are a highly structured functional entity of the myelin 
(Figure 16-F). Each of these compartments carry specific functional components and their 
structural loss is often accompanied by a loss of its specific function, e.g. the propagation of 
the axon potential, what can also be observed in different diseases (Arancibia-Carcamo and 
Attwell 2014). The immunohistochemical analysis of the myelin-associated structures at 16wpi 
on the other hand revealed that both in the nodes and paranodes of the Esco2-depleted 
animals, significant structural changes were present. Measuring the paranode length with an 
immunohistochemical CASPR staining in coronal sections demonstrated that the paranodes 
were significantly longer in the Esco2fl animals compared with the controls (average length of 
2.28±0.14µm in the Esco2wt vs. 3.10±0.06µm in the Esco2fl mice). Also the non-myelin nodes 
whose lengths were determined by measuring the distance between two adjacent paranodal 
CASPR stainings were affected (Figure 16-B and C): an elongation of approximately 50% of 
the nodes in the Esco2-depleted animals was observed (average length of 0.77±0.01µm in 
the Esco2wt vs. 1.18±0.02µm in the Esco2fl mice).  
In order to determine how many of the nodes and paranodes in the Esco2fl mice were affected 
by the elongation, a frequency distribution of different length intervals of these structures was 
performed (Figure 16-D and E). For both the nodes and the paranodes, a length interval of 
0.4µm was chosen, ranging from 0µm to 2.8µm in the nodes and from 1.2µm to 6.0µm in the 
paranodes. This analysis revealed that not all of the structures were elongated, but only some 
of those concentrated in the middle of the chosen range, while the extremely short and long 
structures appeared as often as in the Esco2wt control animals.  
 
Results  41 
 
Es
co
2
wt
Es
co
2
fl
0.0
0.5
1.0
1.5
no
de
 le
ng
th
 [µ
m
]
Es
co
2
wt
Es
co
2
fl
0
1
2
3
4
pa
ra
no
de
 le
ng
th
 [µ
m
]
a‘
a‘‘a‘
a‘‘
0.0 0.4 0.8 1.2 1.6 2.0 2.4 2.8
0
50
100
150
Esco2wt
Esco2fl
node length [µm]
fre
qu
en
cy
1.2 1.6 2.0 2.4 2.8 3.2 3.6 4.0 4.4 4.8 5.2 5.6 6.0
20
40
60
80 Esco2wt
Esco2fl
paranode length [µm]
fre
qu
en
cy
Esco2wt Esco2fl 
C
A
S
P
R
White matter 16wpi
A
B
D
E
E
s
c
o
2
fl 
E
s
c
o
2
w
t
CASPR Kv1.2 merge
W
h
it
e
 m
a
tt
e
r 
1
6
w
p
i
G
C
Node
Paranode
Juxtaparanode
F
*** **
 
Figure 16: Nodes of Ranvier at 16wpi in the cortical white matter. (A) Paranodal CASPR staining in Esco2wt 
and Esco2fl animals. Quantification of average length of the (B) nodes and (C) paranodes in Esco2wt and Esco2fl 
animals. Frequency distribution of length intervals of the (D) nodes and (E) paranodes in Esco2wt and Esco2fl 
animals. (F) Schematic drawing of the node of Ranvier in the CNS. (G) Paranodal (CASPR) and juxtaparanodal 
(Kv1.2) staining in Esco2wt and Esco2fl animals. Dashed lines frame the paranodal CASPR staining (upper and mid 
panel), that is adjacent to Kv1.2 staining in the Esco2wt but overlapping in the Esco2fl animals. White arrows (lower 
panel) indicate discontinuous CASPR staining with Kv1.2 staining (yellow arrows) in between. Scale bars represent 
10µm (A) and 5µm (G). Data are presented as mean±sem. Number of animals: n=3 for each bar. Number of nodes 
and paranodes: n=54 for each animal. Statistical analysis: unpaired student’s t-test, **p<0.001, ***p<0.0001. 
 
In the nodes, an increase in the frequency of lengths between 0.8µm-1.6µm and in the 
paranodes, an increase in the frequency of lengths between 2.0µm and 4.0µm could be 
observed in the Esco2fl mice. 
To identify the onset of the destabilization in the nodes of Ranvier in the Esco2fl mice, we 
performed the immunohistochemical CASPR analysis already at 11wpi (data not shown). 
However, at this earlier timepoint no changes is the nodal and paranodal structures were 
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detected, demonstrating that the disturbances only start at late stages, when already a high 
number of recombined NG2glia have been abalated. 
Disintegration of one component of the node of Ranvier is usually accompanied by the 
disintegration of other physiologically important components like the ion channels, as it occurs 
in different myelin pathologies (Arancibia-Carcamo and Attwell 2014). For this reason, the 
integral localization of the potassium channel Kv1.2 was immunohistochemically analyzed in 
the Esco2fl mice that, under physiological conditions is located at the juxtaparanode without 
overlapping with the paranode (Wang et al. 1993b). At 16wpi we found paranodes with 
overlapping CASPR and Kv1.2 stainings in the Esco2fl animals (Figure 16-G mid), as well as 
discontinuous CASPR stainings with some clustered Kv1.2 channels in between (Figure 16-G 
bottom), meaning that the juxtaparanodal Kv1.2 channels were spreading in the paranode and 
indicating that the juxtaparanodal integrity is also affected in these mice.  
In conclusion, some of the nodes of Ranvier in the cortical WM of the NG2-glia ablated mice – 
the same area were a reduced oligodendrogenesis was observed – showed a disintegration of 
their highly structured compartmentalization. 
3.1.4 NG2-GLIA ABLATED MICE DEVELOP LONG-TERM MOTOR DYSFUNCTIONS 
Proper structural organization of the nodes of Ranvier and subsequently an appropriate 
conduction velocity for propagating the axon potential alongside the axon are important factors 
to fulfil a normal physiology in the body, enable movements and motor coordination. In order 
to analyze whether the disintegration of the paranodal structures led to a phenotype in the 
motoric performance in our animal model, we carried out repetitive long-term behavioral tests 
(Figure 17). Animals were trained for two weeks and received three doses of tamoxifen during 
this time. After the training period, motor assessment was carried out on a weekly basis until 
the animals were perfused 29 weeks later (29wpi). The following standardized behavioral tests 
to assess motor functions were performed: I) a beam crossing test for coordination and 
balance, II) a grid walk test which accounts for a fine limb motor coordination, III) a rotarod 
test for cerebellar coordination and balance, IV) a horizontal irregular ladder test that is specific 
for corticospinal defects, as well as V) an open field test for general activity evaluation. The 
corticospinal-specific test was performed as a control experiment, to rule out that the NG2-
glia ablation not only affected the brain, but possibly also the spinal cord, where NG2-glia are 
less proliferative. In addition, a novel object recognition (NOR) test to evaluate the short-term 
memory of the Esco2fl mice was performed.  
In the beam crossing experiment, a progressive motor deficiency could be observed in the 
Esco2fl mice.  
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Figure 17: Beam crossing, grid walk and rotarod behavioral experiment. (A) Scheme of the experimental 
procedure. (B) Examples of Esco2wt and Esco2fl mice during the beam crossing experiment at 16wpi. Green arrow 
indicates a kyphosis (mid panel), black arrow the clamped hindlimbs (lower panel) in the Esco2fl mice. (C) Beam 
crossing performance of Esco2wt (orange) and Esco2fl (purple) animals at different timepoints after the training 
period. (D) Percentage of forelimb grid walk performance of Esco2wt (orange) and Esco2fl (purple) animals at 
different timepoints after the training period. (E) Percentage of hindlimb grid walk performance of Esco2wt (orange) 
and Esco2fl (purple) animals at different timepoints after the training period. (F) Time spent successfully on 
accelerating rotarod paradigm of Esco2wt (orange) and Esco2fl (purple) animals at different timepoints after the 
training period. Number of animals: Beam crossing: n=9 for for Esco2fl 2, 4, 6, 12wpi, n=8 for for Esco2fl 14wpi, 
n=7 for Esco2wt 2, 4, 6wpi, n=6 for Esco2wt 10 and 12wpi and Esco2fl 29wpi, n=5 for Esco2wt 14wpi, n=3 for Esco2wt 
29wpi. Forelimb and hindlimb grid walk analysis: n=9 for Esco2fl 3, 6, 11wpi, n=8 for Esco2fl 15wpi, n=7 for Esco2wt 
3, 6, 11wpi, n=6 for Esco2fl 29wpi and Esco2wt 15wpi, n=4 for Esco2wt 29wpi. Rotarod: n=3 for each timepoint. 
Data are presented as mean±sem. Statistical analysis: repeated measures ANOVA, nsp>0.05, ***p<0.0001. 
 
These motoric disturbances increased over time and reached several stages: at the beginning 
of the experiment, 100% of the Esco2fl mice crossed the beam normally, at 10wpi only 30% 
of the mice were able to cross the beam and the others were only able to hold themselves for 
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several seconds. By the end of the experiment, all of the mice were incapable to even sit on 
the beam. Finally, all Esco2fl animals lost their ability to cross the wooden beam within 14wpi, 
whereas 100% of the control littermates maintained their ability to do so (Figure 17-C). 
Additionally to the decreased coordination performance, we observed postural abnormalities 
in our mice while crossing the beam that was shown to be typical in de- or dysmyelinating 
diseases (Lappe-Siefke et al. 2003; Kassmann et al. 2007): a kyphosis, (Figure 17-B mid) as 
well as clamping of hind limbs around the beam (Figure 17-B bottom).  
Also in the grid walk experiment testing for fine limb coordination, a progressive misstep rate 
of the forelimbs in the Esco2fl animals was observed until the end of the experiment at 29wpi 
(Figure 17-D, Table 11 in supplementary tables). Both the Esco2wt and the Esco2fl mice started 
with a low misstep rate shortly after the training period at 3wpi (1.8±0.1% for the Esco2wt and 
1.7±0.2% for the Esco2fl mice). In the Esco2wt animals the misstep rate did not increased 
significantly during the course of the experiment, whereas the fine-tuned motor functions of 
Esco2fl animals progressively declined over time. Additionally, we observed progressively 
increasing postural abnormalities in this experimental paradigm: the misstep rate of the mice 
did not only increase, they also became slower and more instable in their movements during 
the motor tasks. The increasing misstep rate in the Esco2fl mice was also observed at the 
hindlimbs, but the effects were generally less severe compared with the forelimbs and also 
started later (Figure 17-E). In accordance with the forelimbs, also at the hindlimbs the Esco2wt 
control mice only showed a tendency to increase the misstep rate during the whole experiment. 
On the accelerating rotarod, Esco2fl mice showed a deteriorating ability to walk and balance 
themselves throughout the experiment compared to the littermate controls, although not 
significant (Figure 17-F, Table 13 in supplementary tables).  
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Figure 18: Open field and horizontal ladder behavioral experiment. (A) Open field performance of Esco2wt 
(orange) and Esco2fl (purple) animals at different timepoints after the training period. (B) Forelimb horizontal ladder 
performance of Esco2wt (orange) and Esco2fl (purple) animals at different timepoints after the training period. Data 
are presented as mean±sem. Number of animals: open field: n=7 for Esco2wt w3, n=6 for Esco2wt w15, n=5 for 
Esco2fl w3, n=4 for Esco2fl w15; ladder: n=7 for Esco2wt w3, n=6 for Esco2wt w15, n=8 for Esco2fl w3, n=8 for 
Esco2fl w15. Statistical analysis: repeated measures ANOVA, nsp>0.05. 
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As this experiment was only performed starting at 5wpi onwards when the Esco2fl mice already 
suffered from behavioral deficits in other paradigms, the two groups were already different 
during the first measurement. 
In contrast, the general activity of the Esco2fl animals in the open field – tested by counting 
the number of crossed fields within a period of four minutes during free movement in an open 
field arena – neither significantly changed over time in the Esco2fl mice (3wpi: 105.4±9.5 
fields/4min, 15wpi: 89.1±14.6 fields/4min), nor was it different compared with the Esco2wt 
mice (3wpi: 93.2±11.6 fields/4min, 15wpi: 100.8±23.0 fields/4min, Figure 18-A). The ability 
of Esco2fl mice to perform the corticospinal-specific horizontal ladder task with different step 
sizes did also not change between 3wpi and 15wpi (3wpi: 6.4±0.8%, 15wpi: 6.3±0.9%) and 
was comparable to age-matched littermate controls (3wpi: 6.3±1.2%, 15wpi: 6.8±0.7%, 
Figure 18-B). 
In order to assess whether the Esco2fl mice did not only develop deficits in motoric tasks, but 
also in establishing a short-term memory at long timepoints after induction, a novel object 
recognition (NOR) test was performed (Figure 19). This test was shown to be specific to short- 
and long-term memory formation located in the perirhinal cortex (Murray and Richmond 2001; 
Balderas et al. 2015). During the acquisition time with the presence of two similar objects, 
both Esco2wt and Esco2fl mice did not favor any of the objects, and explored them in a 
comparable fashion. 
 
 
Figure 19: Novel object recognition (NOR) experiment at 11wpi. (A) Examples of tracking plots from an 
Esco2wt and an Esco2fl mouse during the acquisition (upper panel) with two identical objects (red square) and the 
trial phase where one new object (green square) was placed in the open field arena. (B) Index of recognition 
(percentage of interaction with the new object) in Esco2wt and an Esco2fl mice at around 2 months after induction. 
Data are presented as mean±sem. Number of animals: n=3 for each bar. Statistical analysis: unpaired student’s t-
test, *p<0.05. 
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In the trial phase that was performed 30min after the acquisition phase, one object was 
replaced by a new and obviously different object (Figure 19-A). While the Esco2wt mice 
preferentially targeted the new and unknown object (index of recognition: 91.8±6.9%), the 
Esco2fl mice explored both the old and the new object similarly (index of recognition: 
50.8±6.6%, Figure 19-B), indicating that the Esco2fl mice did not remember the old object 
and hence were not able to establish a short-term memory. 
Summarizing the findings of the described behavioral assessment, Esco2fl mice develop – in 
contrast to littermate controls – progressively worsening motoric dysfunctions, including 
disorders in the fine movement coordination (grid walk), general movement coordination (grid 
walk, beam crossing) as well as in body balance (rotarod, beam crossing). Moreover, they are 
unable to establish a short-term memory that can specifically be located to the perirhinal 
cortex. 
3.1.5 THE NG2CREERT2XCAG-EGFPXESCO2FL/FL CONTROL MOUSE LINE 
As the Sox10 transcription is expressed in all cells of the oligodendrocyte lineage we wanted 
to rule out that the deletion of Esco2 in the genetic mouse model also affected mature 
oligodendrocytes or their derived functions. To prove that the above described phenotype 
solely derives from the ablation of NG2-glia, the inducible NG2CreERT2xCAG-eGFPxEsco2fl/fl line 
served as a control. As the NG2-promoter is only active in NG2-glia, the Esco2 deletion was 
only induced in the cells of interest and not in mature oligodendrocytes or any other cells 
within the oligodendrocyte lineage.  
Analyzing this mouse line by immunohistochemistry in coronal sections at 1wpi (Figure 20), 
we found a similar recombination of NG2-glia in the cortical GM (40.5±2.1% for NG2-Esco2wt 
vs. 46.8±1.7% for NG2-Esco2fl mice) as well as in the cortical WM (49.2±2% for NG2-Esco2wt 
vs. 45.5±4.8% for NG2-Esco2fl mice, Table 14 and Table 15 in supplementary tables). We did 
not find GFP-reporter expression in mature oligodendrocytes (CC1+/GFP+, data not shown) in 
this mouse line in comparison with the Sox10iCreERT2xCAG-eGFPxEsco2fl/fl line shortly after 
recombination (see chapter 3.1.1). Furthermore the recombination within the total NG2-glia 
population was much lower (around 80% in the Sox10-Esco2 and around 40% in the NG2-
Esco2 mouse line for both the Esco2wt and the Esco2fl mice). One year after the initial induction 
(1 year post induction, ypi), the recombined fraction of NG2-glia in the NG2-Esco2fl mice 
significantly decreased to 22.±2.7% in the GM and to 10.1±2.9% in the WM (Table 14 and 
Table 15 in supplementary tables). During this long analysis period, some of the recombined 
NG2-glia differentiated into mature oligodendrocytes (CC1+/GFP+).  
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Figure 20: Long-term analysis of recombined NG2-glia in NG2CreERT2 mice. (A) Recombined and non-
recombined NG2-glia in the cortical gray and white matter at 1wpi and 1ypi. Non-recombined NG2-glia are indicated 
with an asterisk. (B) Scheme of experimental procedure. (C) Absolute numbers of recombined (yellow) and non-
recombined (red) NG2-glia in the cortical GM at 1wpi and 1ypi in NG2-Esco2wt and NG2-Esco2fl mice. (D) Absolute 
numbers of recombined (yellow) and non-recombined (red) NG2-glia in the cortical GM at 1wpi and 1ypi in NG2-
Esco2wt and NG2-Esco2fl mice. Scale bars represent 25µm. Data are presented as mean±sem. Number of animals: 
n=3 for Esco2wt and Esco2fl 1wpi, n=4 for Esco2fl 1ypi. Statistical analysis: One-way ANOVA, *p<0.05, **p<0.001, 
***p<0.0001. 
 
However, the total number of GFP+ cells did not increase as expected because of the 
proliferative behavior of the NG2-glia population, but even slightly decreased over time (data 
not shown). To analyze whether these mice develop a similar phenotype due to a similar loss 
of recombined proliferating NG2-glia and its subsequent differentiation defects, we performed 
the same behavioral experiments that were used for the Sox10iCreERT2xCAG-eGFPXEsco2fl/fl 
line (Figure 21-A).  
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Figure 21: Motor behavior assessment of NG2CreERT2xCAG-eGFPxEsco2fl mice. (A) Scheme of 
experimental procedure. (B) Percentage of forelimb missteps during grid walk of NG2-Esco2fl animals at different 
timepoints after the training period. (C) Percentage of forelimb missteps during grid walk of age-matched control 
animals (45 weeks of age) at different timepoints after the training period. (D) Examples of NG2-Esco2fl mice during 
beam crossing. Arrowheads indicate clamping of the hind limbs (D’, D’’), additional stabilization with the tail (D’’’) 
and kyphosis (D’’’). Data are presented as mean±sem. Number of animals: n=4 for each bar. Statistical analysis: 
repeated measures ANOVA, nsp>0.05, **p<0.001, ***p<0.0001. 
 
The grid walk experiment revealed that also the NG2-Esco2fl mice developed a progressive 
forelimb misstep rate over time (Figure 21-B, Table 16 in supplementary tables), although it 
occured later and less severe compared with the Sox10-Esco2fl mice. Therfore this control 
experiment gave further evidence that the motor phenotype was a result of the NG2-glia 
ablation rather than of malfunctioning oligodendrocytes. Interestingly, the misstep rate of the 
NG2-Esco2fl mice reached a plateau starting at 40wpi and no further increase could be 
observed until 50wpi. As no control littermates of the NG2CreERT2xCAG-eGFPxEsco2fl/fl line 
were available, the control experiments were carried out with mice of a similar breeding 
background (NG2CreERT2xCAG-eGFP mouse line). To rule out that the increase in misstep rate 
was solely caused by the effect of aging, the grid walk experiment was performed at the 
starting age of 45 weeks in those mice what corresponded to the age of the NG2-Esco2fl mice 
at the end of the experiment. The forelimb grid walk performance of those age-matched 
control animals did not increase between 3wpi and 15wpi (Figure 21-C, Table 17 in 
supplementary tables), proving that the motor phenotype was not an age-correlated effect. In 
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addition to the grid walk experiment, the NG2-Esco2fl mice were analyzed for their beam 
crossing performance during the whole period. Although only 75% the mice (three out of four) 
failed to cross the wooden beam by the end of the experiment at 50wpi, all of them developed 
similar postural abnormalities that were already observed in the Sox10-Esco2fl mice (Figure 
21-D). During the motor performance tests, they clamped their hindlimbs around the beam 
(D’ and D’’), sometimes additionally twisted their tail around the beam (D’’’) or showed the 
typical kyphosis (D’’’’).  
As the experiment proved, the NG2-Esco2fl mice developed a motor phenotype comparable to 
the Sox10-Esco2fl mice, however the effects were lower and appeared later in this mouse line. 
The difference could be explained by the significantly lower recombination rate of NG2-glia in 
the NG2CreERT2xCAG-eGFPxEsco2fl/fl line. To correlate the observed phenotype with subcellular 
changes in the cortical WM, both the average lengths of the paranodes and nodes of these 
mice were immunohistochemically measured in coronal sections at 1ypi for the NG2-Esco2fl 
mice as well as for the age matched control animals that were used for the behavioral 
experiments (Figure 22). Indeed, the NG2-Esco2fl mice showed a significantly longer average 
node length (1.14±0.03µm) compared with aged-matched controls (0.81±0.02µm). Moreover, 
the paranodes of these mice were similarly elongated (2.40±0.06µm in the control and 
3.16±0.03µm in the NG2-Esco2fl mice). 
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Figure 22: Nodes of Ranvier in the NG2CreERT2xCAG-eGFPxEsco2fl mice. (A) Paranodal CASPR staining in 
the cortical WM of 15mo old recombined control and NG2-Esco2fl mice. Quantification of average length of the (B) 
paranodes and the (C) nodes in control and NG2-Esco2fl animals at the age of 15 months. Data are presented as 
mean±sem. Number of animals: n=4 for each bar. Number of nodes: n=58 for each animal. Statistical analysis: 
unpaired student’s t-test, ***p<0.0001.  
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In summary, Esco2- and the resulting NG2-glia-ablation could also be achieved using the NG2 
promoter in the NG2CreERT2xCAG-eGFP mouse line, but as the recombination rate in this 
mouse line was much lower, the ablation effects were less severe. However, these mice also 
developed a motor phenotype as well as nodal disturbances, although both observations 
appeared milder and at later timepoints after the induction. 
3.1.6 BEHAVIORAL PHENOTYPE IS NOT DERIVED FROM THE PERIPHERAL NERVOUS SYSTEM 
Sox10 is a promoter that is not only active in all cells within the oligodendrocyte lineage in the 
adult brain, but also in several cells of other tissues including the Schwann cells in the 
peripheral nervous system (PNS) and in neuromuscular junctions. Given the described 
reduction in motor skills, it was mandatory to exclude the possibility that this phenotype was 
intensified or even induced by the ablation of recombined cells in the PNS. Therefore, Schwann 
cells in the sciatic nerves as well as in muscle spindles and neuromuscular junctions of multiple 
skeletal muscles were analyzed in the Esco2fl mice. Although we found a high number of 
recombined cells within the Schwann cell population in the sciatic nerve at 5dpi (data not 
shown), the number of these cells was not changed in the Esco2-ablated animals at 16wpi 
compared with the Esco2wt mice (88.7±0.4% for the Esco2wt and 88.9±1.1% for the Esco2fl, 
see Figure 23-A and B). However, as Schwann cells in the adult mouse were shown to be 
postmitotic under physiological conditions (Cheng and Zochodne 2002), a cell death of 
recombined Schwann cells in the Esco2fl mice was not expected. Analyzing the total number 
of DAPI+ in sciatic nerves (data not shown), we did not find any differences in the Esco2fl 
(1926±23.6 cells/mm2) compared with the Esco2wt animals (1889±6.5 cells/mm2), indicating 
that also other cell types were not affected in the sciatic nerve. This leads to the assumption 
that the genetic deletion of Esco2 in postmitotic peripheral Schwann cells did neither induce 
cell death in this population, nor did it affect the cellular composition of peripheral nerves. 
In order to determine if the myelin structure in the periphery shows some abnormalities in 
their nodal organisation as it could be observed in the corpus callosum, we additionally 
analyzed teased fibers of sciatic nerves, measured the internode length and analysed the 
organization of the nodal structures by means of immunohistochemical CASPR staining. Again, 
this analysis did neither reveal any difference in the average internode length between the 
NG2-depleted animals and their controls (143.7±2.1µm for the Esco2wt and 142.9±2.1µm for 
the Esco2fl mice), nor in the structural organization of the node of Ranvier (Figure 23-C and 
E). 
Moreover, Schwann cells are not only essential for the development and maintenance of the 
neuromuscular junction (NMJ) (Wu et al. 2010a), but they also play an important role in muscle 
spindles.  
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Figure 23: Schwann cells and nodes of Ranvier in the PNS. (A) Quantification of recombined (yellow) and 
non-recombined (red) Schwann cells (S100β+) in Esco2wt and Esco2fl mice at 16wpi. (B) Examples of recombined 
(yellow) and non-recombined (red) Schwann cells in longitudinal sections of the sciatic nerve. (C) Internode length 
in teased fibers of peripheral sciatic nerves in Esco2wt and Esco2fl animals at 16wpi. (D) CASPR staining in teased 
fibers of peripheral sciatic nerves in Esco2wt and Esco2fl animals at 16wpi. Arrows indicate CASPR+ nodes of Ranvier, 
the distance between two nodes was considered as internode length. (E) CASPR+ nodes of Ranvier in longitudinal 
sections of sciatic nerves in Esco2wt and Esco2fl mice at 16wpi. Scale bars represent 20µm (B), 50µm (D), and 10µm 
(E). Number of animals: n=3 for each bar. Data are presented as mean±sem. Statistical analysis: unpaired student’s 
t-test, nsp>0.05. 
 
Their death can lead to the fragmentation and disruption of these structures, resulting in 
severe deficits (Reddy et al. 2003). Therefore we analyzed the neuromuscular junctions by α-
Bungarotoxin (αBTX) staining as well as the muscle spindles by neurofilament staining (NFH) 
in different skeletal muscles at 16wpi in this mouse model (collaboration with Yina Zhang and 
Stephan Kröger, Institute of Physiology, Ludwig-Maximilians-Universität). In this analysis we 
neither found an accumulation of fragmented NMJs, nor a disruption of the GFP-associated 
muscle spindles (data not shown). 
Summarizing, tamoxifen induction in the Sox10iCrexCAG-eGFPxEsco2fl/fl mouse line resulted in 
a high recombination rate of Sox10-expressing cells in the PNS, as well as in muscle-associated 
Schwann cells. However, as these cells are postmitotic in the adult peripheral nerve, genetic 
Esco2 ablation did not trigger cell death in this area and thus, did not seem to affect these 
structures. 
3.1.7 NG2-GLIA ABLATED MICE DEVELOP A DECELERATING NERVE CONDUCTION VELOCITY 
Experiments and results of this chapter have been performed in collaboration with José Maria 
Delgado García and Agnès Gruart I Massó from the Universidad Pablo de Olavide in Sevilla. 
The content was used herein and printed with their permission. 
Results  52 
 
A highly structured and functional organization of the nodes of Ranvier are one of the 
prerequisites for proper action potential conduction alongside the myelinated axon. Any 
disturbances in these structures – even to a low degree – were shown to strongly influence 
electrical properties in the nodal regions and therefore negatively influence the action potential 
propagation. Thus, as the Esco2fl mice showed a high degree of disintegration in their nodes 
of Ranvier, it was inevitable to determine the nerve conduction velocity of myelinated fibers in 
the cortical WM. As in our lab we did neither have the expertise nor the equipment to perform 
these kind of experiments, they were performed by our collaboration partners José Maria 
Delgado García and Agnès Gruart i Massó (División de Neurociencias, Universidad Pablo de 
Olavide, Sevilla, Spain).  
 
 
Figure 24: Electrophysiological recordings of the nerve conduction velocity. (A) Example of an awake 
mouse with implanted electrodes. (B) Exemplary electrode localization in the cortical white matter in a coronal brain 
section. One electrode was used to evoka a stimulus, the electrode in the other hemisphere recorded the latency 
of the evoked field potential at this place. (C) Scheme of experimental procedure. (D) Exemplary histogram of the 
recorded field potentials. Time between the stimulus and the second minimum (blue arrow, latency) indicated the 
latency of the first component representing the myelinated fibers. (E) Latency recordings of Esco2wt and Esco2fl 
mice during different sessions (S1-S11) after the surgery. Number of electrodes: n=4 for each timepoint. Data are 
presented as mean±sem. Statistical analysis: One-way ANOVA, *p<0.05.  
Experiments were performed and data nicely provided by collaboration partners José Maria Delgado García and 
Agnès Gruart i Massó (División de Neurosciencias, Universidad Pablo de Olavide, Sevilla, Spain). 
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Adult mice at the age of eight to ten weeks were induced with tamoxifen and two weeks later 
underwent surgery to permanently implant teflon-coated tungsten wire electrodes into the 
corpus callosum (Figure 24-B, coordinates of stimulating electrode: +1.5mm lateral, 1.34 mm 
posterior to bregma; coordinates of recording electrode: -1.5mm lateral, 1.34 mm posterior to 
bregma), as recently reported in (Murcia-Belmonte et al. 2015). After some time of recovery, 
mice passed eleven recording sessions (S1 – S11) between 4wpi and 15wpi in which the 
latency of the evoked field potential from the stimulating electrode of the response at the 
recording electrode was measured. During the first recording sessions (S1 – S5) the latencies 
of the first component were similar in both the Esco2wt and the Esco2fl mice (Figure 24-E, Table 
18 in supplementary tables). However starting from S6 (corresponding to 8wpi), a slight 
increase in the latencies could be observed in the latter ones that was further ascending until 
the end of the experiment, while the wildtype controls retained their starting latencies over 
the whole time. These results therefore demonstrate a reduction in the nerve conduction 
velocity in the Esco2fl mice starting from around 8wpi, becoming significant at 15wpi. 
Interestingly, around the same time after induction, a significant increase in the nodal and 
paranodal lengths in the WM could be observed.  
Although the latency does not explicitly represent the nerve conduction velocity, it can directly 
be correlated to it. Both electrodes were permanently implanted using the same coordinates 
in all mice, therefore the distance of the recorded signal remains stable and a delay in the 
latency necessarily describes the slowing down of the nerve conduction velocity in myelinated 
axons.  
Succinctly, these data clearly demonstrate that the maintenance of the oligodendrocyte lineage 
equilibrium and the structural organization of the node of Ranvier are necessary to keep 
electrophysiological brain properties, and that the disturbance can lead to long-term 
perturbation in the nerve conduction velocity.  
 
3.2 NG2-GLIA ABLATION IN THE INJURED BRAIN 
As described in the previous chapter, genetic deletion of Esco2 in NG2-glia cells in the 
Sox10iCrexCAG-eGFPxEsco2fl/fl mouse line is an efficient mechanism to induce apoptotic cell 
death in recombined cells and to reduce the total number of GFP+ cells in the healthy brain 
over time. However, as the cell cycle of NG2-glia in the healthy GM is rather slow, non-
recombined cells have enough time to compensate for this loss, leading to stable numbers of 
NG2-glia.  
On the other hand, NG2-glia are well-known to increase their cell numbers after different kinds 
of injury. They achieve this increase by shortening their cell cycle length and enhancing their 
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proliferation rate as well as by actively migrating into the lesion site. The functions behind 
these active cellular dynamics, however, remain unclear. To analyze the possible functions of 
NG2-glia after injury, we used the Sox10iCrexCAG-eGFPxEsco2fl/fl mouse line to deplete 
proliferating cells after injury and thus achieve a reduction of NG2-glia in close proximity to 
the lesion site. 
3.2.1 ESCO2 DELETION CAUSES FAST LOSS OF PROLIFERATIVE RECOMBINED NG2-GLIA IN CLOSE PROXIMITY 
TO THE LESION SITE 
Being eight to ten weeks-old, adult Sox10iCreERT2xCAG-eGFPxEsco2fl/fl mice were induced with 
tamoxifen according to the protocol described above. After a short five day wash-out period 
of the tamoxifen, a stab wound lesion of 0.6mm in depth and 1.5mm in length was applied to 
the somatosensory cortex (Figure 25-A). Coronal sections of the animals’ brains were 
subsequently immunohistochemically analyzed at two, four, seven and 14 days post lesion 
(dpl). 
The GFP+ cells in the Esco2wt mice – within a distance of approximately 250µm from both sides 
of the lesion – showed the normal reaction of NG2-glia after injury with an increase in cell 
numbers within the first 7dpl and a subsequent stabilization of cell numbers toward control 
levels until 14dpl. The numbers of GFP+ cells in Esco2fl mice on the contrary continuously 
decreased until 14dpl (Figure 25-C, Table 19 in supplementary tables). 
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Figure 25: Model of stab wound injury. (A) Schematic drawing of lesion area and lesion size in the cortical GM. 
(B) Scheme of experimental procedure. (C) Quantification of GFP+ cells/mm² at different timepoints after injury 
surrounding the stab wound lesion in the cortical GM in Escowt and Escofl mice. Data are presented as mean±sem. 
Number of animals: n=3 for each bar. Statistical analysis: One-way ANOVA, nsp>0.05, ***p<0.0001. 
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Figure 26: Recombined and non-recombined NG2-glia at early timepoints after lesion. Recombined and 
non-recombined NG2-glia on the contralateral side and in close proximity to the stab wound lesion (indicated with 
a dashed line) at the control side and at 2dpl and 4dpl in Esco2wt and Esco2fl mice. Non-recombined NG2-glia in 
the blow-up pictures are indicated with an asterisk. Scale bars represent 50µm, and 25µm in the blow-up pictures. 
 
Although the total number of GFP+ cells includes all oligodendrocyte lineage cells, it is most 
likely that the reduction of the GFP+ cell pool was a result of the depleted proliferating NG2-
glia, as postmitotic oligodendrocytes should not be affected by the lack of Esco2. Hence, 
stimulating the environment by outer insult triggered the proliferative capacity of NG2-glia, 
and therefore increased the cell death in the NG2-glia population that is lacking the cell cycle 
protein Esco2.  
In order to see how specifically recombined NG2-glia react within the total GFP+ cell pool after 
cortical stab wound injury, NG2/GFP double staining was performed in coronal sections and 
quantified in the same distance around the lesion site (Figure 26, Figure 27 and Figure 28-A). 
Indeed, comparable to the whole GFP+ cell population, the total number of recombined NG2-
glia (NG2+/GFP+) in Esco2fl mice was continuously declining, starting at 2dpl, finally at 14dpl 
most of the GFP+NG2-glia have disappeared (Figure 28, Table 20 in supplementary tables).  
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Figure 27: Recombined and non-recombined NG2-glia at late timepoints after lesion. Recombined and 
non-recombined NG2-glia in close proximity to the stab wound lesion (indicated with a dashed line) at 7dpl and 
14dpl in the Escowt and Escofl mice. Non-recombined NG2-glia in the blow-up pictures are indicated with an asterisk. 
Scale bars represent 50µm, and 25µm in the blow-up pictures.  
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Figure 28: Total numbers of recombined and non-recombined NG2-glia at different timepoints after 
lesion. (A) Absolute numbers/mm² of recombined (yellow) and non-recombined (red) NG2-glia in the distance of 
250µm around the lesion site in the Escowt and Escofl mice at different timepoints after the lesion. (B) Absolute 
numbers/mm² of recombined (yellow) and non-recombined (red) NG2-glia in the lesion core (50µm around the 
lesion) in the Escowt and Escofl mice at different timepoints after the lesion. Data are presented as mean±sem. 
Number of animals: n=3 for each bar, n=4 for Escofl at 2dpl and 4dpl in A. Statistical analysis: One-way ANOVA + 
Tukey post-test, nsp>0.05, **p<0.001, ***p<0.0001. 
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This reduction in the recombined cell fraction resulted in a significantly reduced overall density 
of NG2-glia compared with Esco2wt mice at every timepoint that was analyzed. 
Having a close-up look at NG2-glia, it appeared that their cell body as well as their processes 
occupied a smaller surface and therefore were less hypertrophic as well as less ramified and 
branched in the Esco2fl mice compared with those in the Esco2wt controls. Moreover, especially 
at 4dpl the NG2-glia in the Esco2fl mice around the lesion were not homogeneously distributed: 
NG2-glia-depleted patches of up to 100x100µm² could be found (data not shown). Starting at 
4dpl, the non-recombined NG2-glia in the Esco2fl mice began to compensate for the loss of 
recombined cells by increasing their rate of proliferation (data not shown), however, at this 
stage they were not yet able to fully compensate. In contrast to the contralateral side, the 
total number of NG2-glia – both NG2+/GFP- and NG2+/GFP+ – significantly decreased in the 
Esco2wt mice within the first four days after the lesion as well (most likely due to direct cell 
damage). Nevertheless, a significant enrichment in the cell density was measured thereafter 
that is kept until 14dpl. Notably, the fraction of non-recombined NG2-glia (NG2+/GFP-) was 
increasing in proportion to the whole NG2-glia population in Esco2wt mice after the lesion (2dpl: 
25.4±0.3%, 4dpl: 29.6±1.7%, 7dpl: 35.3±1.9%, 14dpl: 38.4±2.8%), due to higher 
proliferation rates of this cell fraction compared with its recombined counterpart (data not 
shown). Looking at the NG2-glia reaction after stab wound injury in the lesion core (around 
50µm from each side of the insult), the NG2-glia dynamics in the Escowt mice were different 
from the wider surrounding that was analyzed before (Figure 28). The peak of total NG2-glia 
numbers in the lesion core was already reached at 4dpl in contrast to the 250µm area which 
peaks only at 7dpl, with more than a two-fold increase compared with the controls. This NG2-
glia accumulation was so pronounced that individual NG2-glia in the lesion core were difficult 
to be identified. 
Thereafter, cell numbers were rapidly declining, reaching almost their control level at 14dpl. 
In the Esco2fl mice, recombined NG2-glia (GFP+/NG2+) were – similar to the bigger surrounding 
of the lesion – progressively reduced compared with Esco2wt littermate controls (Figure 28-B, 
Table 22 in supplementary tables). Although the non-recombined NG2-glia fraction in the 
Esco2fl mice (NG2+/GFP-) increased at 7dpl, the whole NG2-glia population (GFP+ and GFP-) in 
the lesion core was always kept at control levels and NG2-glia did not increase significantly in 
the lesion core as it was observed in the Esco2wt mice (Figure 28-B, Table 23 in supplementary 
tables).  
Summarizing, we found that following stab wound injury, recombined NG2-glia in the Esco2fl 
mice were – especially inside the lesion core - ablated rapidly. This resulted in a significant 
reduction in total NG2-glia numbers in close-proximity to the lesion core until 14dpl, as the 
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remaining non-recombined cells did not have enough time to compensate for the occurred 
rapid loss. 
3.2.2 NG2-GLIA ABLATION DELAYS WOUND CLOSURE 
Just recently, NG2-glia were shown to actively migrate into the lesion site and were therefore 
suggested to play a more important role in the early stages of wound closure after insult in 
contrast to what has previously been anticipated (von Streitberg and Schneider et al. 
submitted). To address their role in this context, the size of the lesioned area in both Esco2wt 
and Esco2fl mice was analyzed at different timepoints after the lesion (Figure 29), at which the 
total number of NG2-glia in close-proximity to and inside the lesion core was significantly 
reduced (Figure 28). At 2dpl, the lesion size in Esco2wt (0.133±0.025mm2) and Esco2fl 
(0.144±0.014mm2) animals was comparable. While in the control mice the lesion size was 
significantly reduced within 4dpl (0.058±0.004mm2) and almost closed within 7dpl 
(0.035±0.009mm2), no signs of wound closure could be observed in Esco2fl mice at 4dpl, the 
size of the lesion even slightly increased to 0.153±0.017mm2.  
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Figure 29: Lesion size at different timepoints after injury. (A) Lesion size (surrounded by dashed line). (B) 
Quantification of lesion size in mm2 of Esco2wt and Esco2fl mice at different timepoints after the lesion. Scale bar 
represents 200µm. Data are presented as mean±sem. Number of animals: n=3 for Esco2wt at 2dpl and 7dpl, n=4 
for Esco2wt at 4dpl, n=5 for Esco2fl at 2dpl and n=6 for Esco2fl at 4dpl and 7dpl. Statistical analysis: One-way 
ANOVA + Tukey post-test, **p<0.001. 
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Only between 4dpl and 7dpl, the lesion became smaller (0.091±0.018mm2). Within 14dpl, the 
lesion was almost closed both in the Esco2wt (0.003±0.0mm2) and the Esco2fl animals 
(0.008±0.002mm2), indicating that the wound closure capacity has not been completely 
abolished but only delayed. 
Summarizing, the significant reduction of NG2-glia in Esco2fl mice in close proximity to the 
lesion site and inside the lesion core induced a significant delay in the physiological process of 
wound closure. 
3.2.3 CLOSURE OF THE BLOOD-BRAIN-BARRIER 
In brain injuries in which the vasculature was damaged, the fast and efficient closure of the 
BBB to avoid further cell infiltration and tissue destruction is a normal process of cellular wound 
healing and repair. As the depletion of proliferating, recombined NG2-glia in the Esco2fl mice 
after stab wound injury significantly delayed the wound closure (Figure 29), it was reasonable 
to analyze the blood vessel leakage in our mouse model and to determine if the reduced 
numbers of NG2-glia induces any delay in the closure of the BBB. To specify whether the 
closure of the BBB is delayed in Esco2fl mice, we analyzed the leakage of a tail vein-injected 
green fluorescent dextran into the brain parenchyma at 5dpl in both the Esco2wt and the Esco2fl 
group. This specific timepoint was chosen because control experiments revealed that the BBB 
was closed at 5dpl, but still open at 4dpl, as demonstrated in the positive control (Figure 30). 
However, leakage of the fluorescent dye into the brain parenchyma at 5dpl could neither be 
detected in Esco2wt, nor in Esco2fl animals. These results indicated that in both groups the BBB 
was successfully closed within 5dpl and that the loss of NG2-glia in the Esco2fl mice did not 
significantly influence the astrocyte function in terms of the vasculature repair. 
 
 
Figure 30: Closure of the blood-brain barrier. (A) Scheme of experimental procedure. (B) Dextran-fluorescein 
injected into the tail vein of mice is leaking into the brain parenchyma when the BBB is not closed at 4dpl (positive), 
whereas leakage can neither be detected in Esco2wt nor in the Esco2fl animals at 5dpl, meaning that the BBB was 
closed equally fast. These data were obtained in collaboration Axel von Streitberg, Institute of Physiology, LMU 
Munich. 
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3.2.4 REDUCED INJURY RESPONSE OF OTHER GLIAL CELL POPULATIONS 
The previous chapters revealed that the loss of recombined NG2-glia after injury causes a 
reduction in the total NG2-glia population, however as glial cells in the healthy adult brain are 
highly interactive and dependent on each other, it would not be surprising that glial cells 
communicate with each other also after TBI.  
 
 
Figure 31: Reaction of resident microglia and invading macrophages. (A) Microglia/macrophages in 
Esco2wt and Esco2fl mice in the surrounding of around 250µm from the lesion site at 2dpl and 4dpl. (B) Quantification 
of Iba1+ microglia/mm² in Esco2wt and Esco2fl mice at different timepoints after the lesion. (C) Microglia (Iba1+), 
reactive microglia (Iba1+/CD45+) and invading macrophages (Iba1-/CD45+) in Esco2wt and Esco2fl mice in close 
proximity to the lesion site at 2dpl and 4dpl. (D) Quantification of Iba1+/CD45+ activated microglia/mm² in Esco2wt 
and Esco2fl mice at different timepoints after the lesion. (E) Quantification of CD45+ macrophages/mm² in Esco2wt 
and Esco2fl mice at different timepoints after the lesion. Scale bars represent 50µm. Data are presented as 
mean±sem. Number of animals: n=3 for each bar. Statistical analysis: One-way ANOVA + Tukey post-test, 
nsp<0.05, **p<0.001, ***p<0.0001. 
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Although this research area is just emerging currently, there is already a high body of evidence 
that glial cells do indeed activate and regulate each other after injury by releasing different 
factors (Wu et al. 2010b; Kang et al. 2013; Clemente et al. 2013). 
In order to determine whether and to which extent NG2-glia affect microglia/macrophages 
and astrocytes after injury, the two other glial cell types were immunohistochemically analyzed 
following significant NG2-glia ablation at two, four and seven days after stab wound injury in 
coronal brain sections within a distance of approximately 250µm around the lesion site. 
As mentioned in the introduction, microglia are amongst the first cell types to respond after 
stab wound injury. Indeed, in the Esco2wt control animals, Iba1+ microglia rapidly increased in 
number until 4dpl in response to injury and slowly decreased thereafter to almost normal 
levels. In the Esco2fl mice on the other hand this cellular increase at 4dpl could not be observed, 
however the analysis for the other timepoints at 2dpl and 7dpl did not reveal any significant 
differences in cell numbers (Figure 31-A and B, Table 24 in supplementary tables).  
Although lower in absolute numbers, significantly more microglia in Esco2fl mice at 4dpl turned 
out to be positive for the marker CD45 (Iba1+/CD45+) compared with the controls, indicating 
that more microglia were reactive. This phenomenon could still be observed at 7dpl, 
demonstrating that microglia/macrophages in the Esco2fl mice were also activated for a longer 
time compared with those in the littermate controls, whose the microglia activation went back 
to almost physiological levels at this timepoint (Figure 31-C and D, Table 25 in supplementary 
tables).  
Besides the activation of microglia, the infiltration of bone-marrow-derived macrophages that 
are CD45+/Iba1- is a physiological reaction upon injury, going along with a disruption of the 
BBB. However this population in the Esco2fl animals, was significantly higher at 4dpl compared 
with the controls, where only less than half of these numbers could be identified. At 7dpl, the 
invading CD45+/Iba1- cell fraction in the wildtype was significantly reduced, while they were 
still present in high numbers in the Esco2fl mice (Figure 31-E, Table 26 in supplementary 
tables). 
In order to analyze whether the loss of NG2-glia in the Sox10iCreERT2xCAG-eGFPxEsco2fl 
mouse model induces similar effects in the reaction of astrocytes as it did in 
microglia/macrophages, the total numbers (determined as S100ß+) as well as the reactivity 
status of astrocytes (determined as GFAP+) were immunohistochemically analyzed in coronal 
brain sections at 4dpl and 7dpl (Figure 32). At 4dpl, the total number of S100β+ astrocytes in 
Esco2fl mice was significantly reduced in comparison to the wildtype controls. Between 4dpl 
and 7dpl, the astrocyte numbers in the Esco2wt mice significantly increased as a normal 
reaction to the injury. This injury-specific increase was also observed in the Esco2fl mice, 
however at this stage the total cell numbers were still significantly lower in the Esco2-depleted 
Results  62 
 
animals compared with the Esco2wt mice (Table 27 in supplementary tables). Preliminary data 
suggest that at 14dpl the total numbers of GFAP up-regulated cells again reached the level of 
the controls (data not shown), indicating that the astrocyte activation is not fully disturbed but 
only delayed.  
Astrocytes in their physiological reaction to injury did not only increase in numbers, they also 
upregulated the reactivity marker GFAP. Besides the difference in astrocyte numbers between 
Esco2wt and Esco2fl mice, also their reactivity status was changed. At 4dpl 81.5±1.2% of the 
astrocytes were reactive (S100β+/GFAP+) in the Esco2wt, while only 58.1±4.2% of these 
double-positive cells could be found in the Esco2fl mice. Although the proportion of reactive 
astrocytes in the Esco2fl mice increased to 83.4±0.9% until 7dpl and was therefore not 
different from the Esco2wt group (89.5±2.1%), the absolute number of reactive astrocytes 
remained significantly lower (Figure 32, Table 27 in supplementary tables). 
The GFAP-expressing astrocytes in the Esco2fl mice first seemed to be less hypertrophic in 
their morphology and secondly to express lower levels of the GFAP protein compared with the 
hypertrophic astrocytes that could be observed in the wildtype controls (Figure 32-A blow-up 
pictures). 
In conclusion, the analysis of the other glial cell types in the context of a reduced NG2-glia 
population revealed that the physiological reaction of both microglia and astrocytes was 
significantly altered compared to the wildtype condition where sufficient numbers of NG2-glia 
were present. Moreover, these mice showed an increased number of infiltrated blood cells 
inside the lesioned tissue even at late stages after injury. These data are giving evidence that 
NG2-glia play an important role in the communication with and cross-activation of other glial 
cell populations in the adult brain after injury. 
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Figure 32: Astrocyte reaction after injury. (A) GFAP-reactive astrocytes in Esco2wt and Esco2fl mice at 4dpl. 
Lesion is indicated with a dashed line. Numbered boxes indicate individual GFAP-expressing astrocytes. (B) 
Quantification of reactive (S100β+/GFAP+) and non-reactive (S100β+) astrocytes at 2dpl and 4dpl in Esco2wt and 
Esco2fl animals. Scale bars represent 50µm and 10µm in blow-ups. Data are presented as mean±sem. Number of 
animals: n=3 for each bar. Statistical analysis: One-way ANOVA + Tukey post-test, nsp>0.05, ***p<0.0001.
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4 DISCUSSION AND FUTURE PERSPECTIVES 
4.1 ABLATION OF NG2-GLIA IN THE HEALTHY BRAIN 
4.1.1 NG2-GLIA NETWORK IS MAINTAINED AT THE EXPENSE OF OLIGODENDROGENESIS 
NG2-glia in the adult cerebral cortex carry the unique feature of being proliferative while at 
the same time they keep generating mature oligodendrocytes throughout life – two features 
that turn them into progenitors of their own lineage. Many fate mapping studies of some 
cortical regions already addressed these cellular properties and described them extensively 
(Dimou et al. 2008; Simon et al. 2011; Clarke et al. 2012; Young et al. 2013). However, the 
physiological importance for this lifelong cycling capacity has not been addressed to the same 
extend so far. In the present study, we aimed to specify the underlying function and the 
importance of mitotically active NG2-glia by ablating them in the Sox10iCreERT2xCAG-
eGFPxEsco2fl/fl mouse line, in which specifically proliferating NG2-glia were targeted to undergo 
apoptosis.  
Although the apoptotic ablation was efficient in Esco2fl mice both in the GM and in the WM of 
the cerebral cortex (Figure 9 and Figure 10), not all recombined cells could be ablated even 
within four months, although it was demonstrated that between 80% and 100% of all NG2-
glia re-enter their cell cycle within approximately one month in young adult mice (Simon et al. 
2011; Young et al. 2013). Moreover, especially in the GM, some of the recombined NG2-glia 
incorporated BrdU, clearly indicating that these cells could finish their cell cycle even in the 
apparent absence of Esco2. One reason could be that although Esco2 is ablated in these cells, 
they are still able to finish their cell cycle properly by using alternative mechanisms to 
compensate for the lack of the Esco2 protein. The orthologue Esco1 is still present and 
therefore some of the cycling cells could have overcome the loss of Esco2 due to its partial 
redundancy and potentially different mechanisms to provide cohesion of sister chromatids 
(Hou and Zou 2005; Minamino et al. 2015). It seemed that especially cells having an extremely 
slow cell cycle length could escape the loss of Esco2, while faster cycling cells, e.g. from the 
WM seemed to be depleted more efficiently. Furthermore, tamoxifen-mediated Cre-
recombination was shown to be not equally efficient at different loci in the genome. This could 
result in the successful recombination of the GFP, but not the Esco2 locus (Nagy 2000), also 
allowing a normal cell cycle despite a visually apparent recombination, as Esco2 is expressed 
in normal levels. However, as in this mouse line all cells carry several copies of the BAC 
encoding the Cre-recombinase (Simon et al. 2012), the probability thereof is rather low. As 
there are no antibodies working in immunohistochemistry that could be used to stain the very 
shortly expressed Esco2 protein, the ablation of Esco2 could not be verified with 
immunohistochemistry in this work. In situ hybridization for testing the mRNA-expression 
Discussion and future perspectives  64 
 
levels of the Esco2 locus in sections of this mouse line would be a reliable method to address 
this issue. However, as the timely expression of Esco2 is very short and no data exist on the 
number of NG2-glia expressing it at a specific timepoint, this would be difficult to realize. 
Besides the death of NG2-glia in the knockout mice, both the number as well as the proportion 
of recombined NG2-glia was also slightly decreasing over time in Esco2wt mice, mainly in the 
WM but not as prominent in the GM (Figure 11). One explanation hereof would be the 
existence of a perpetually added pool of non-recombined NG2-glia originating from the SVZ, 
that only migrate into the WM but not into the GM (Menn et al. 2006; Ortega et al. 2013). 
Another hypothesis could be the existence of two different subsets of NG2-glia with different 
proliferation capacities. Low Sox10 expressing cells (the non-recombined ones) might 
preferentially proliferate to maintain the NG2-glia population compared with the high Sox10 
expressing (the recombined) ones, which in turn could then be preferentially differentiating. 
So far, it is supposed that Sox10 is expressed in all NG2-glia (Kuhlbrodt et al. 1998), however, 
Sox10 expression levels in these cells have not been addressed so far. A pilot experiment with 
the mouse line used in this study strengthened the hypothesis of two subpopulations: Inducing 
Esco2fl mice a second time with tamoxifen after 16wpi when most of the recombined NG2-glia 
were already ablated did only result in half of the recombination rate compared with the first 
round of induction. This could mean that these cells did intrinsically not express enough of the 
Sox10 transcription factor and subsequently the CreER fusion protein in order to achieve 
recombination. Moreover, preliminary Sox10-stainings in this experiment revealed that only 
GFP-expressing NG2-glia were also strongly positive for Sox10, whereas the non-recombined 
NG2-glia did not seem to express it at detectable immunohistochemistry levels. However, it 
cannot be ruled out that the reduced recombination rate after the second recombination at 
16wpi was only an effect of the aging brain where the recombination rate is generally less 
efficient and not due to non-recombinable subsets. To further strengthen the hypothesis of 
different subpopulations, recent work from our lab demonstrated that GPR17-expressing NG2-
glia serve as a reserve pool for the total NG2-glia population. However, the overlap between 
this GPR17-expressing reserve pool of NG2-glia and the non-recombined (low Sox10-
expressing) cells remains to be elucidated (Viganò and Schneider et al. in press). 
Besides the proliferative capacity and the resulting death of NG2-glia, the closely linked 
differentiation capacity was also altered in this study. Proliferation and differentiation of NG2-
glia are well described for some brain areas (Dimou et al. 2008; Psachoulia et al. 2009; Simon 
et al. 2011; Young et al. 2013), these two distinct features have however always been 
addressed simultaneously in one experimental setup by applying BrdU or EdU. So far, no tools 
allowed the separation of these distinct cellular properties. With the herein described mouse 
model, we established for the first time a tool to diminish the differentiation of NG2-glia into 
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mature oligodendrocytes while keeping the cell numbers of the NG2-glia network unaltered. 
Despite using a novel genetic approach for the ablation of proliferating NG2-glia, the findings 
in this work are supported by the outcome of previous studies. Ablating proliferating NG2-glia 
with a high-dose X-irradiation or a continuous infusion of the mitotic blocker cytosine-β-
arabinofuranoside (AraC) resulted in a transient ablation of NG2-glia that was restored within 
a short period of time by the endogenously remaining NG2-glia pool from either the same or 
adjacent areas (Irvine and Blakemore 2007; Robins et al. 2013). So far no approach ever 
achieved full ablation of NG2-glia but in all models cells were successfully repopulating. By 
sensing their environment, these cells were shown to react upon loss of contact inhibition with 
enhanced proliferation or migration to fill the newly formed gap (Hughes et al. 2013). 
Accordingly, NG2-glia in this thesis similarly compensated for the loss of neighboring cells 
(Figure 12), although the compensation mechanism has not been addressed. However, the 
above mentioned studies did not take the differentiation properties of NG2-glia maturation into 
new oligodendrocytes into account. This work revealed two major differences compared with 
the previously reported studies: I) a continuous ablation of single cells over longer times 
compared with an ablation of the majority of the cells within a short period of time as NG2-
glia do have a long cell cycle length and are not synchronized (time effect), and II) a chronic 
but low ablation effect compared with a complete NG2-glia ablation followed by quick tissue 
regeneration (cell number effect). These combined effects could only be exploited in this novel 
mouse model because NG2-glia in the physiological brain are not synchronized in their cell 
cycles. Hence, the described genetic approach only ablated single cells at different timepoints 
and in different regions, while not inducing a strong immune reaction to clear the cell debris 
(Figure 13). The remaining gap of apoptotic cells were closed within a short time window and 
the absolute number of NG2-glia remained stable, both in the GM and WM at every analyzed 
timepoint (Figure 11). However, as this cell loss continued over a period of four months, non-
recombined NG2-glia were required to keep proliferating at the expense of differentiation 
(Figure 14). Another hypothesis that would explain the diminished oligodendrogenesis would 
be an intrinsically distinct differentiation capacity of recombined (GFP+) and non-recombined 
(GFP-) NG2-glia in which the first ones are more prone to proliferate and the latter ones to 
differentiate. As a result of the depletion on the GFP+ cells, the cell numbers would remain 
stable while only the differentiation would be reduced, as it was observed in this mouse model. 
The proliferative capacity of NG2-glia that were shown to proliferate at least twice (Simon et 
al. 2011) is still highly debated, and it is unclear whether they have an unlimited number of 
cell cycles or if they exhaust after a particular yet unknown number of cycles. Some scientists 
support the idea of NG2-glia passing a certain amount of limited cell cycles before their final 
differentiation into mature oligodendrocytes (Ffrench-Constant 1994; Raff 2007). Hughes et 
Discussion and future perspectives  66 
 
al. (2013) demonstrated a direct differentiation from NG2-glia into mature oligodendrocytes 
without a preceding proliferation in vivo, providing some kind of counterevidence for the need 
of proliferation before differentiation – at least in superficial layers of the cortex. However, as 
the authors did not follow individual cells over a long time, the possibility remains that these 
apparently directly differentiating cells have proliferated before and only passed a quiescent 
state during the time of analysis. Unfortunately, this study could also not dissolve the question 
about the possible cell cycle numbers of NG2-glia. However, there could still existe of self-
renewing subpopulation within the overall population with an unlimited proliferation rate, 
comparable to neural stem cells. EdU-labeling experiments on the other hand demonstrated a 
labelling of 100% of NG2-glia in young adult mice within approximately one month, both in 
the GM and the WM of the cerebral cortex (Clarke et al. 2012; Young et al. 2013), negating 
this theory. However, the possibility of a NG2-glia stem cell pool could still apply despite all 
other cells proliferating, as in the SVZ where both the NSC as well as the transient amplifying 
progenitor cells (TAPs) are able to proliferate, although the latter ones are not stem cells any 
longer (Doetsch et al. 1997). The mouse model that was used in this work brings forward the 
debate about the proliferative capacity. The continuous cell death of recombined cells forced 
the remaining cells into a higher number of cell cycles, but even at late stages after 
recombination no signs of exhaustion were observed. This could be verified with an experiment 
in which both the Esco2fl and the Esco2wt mice received BrdU not directly after the induction, 
but between 9wpi and 11wpi and were sacrificed directly afterwards. Even at this late stages, 
non-recombined NG2-glia in the Esco2fl mice had incorporated significantly more BrdU 
compared to the controls, indicating that their proliferative capacity is at least not limited to a 
few number of cycles, as they were probably proliferating before, in order to compensate. 
However, the possibility remains that those cells compensating for the loss at the beginning 
are another subset of cells than those that are proliferating normally at the late stages after 
induction, when no compensation would be necessary anymore. To address this topic in more 
detail, the Esco2fl mice could be analyzed at even later timepoints after induction to see if their 
proliferative capacity eventually declines at some point. Challenging this already altered 
environment with a stab wound or other kinds of injury at 16wpi would be another possibility 
to address this question. NG2-glia that have already extensively proliferated would be forced 
to undergo a high number of cell cycles after injury and would eventually exhaust.  
Moreover, this work disclosed some differences in the proliferative capacity between the GM 
and the WM of the cerebral cortex. In the WM, most of the NG2-glia were able to proliferate 
within 16wpi because the majority of the recombined cells died at this timepoint. In contrast 
to that, it seems that in the GM only a certain pool of NG2-glia was able to proliferate, as even 
at this long timepoint after induction a high number of recombined NG2-glia that have not 
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incorporated BrdU and therefore escaped, could be detected. Unfortunately no extensive fate 
mapping studies at this age of the mice do exist to compare these data with, most of the 
studies were carried out in young adult mice. However, some of the recombined NG2-glia in 
the WM of the Esco2fl mice could have directly differentiated into mature oligodendrocytes, 
therefore these cells would not count into the recombined NG2-glia pool any longer (without 
having proliferated). One possible experiment to approach this question and to verify this 
hypothesis could be the long-term application of BrdU following EdU in order to see whether 
all cells carry the same proliferative capacity or if a specific population is more prone to 
proliferate. 
Besides the potentially different proliferative capacity, NG2-glia in WM tracts are known to 
proliferate more often and faster compared with those in GM tracts (Dimou et al. 2008; Young 
et al. 2013). For this reason, recombined cells in this mouse model were ablated faster in these 
tracts (Figure 11). However, the cell cycle length of NG2-glia is also very variable between 
different WM tracts in the brain. This work revealed that the magnitude of NG2-glia ablation 
in WM tracts is in line with the cell cycle length: in the corpus callosum, the ablation was faster 
compared with the optic nerve (data not shown), where the cell cycle was determined to be 
twice as long (around 20 days in the optic nerve vs. around ten days in the corpus callosum) 
(Clarke et al. 2012; Young et al. 2013). 
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Figure 33: Cellular fate switch of NG2-glia upon long-term cell ablation. Under physiological conditions 
(left panel), NG2-glia keep a regulated ‘steady state’ between proliferation and differentiation. However, when 
many cells are taken out of the network over a long period of time, NG2-glia shift their behaviour and become 
highly proliferative (green arrow), while at the same time their differentiation capacity is declining (dashed arrow). 
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Although the cell cycle length was calculated to be around 37 days for the cortical GM in 
several studies (Simon et al. 2011; Clarke et al. 2012; Young et al. 2013), they did not 
discriminate between different cortical areas. Figure 10 shows that the death of recombined 
NG2-glia in this work is not distributed within the GM to the same extent, but is more prominent 
in the somatosensory and the visual cortex compared with the motor cortex. Thus, it can be 
assumed that the average cell cycle length of NG2-glia – similar to different WM tracts – is 
also highly variable between different cortical GM areas. The exact cell cycle lengths of 
different areas should be determined distinctively in future studies. The reason for these 
variable cell cycle properties could be the area-intrinsic differences in the activity of neurons, 
as NG2-glia are known to increase their proliferation rate upon neuronal activity (Gibson et al. 
2014). To prove this hypothesis, it would be interesting to artificially increase the endogenous 
neuronal activity in the Sox10iCreERT2xCAG-eGFPxEsco2fl/fl mouse line either by physiological 
stimuli (enriched environment or voluntary running on a wheel) or by tetanus toxin induced 
epilepsy that was shown to permanently hyper-activate neurons in the respective area (Simon 
et al. 2011; Mainardi et al. 2012). 
In conclusion, these data showed that NG2-glia maintain their homeostatic network, even 
when a long-term apoptotic cell death is induced in the majority of the cells. Moreover, they 
do so by increasing their proliferation at the expense of differentiation, meaning that the 
oligodendrocyte lineage loses its physiological ‘steady state’ between proliferation and 
differentiation (Figure 33). Given this fact, one could conclude that the homeostatic network 
and its underlying physiological functions are more important for the overall brain physiology 
than the de-novo generation of oligodendrocytes. However, whether this switch in the cellular 
fate is an active regulation, a matter of subpopulation-intrinsic differences in their proliferation 
and differentiation capacity, or simply a normal evolutionary mechanism that cannot be 
overcome by an externally applied insult is not known. 
4.1.2 OLIGODENDROCYTE LINEAGE EQUILIBRIUM IS REQUIRED TO MAINTAIN NODES OF RANVIER IN THE 
WHITE MATTER  
The signals deciding whether a cell inside this physiological ‘steady state’ is differentiating into 
an oligodendrocyte or remains a proliferating progenitor are still unknown, as is the functional 
importance of this lifelong dynamic process. The recent years of research provided evidence 
that adult oligodendrogenesis as well as subsequent myelin remodeling is relevant to maintain 
at least some grade of plasticity in the adult brain. It has been shown that oligodendrogenesis 
and subsequent myelin remodeling are required to learn a complex motor skill in rodents, while 
the general physiological brain function remained unchanged in the absence of this remodeling 
(McKenzie et al. 2014). Moreover, human fMRI studies revealed a high remodeling as well as 
Discussion and future perspectives  69 
 
an increase in the volume of WM tracts in the late adult brain after learning different motor 
tasks like juggling, studying a second language or playing the piano (Bengtsson et al. 2005; 
Scholz et al. 2009; Takeuchi et al. 2010; Lebel et al. 2012). Although these studies provided 
confirmation for myelin remodeling, they have to be interpreted with precaution. Myelinated 
fibers can only be identified indirectly with fMRI, by measuring the fractional anisotropy (FA) 
of the water, and the detected changes are frequently interpreted as changes in myelination. 
However, changes in FA can also be triggered by solely cellular changes and tissue reactions, 
without affecting myelination (Pierpaoli and Basser 1996; Yamasaki et al. 2005; Hayashida et 
al. 2006). As in the adult cortical white matter only 30% of the axons are myelinated (Sturrock 
1980), de-novo myelination of previously unmyelinated circuits that could be needed to learn 
a new task and to strengthen a novel circuit is highly supposable. Hence, adult 
oligodendrogenesis would be required to provide myelin in sufficient amounts. All of these 
studies commonly addressed the myelin remodeling process in variable learning paradigms in 
which the brain function could consequently be improved. However, there was no evidence 
for the physiological need of oligodendrogenesis where no learning is required to simply 
maintain the brain’s structure and function. The optic nerve on the other hand is giving 
counterevidence for this suggestion: although fully myelinated (>98% of the axons), adult 
oligodendrogenesis and myelin remodeling could also be found in comparable amounts as in 
other WM tracts (Honjin et al. 1977; Young et al. 2013). However, oligodendrocyte 
differentiation and myelin insertion into already existing sheaths in WM tracts does not only 
provide plasticity, but it is also a normal process of aging (Lasiene et al. 2009). 
Besides the plasticity in the global myelination, the nodes of Ranvier with their highly 
structured compartments can undergo plastic changes, although the role of this plasticity is 
far from being understood (Arancibia-Carcamo and Attwell 2014). The elongation of the nodes 
and paranodes as well as distortions in the distribution pattern of the potassium channel Kv1.2 
in the WM of Esco2fl mice (Figure 16) is giving evidence for the first time that an adequate 
amount of both functional NG2-glia as well as newly generated oligodendrocytes is required 
to maintain the highly structured brain architecture without any functional improvement. 
Changes in the molecular structure in the nodes of Ranvier were so far only observed after 
auto-inflammatory conditions, while the knowledge about molecular changes and dynamics of 
the node of Ranvier under physiological conditions is low. In some MS patients, auto-antibodies 
against paranodal anchor proteins could be observed. The damage cused by specific antibodies 
leads to comparable changes in nodal structures in these patients (Mathey et al. 2007; Elliott 
et al. 2012) as they were observed in this study. Taking this into account, the changes in the 
structure of the nodes of Ranvier could be a result of: I) the lack of physiological NG2-glia 
function due to increased proliferation, II) the lack of physiological oligodendrocyte 
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differentiation and myelin turnover, or III) both together. Regarding the first point, some 
studies reported already long time ago that some NG2-glia contact and sweep the 
unmyelinated axolemma in the nodes of Ranvier with their very fine processes (Butt et al. 
1999; Huang et al. 2005). NG2-glia were also ascribed the function of clustering and 
maintaining ion channels at the correct place inside the node of Ranvier – a function that is 
normally attributed to perinodal astrocytes (Waxman and Ritchie 1993; Butt et al. 1999). 
Although the full role of node-sensing NG2-glia is not completely understood yet, a model 
(Figure 34 left column) could be suggested: retractions of the myelin loops and other structural 
changes in the nodes of Ranvier could occur throughout lifetime also in the wildtype condition. 
Node-sensing NG2-glia might recognize these changes and subsequently start to differentiate 
and insert a new myelin sheet into the emerged gap, pushing the old heminodes further apart 
from each other (Figure 34 mid panel, arrow indicates direction of movement). This would 
support the hypothesis of aging myelin sheaths with their inherent functions declining over the 
years. With age, internodes are increasing in number and newly generated internodes in the 
adult are per se shorter compared with their postnatal counterparts, what would further 
strengthen the above described hypothesis (Lasiene et al. 2009; Young et al. 2013). As NG2-
glia in the herein described mouse model were shown to be much more proliferative compared 
with their wildtype counterparts (Figure 12), it could be assumed that this was due to their 
required function of keeping the NG2-glia network stable. Hence it would be possible that 
during the course of proliferation, they retract their processes from the node of Ranvier. 
Although this distinct process has not been shown yet, the described nodal retractions could 
occur, as proliferating NG2-glia – at least in a recent study – were shown to also lose their 
functional synapses with neurons (Sahel et al. 2015). It is even possible that in the long term, 
the overall population of NG2-glia undergoes some changes upon ablation in Esco2fl mice with 
those cells that repopulate the WM not being able to form the physiologically required nodal 
contacts. So far there is no evidence that all NG2-glia have this ability, and it could be the case 
that only a subpopulation is able to do so. Due to the loss of their nodal connections, either in 
the short or long term, proliferative NG2-glia could no longer be able to sense eventually 
occurring nodal and paranodal elongations, and would consequently not be triggered to 
differentiate and repair the emerging gap. This hypothesis would explain both the nodal 
phenotype that was observed in Esco2fl mice as well as the reduced number of 
oligodendrocytes in WM tracts of these mice. Summarizing, the structural changes in the nodes 
could be explained by a combination of abnormal NG2-glia function and reduced 
oligodendrocyte maturation. The fact that a very high proportion of elongated nodes and 
paranodes (Figure 16), but only an extremely low number of newly differentiated 
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oligodendrocytes in relation to the total number of mature oligodendrocytes could be found 
(Figure 14), reinforces this combined approach. 
However, it cannot be completely ruled out at this point that these disturbances are based on 
the continuous lack of oligodendrogenesis with NG2-glia solely serving as the respective 
progenitors and not fulfilling any specific function in this context. Oligodendrocyte 
differentiation and subsequent myelin sheet insertion might be driven by oligodendrocytes 
themselve in a yet unknown manner (e.g. like neuronal activity). The possibility that the 
deletion of Esco2 or arbitrary functions in mature recombined oligodendrocytes lead to the 
observed nodal phenotype could however be ruled out by fact that these postmitotic cells lack 
the mRNA expression of the Esco2 transcript (Zhang et al. 2014). In addition, the 
NG2CreERT2xEsco2fl/fl mouse line that allows the recombination of a pure NG2-glia population 
was used for a control experiment, resulting in a similar nodal phenotype (Figure 22). 
Although node-sensing NG2-glia and adult oligodendrogenesis might play a major role in the 
functional maintenance of the nodes of Ranvier, perinodal astrocytes, microglia and possibly 
other yet unknown cell types and factors are also known to contribute to this process (Ffrench-
Constant et al. 1986; Hildebrand et al. 1993; Howell et al. 2010). Preliminary analysis of the 
fibrous astrocytes in the WM of Esco2fl mice at long timepoints after tamoxifen induction 
revealed a decline in the expression level of GFAP in contrast to Esco2wt mice, suggesting that 
these cells encounter some cellular changes derived from the environment. In the long term 
this could influence their function in the stabilization of the node. Along the same line, 
astrocytes are involved in the nutritional and energy support to neurons. It was recently 
reported, that nodes and paranodes in a cell culture system actively react within minutes 
toward energy deprivation with a significant elongation of these structures (Arancibia-Carcamo 
et al, unpublished data). In the context of structural or nutritional support malfunctioning, 
perinodal astrocytes could therefore contribute to the nodal phenotype in Esco2fl mice as well.  
Analyzing the nodes of Ranvier in the cortical GM could further disclose the question about the 
physiological need of oligodendrocyte lineage plasticity and myelin remodeling, as many GM 
areas also show a high amount of myelinated fibers (Shafee et al. 2015). Malfunctioning of, 
or structural changes in these GM fibers is very often associated with mental diseases like 
schizophrenia (Haroutunian et al. 2014). In case of severe damage, they additionally show a 
high grade of plasticity, comparable to myelinated fibers in the underlying WM (Hashim et al. 
2015). Taking these recent findings into account, there is the chance that at least in highly 
myelinated GM areas, some structural changes in the nodes of Ranvier could be observed in 
the Esco2fl mice. Performing behavioral tests to address eventual psychological disorders in 
these mice could give a deeper insight in the physiological implications of myelin plasticity in 
the GM and other cell types involved. 
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Figure 34: Hypothetical role of NG2-glia at the nodes of Ranvier. Node-sensing NG2-glia (red) that fulfill 
their normal function, contact the nodes of Ranvier with their processes (left column, top). One possible explanation 
could be that, as soon as the node and the paranode elongate, the node-sensing NG2-glia perceive these changes 
and start to differentiate and create a new internode by pushing the old heminodes apart (left column, bottom). 
Highly proliferative NG2-glia (orange) that can be found in Esco2fl mice, lose the nodal contact (right column, top). 
Therefore nodal changes cannot be sensed anymore by NG2-glia, hence differentiation does not occur resulting in 
the phenotype of elongated nodes and paranodes (right column, bottom). 
 
Concluding, the herein discussed data demonstrated for the first time that the maintenance of 
the oligodendrocyte lineage’s ‘steady state’ with regard to the network maintenance and 
ongoing oligodendrogenesis, is not only important in learning conditions where brain plasticity 
is required, but also to maintain cellular structures. 
4.1.3 NODES OF RANVIER ARE IMPORTANT TO MAINTAIN PHYSIOLOGICAL MOTOR FUNCTIONS 
Formerly, myelin-related disorders have mostly been associated with neuronal damage or the 
direct loss of oligodendrocytes and the subsequent demyelination, while the node of Ranvier 
was neglected. Only since recently, there is evidence that the entire nodal region with its 
structural anchor proteins plays an important role in brain physiology (Faivre-Sarrailh and 
Devaux 2013; Arancibia-Carcamo and Attwell 2014). Disturbances of these structures can be 
observed in different pathological conditions that comprise myelin breakdown, e.g. multiple 
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sclerosis, hypoperfusion, as well as during the normal process of aging (Hinman et al. 2006; 
Howell et al. 2006; Reimer et al. 2011). Vice versa, some kind of disruptions in the nodes of 
Ranvier without general myelin disorders are thought to cause different neurological and 
psychiatric diseases (Roussos et al. 2012; Susuki 2013). However, whether nodal disruptions 
alone are the cause for such pathologies, and to which extent other factors are playing a role 
in this context, remains to be elucidated.  
The findings based on Esco2fl mice in this study that show a disarrangement in the nodes of 
Ranvier while progressively developing motoric dysfunctions (Figure 16 and Figure 17), 
support the idea that a physical disorder (in this case motor limb dysfunctions) can directly be 
caused by structural disarrangements in the WM-located nodes of Ranvier. Taking also the 
conclusions from the previous chapters into account, a conclusive theory can be presented. 
The lack of functional NG2-glia in the WM leads to structural disturbances in the nodes of 
Ranvier, what in turn could result in the loss of motor abilities due to the functional loss of the 
nodes. The control experiments with the NG2CreERT2xEsco2fl/fl line strengthened this theory. 
These mice developed a similar motor phenotype as mice of the Sox10iCreERT2xEsco2fl/fl line 
although it appeared much later, confirming that the motor phenotype is a dose-dependent 
effect. As the recombination in NG2-glia was much lower, fewer NG2-glia were ablated and to 
achieve the same effect compared with the other mouse line, a longer time was required. To 
provide further proof that the cell ablation is directly linked to a behavioral phenotype, different 
functional behavioral tests specific to distinct WM tracts could be performed. NG2-glia ablation 
was also prominent in the optic nerve, therefore conducting tests addressing the vision, or 
electroretinography with Esco2fl mice late after induction would be a consequent next step 
(Tanimoto et al. 2009). 
Most interestingly, the grid walk experiment gave the wrong impression that the severity of 
the motor dysfunctions was higher at the forelimbs opposed to the hindlimbs in the Esco2fl 
mice (Figure 17). However, when stepping with the hindlimbs in this experiment, mice used a 
bigger surface of the paw than with the forelimb. Therefore, the probability of a hindlimb 
misstep is much lower compared with the forelimb, although the hindlimbs are still affected to 
the same extend. This becomes especially evident during the beam crossing performance, 
where in all of the cases the mice were only clamping their hindlimbs around the beam while 
the forelimbs seemed to be placed normally. These observations are giving evidence that all 
parts of the body are evenly affected by the motor malfunctions, but the phenotype is 
especially highlighted under motor performance. 
The distinct mechanisms acting between the structural disturbances of the nodes of Ranvier 
and the resulting phenotype are currently unknown. The poor performance in beam crossing 
in the Esco2fl group strengthens the assumption that the phenotype is majorly WM-derived, 
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as this test has just recently been shown to be specific for WM tasks (Scafidi et al. 2013). The 
main function of cerebral WM is the axonal connection between different cortical areas, 
therefore changes in the nerve conduction of these WM fibers might be involved. Indeed, in 
Esco2fl mice a late stage delay in the nerve conduction latency in myelinated fibers was 
observed (Figure 24). Moreover, the onset of this delay could clearly be correlated with the 
timepoint when nodal and paranodal elongations occurred. Just recently Murcia-Belmonte et 
al. (2015) reported about elongations of the nodal and paranodal structures together with an 
increase in myelination in the WM leading to significant changes in the nerve conduction 
velocity in adult mice, which supports the findings on the correlation between the nodal 
changes and the changes in the nerve conduction velocity in this work. However, the authors 
did not address the motor abilities of their mice. Literature yields many examples and 
explanations why and how changes in the organization of the nodes of Ranvier can influence 
the conduction velocity of myelinated nerve fibers and therefore result in a disturbed motor 
output: (I) the right amount of ion channels at the right places and (II) the length of the nodes 
themselves (Rosenbluth 2009; Arancibia-Carcamo and Attwell 2014; Li 2015).  
Regarding the first point, one study reported that the juxtaparanodally located potassium 
channels Kv1.1 and Kv1.2 are necessary for the fine tuning of action potentials in axons (Wang 
et al. 1993a). Furthermore, the channels are known to be involved in the fast repolarization of 
the potential for repetitive stimulation (Devaux et al. 2004). A mislocation of these channels 
increases the unwanted current flow beneath the myelin sheath, having detrimental effects on 
action potential propagation (Jensen and Shi 2003; Arancibia-Carcamo and Attwell 2014). 
These examples are giving further evidence that the misplacement of the Kv1.2 channels in 
Esco2fl mice could lead to changes in the nerve conduction velocity and could be one of the 
major reasons for the observed motor phenotype. However, other recently discovered 
subtypes of potassium channels (Kv7.2/3) were shown to be additionally involved in the 
electrical current flow in juxtaparanodal regions (Battefeld et al. 2014). Along the same line, 
voltage-gated sodium channels (Nav) that are majorly involved in the action potential 
propagation could also play a role in this mouse model. 
Secondly, elongations of the central nodes alone were shown to negatively influence 
conduction velocities due to a higher nodal capacitance accompanied by other disturbances 
(Arancibia-Carcamo and Attwell 2014), while the para- and juxtaparanodal structures remained 
stable (Rosenbluth 1987; Bhat et al. 2001). Furthermore, already subtle nodal changes can 
strongly influence the nerve conduction velocity (Babbs and Shi 2013). As in the Esco2fl mice, 
both elongation of the nodal regions and dislocation of the potassium channels were detected, 
the motor phenotype is most likely derived from a combination of these two effects. 
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During the analysis after approximately six months, disintegration of the node of Ranvier, the 
thereof resulting nerve conduction velocity issues, and motor disturbances were non-reversible 
effects. The respective mice did not regain their motor functions, even after the majority of 
recombined NG2-glia were ablated and therefore no further impairment from the cellular 
composition within their brain was expected. The reason could be that once the nodes of 
Ranvier were destroyed, active repair mechanisms for this structures as found in demyelinating 
diseases (Rasband et al. 1998) would be required. Indeed, some of the disrupted nodes in the 
Esco2fl group seemed to be actively repaired, noticeable by the patchy paranodal CASPR 
stainings that are thought to be a sign of recovery (Figure 16, Craner et al. 2003; Howell et 
al. 2006; Gu and Gu 2011). However, these mechanisms were apparently not able to fully 
repair the defects. Functional NG2-glia are most likely involved in this restoration mechanism, 
hence the proliferative changes of the NG2-glia population and the loss of their nodal contacts 
in the Esco2fl mice as discussed in the previous chapter are probably connected to the failure 
to achieve a full recovery as they are probably not able any more to sense the changes. 
Despite that distortions in the WM are the causative reason for the motor phenotype, other 
possible factors need to be considered. This holds especially for the early onset of the motor 
phenotype (around 4wpi), happening long before the first nodal/paranodal elongations 
(around 16wpi) were detected. Preliminary results in this study (data not shown) exhibited 
some depositions of the amyloid precursor protein (APP) in axons running through the WM, 
indicating that these neurons are exposed to sub-lethal cellular stress as demonstrated in a 
previous study (Lappe-Siefke et al. 2003). Moreover, some of the WM projection axons in the 
Esco2fl mice appeared black in the electron microscopy, what is known to be another indicator 
for the neurons to be stressed (Bignami et al. 1981; Narciso et al. 2001). These findings lead 
to the assumption that any cellular or even sub-cellular changes in the cortex in Esco2fl mice 
(for details see chapter 4.1.4) could influence the neuronal excitability. Thereof evoked 
disturbances or malfunctions subsequently would result in the motor phenotype, independent 
from the structural integrity of the nodes of Ranvier. To prove this hypothesis, it would be 
interesting to specifically address the neuronal activity at different stages after the induction 
in our mouse model.  
In addition to possible physiological interactions that could be involved in the black box 
between the immunohistochemical observations and the resulting motor phenotype, this study 
could at least rule out some factors that might be a reason for the motor dysfunctions. 
Although this mouse line showed a great intervention into the whole oligodendrocyte lineage 
progression, and hence, into the physiology of myelin producing cells, global demyelination or 
other destructions of the already existing myelin sheaths could not be detected (Figure 15). 
This finding is consistent with a recent study in which the blockage of adult myelin generation 
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did not affect already existing myelinated tracts (McKenzie et al. 2014). Analysis of the spinal 
cord in the Esco2fl mice did also not reveal any differences compared with Esco2wt mice. NG2-
glia in the spinal cord are known to be less proliferative under physiological conditions in 
contrast to their brain-derived counterparts (Huang et al. 2014a). Therefore, apoptotic loss of 
recombined NG2-glia in the spinal cord was very unlikely to occur or at least to a much lower 
extent compared with the brain. Motor projection neurons running through the dorsal horn of 
the spinal cord that are important for peripheral movements, did also not show any signs of 
damage in the Esco2fl mice. In addition to the lack of defects after immunohistochemistry, the 
horizontal ladder test in which Esco2fl mice performed well throughout the experiment, further 
proved that the spinal cord was not affected by the ablation of proliferating NG2-glia. 
Moreover, yielded by the analysis of the peripheral nervous system (Figure 23), the muscle 
spindles as well as the neuromuscular junctions did not reveal any structural changes in Esco2fl 
mice compared with the wildtype littermate controls (data not shown). As Schwann cells in 
the intact nerve were shown to not proliferate (Cheng and Zochodne 2002), cell death was 
not expected to occur in our Esco2-depleted mice. Consequently, a contribution of the 
periphery that could explain the motor phenotype can be excluded. 
As a concluding remark, the nodal disruptions that subsequently result in a motor phenotype 
in this work gave further evidence in this novel field of research that the nodes of Ranvier are 
not only a termination of a myelinated segment, but also comprise important functions for the 
maintenance of brain and body physiology. 
4.1.4 NG2-GLIA FUNCTIONS ARE LOST DESPITE NETWORK MAINTENANCE 
Major perpetual cell death of recombined NG2-glia in the Esco2fl mice and cellular as well as 
structural changes could be identified in WM areas in this study, in which the driving force of 
NG2-glia differentiation was shown to be very high (Clarke et al. 2012; Young et al. 2013). 
However, outside the areas showing extensive oligodendrogenesis, NG2-glia are also 
important because of their unique glia-neuron synapses (Bergles et al. 2000; Káradóttir et al. 
2005; Mangin and Gallo 2011), as well as due to their just recently discovered role in 
neuromodulation (Sakry et al. 2014; Sakry et al. 2015) and potentially other yet unknown 
functions. Although these features have already been described thoroughly, their herein 
described functional importance to memory consolidation has not yet been assigned. 
Although it was long thought that NG2-glia maintain most of their neuron-NG2-glia synapses 
during proliferation (Fröhlich et al. 2011), a recent study demonstrated that these synapse 
cannot be functionally maintained (Sahel et al. 2015). Therefore, a change in the NG2-glia 
network including its NG2-glia-neuron synapses in Esco2fl mice could functionally be altered 
over time, despite the maintenance of the cellular network. Therefore, it might be possible 
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that the cells compensating for the loss of recombined cells could not fulfill their physiological 
functions any longer. The finding that Esco2fl mice apparently have defects in their short-term 
memory at 11wpi argues for a progressive decline of the physiological functions of the 
homeostatic network due to changes in their cellular composition. The short-term working 
memory is mainly based on fast acting neurotransmitter signaling and processing between 
different cells including neurons and glial cells (Mongillo et al. 2008), but less on cellular or 
even myelin rearrangements, as for example complex motor learning skills (McKenzie et al. 
2014). Unpublished observations from our lab indicate that NG2-glia are involved in this 
process, due to the fact that hippocampal learning and training paradigms seem to influence 
their cell cycle properties (Schneider and Dimou unpublished data). Vice versa, NG2-glia are 
also able to influence neuronal activity: Sakry et al. (2014, 2015) recently demonstrated that 
NG2-glia are capable of directly modulating neurons through secretion of the shed 
proteoglycan NG2 and other factors. Transferring these facts to our mouse model, it can be 
hypothesized that despite the maintenance of their cellular numbers, the NG2-glia network 
and their synaptic transmissions to neurons are not properly functioning in Esco2fl mice. This 
hypothesis is strengthened by the learning paradigm that was used in this work: the time 
window of 30min in which the mice had to establish a working memory was too short to involve 
the long process of oligodendrogenesis, thus might be the reason of malfunctioning NG2-glia 
itself (other cell types were also not obviously affected). Hence it can be suggested that in the 
NG2-glia ablated model, the total NG2-glia network in general could receive less synaptic input 
compared with the wildtype controls due to a higher proportion of actively cycling cells. This 
reduced synaptic activity could then be the cause of the failure to establish a short-term 
memory.  
Many studies addressed the neuron-NG2-glia synapse interaction (reviewed in Mangin and 
Gallo 2011; Sun and Dietrich 2013), however, it is not known whether all NG2-glia are able to 
form functional synapses in the same way, or if there exist subpopulations preferentially doing 
that. Although no study specifically addressed this question so far, most of the authors are 
using terms like ‘synapse-bearing’ NG2-glia (Sakry et al. 2014), indicating that there are 
distinctions between different cells from the same cortical regions (Somkuwar et al. 2014). 
Likewise, it can be hypothesized that in the used mouse model, the highly proliferative non-
recombined NG2-glia repopulating the ablated areas receive less synaptic input compared with 
the recombined NG2-glia that have been resident before the ablation. Consequently, in the 
long-term the NG2-glia network would be changed progressively and its function would then 
decline with these occurring changes. 
Although NG2-glia seem to play an important role in memory consolidation, they cannot alone 
be accounted for this process. Certainly neurons, but also astrocytes, microglia and probably 
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other still unidentified cells are playing an additional role (Gibbs and Bowser 2010; Jiang et al. 
2015). The ablation of recombined NG2-glia did not induce any obvious cellular changes in the 
other cell populations (astrocytes, neurons, or microglia) in the cortical GM in Esco2fl mice, 
being an indication that other cell types might neither be affected. However, in the Esco2fl 
mice nothing specific is known about NG2-glia proliferation or the functionality of other cell 
types in the perirhinal cortex, where the used NOR paradigm is assigned to (Murray and 
Richmond 2001). 
In conclusion, these data demonstrated that NG2-glia are involved in the consolidation process 
of a short-term memory. With these findings, for the first time a distinct cellular function can 
be attributed to NG2-glia that is important in cortical areas where oligodendrogenesis does not 
seem to play to play a major role. 
 
4.2 INJURY 
4.2.1 ABLATION OF RECOMBINED NG2-GLIA INDUCES A DEFICIT IN CELL NUMBERS IN THE LESION SITE 
NG2-glia have been shown to react upon acute traumatic brain injury with a significant increase 
in their proliferation. Following stab wound injury, a high number of these cells are re-entering 
their cell cycle and shortening their cell cycle length within a few days (Tan et al. 2005; Buffo 
et al. 2005; Simon et al. 2011). These proliferative properties could successfully be exploited 
in the Sox10iCreERT2xCAG-eGFPxEsco2fl/fl mouse line that ablated high numbers of recombined 
NG2-glia in close-proximity to the lesion site (Figure 27). The proliferation and subsequent 
death of these recombined Esco2-ablated NG2-glia occurs relatively fast, starting already at 
2dpl. Therefore, in comparison with the healthy situation where non-recombined cells had 
enough time to compensate, the death of the recombined cells occurred to fast to be fully 
compensated by the remaining cells. Although the remaining, non-recombined NG2-glia 
increased their proliferation rate even further compared with the wildtype controls, full 
compensation for the lost cells could not be reached, even at 14dpl. In the wildtype condition, 
NG2-glia in close-proximity to the lesion site recede to non-injured levels within one month 
after injury (von Streitberg and Schneider et al. submitted). However, it is not known whether 
late-reactive NG2-glia (the non-recombined in this case) are normalizing their numbers equally 
fast in the Esco2fl mice compared with the Esco2wt controls. 
At 14dpl, only a small number (around 5%) of recombined NG2-glia survived around the lesion 
site in the Esco2fl mice, indicating that the apoptotic loss after injury was more efficient than 
without an injury. In the non-lesioned situation, only half of the recombined cells underwent 
apoptosis in the GM within 16wpi (Figure 11). One reason for this divergence could be that 
less cells are able to escape the Esco2-deletion. After injury, NG2-glia re-enter their cell cycle 
quickly, hence they switch from a slow into a fast mode of proliferation. Being in a fast 
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proliferation mode, other intracellular signaling mechanisms that regulate the cell cycle could 
be required (Martinho et al. 2015; Moyon et al. 2015b). Therefore, the loss of the Esco2 protein 
could be more detrimental during fast proliferation compared with slow proliferation, where 
more cells escape due to an alternative or compensating mechanism. In this regard, the 
homolog protein Esco1 that only exists in mammalian cells, could play an important role (Hou 
and Zou 2005; Whelan et al. 2012b). A second reason for the almost complete ablation of 
recombined cells could be an intercellular feedback loop between NG2-glia boosting the overall 
ablation effect. NG2-glia were recently shown to auto-activate themselves during disease via 
the secreted cytokines IL-1ß and CCL2 (Moyon et al. 2015a). As soon as some recombined 
NG2-glia in Esco2fl mice proliferate and subsequently die, the following autocrine signaling of 
their neighboring cells would activate them to proliferate as well, although they would not do 
so under normal conditions. As those neighboring cells displayed recombined cells with a 
probability of 80%, they consequently underwent apoptosis as well. 
The non-recombined NG2-glia started to re-populate free spots left by ablated cells already 
between 4dpl and 7dpl in the Esco2fl mice. However, the morphology of these repopulating 
cells seemed to be less complex and they appeared smaller and therefore occupied a smaller 
surface area than NG2-glia in the wildtype mice. Thus, in the Esco2fl mice the NG2-glia-free 
brain surface area was even bigger. In addition, the remaining and re-populating NG2-glia 
rarely formed contacts with each other, being a further trigger for the remaining cells to 
proliferate in order to try to compensate, as they were not inhibited by neighboring cells 
(Hughes et al. 2013). These findings are consistent with a previous study, where the authors 
reported about less branched re-populating NG2-glia compared to non-proliferating ones after 
diphtheria toxin (DT)-induced ablation of a major fraction of the population (Birey and Aguirre 
2015). The observed lack of cell complexity could be due to the fast proliferation mode, in 
which these cells do not have enough time to fully regenerate their typical morphology. That 
applies especially to those cells that cycle more than once in response to the ablation and to 
injury. Intercellular signaling mechanisms could play an additional role in this regard: in the 
same study, the blockage of netrin-1 (NTN1) was reported to be involved in the regulation of 
NG2-glia morphology (Birey and Aguirre 2015). NTN1 is expressed by neurons as well as by 
OPCs and by astrocytes at least in postnatal stages (Zhang et al. 2014). Further, it is likely 
that other yet unknown factors could become important as well. Thus, the changed reaction 
of glial cells that was observed in the Esco2fl mice and the thereof induced lack of signaling 
molecules could lead to a less complex NG2-glia morphology. 
Similar to the non-lesioned condition in the WM, the fraction of non-recombined (NG2+/GFP-) 
NG2-glia in the Esco2wt mice proliferated stronger than the recombined fraction (NG2+/GFP+) 
at later stages after injury. This resulted in an overall increase in their ratio of the whole NG2-
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glia population. Along the same line, Birey and Aguirre et al. (2015) also reported about the 
existence of two distinct cell populations after injury-like conditions: (I) fast and (II) slowly 
proliferating NG2-glia with the latter ones being a reserve pool for other cells that were lost. 
Another recent study used the RNA sequencing technique in the somatosensory cortex where 
they identified six distinct cell populations within the oligodendrocyte lineage that could 
potentially react differently to environmental changes (Zeisel et al. 2015). Recent findings from 
our lab identified an additional GPR17-expressing NG2-glia subpopulation acting as a reserve 
pool after injury (Viganò and Schneider et al. in press). Although these newly identified 
subpopulations have been described, only little about their origin and cellular differences is 
known. However, these studies give further indications that some NG2-glia – in our case the 
low Sox10-expressing, non-recombined NG2-glia – could display at least one genetically 
different and slower reacting subpopulation. This subpopulation could be more prone to 
proliferate at later stages after injury, while the other recombined cells could preferentially 
proliferate at earlier stages.  
The reaction of NG2-glia to injury is known to be quite complex. Besides proliferation, these 
cells are reacting quite variable to injury, including migration, polarization, and hypertrophy. 
The majority of cells are even showing a combination of those (Hughes et al. 2013; von 
Streitberg and Schneider et al. submitted). Whether these different types of reactions originate 
from genetically different subclasses, or whether they are induced by the extracellular 
environment remains unclear. In the Esco2fl mice on the other hand, the composition of the 
heterogeneous NG2-glia population might look differently. As those NG2-glia that immediately 
react to injury have been ablated, the decline in cell numbers could already be detected within 
the first 2dpl. Induced by yet not fully known mechanisms, remaining NG2-glia are forced to 
proliferate, although their usual response to injury would be different. As a result, they might 
not be able to fulfill the full range of their normal reaction to injury (hypertrophy, migration, 
polarization or proliferation) and one category could appear preferentially. Using repetitive 
two-photon in vivo live imaging of NG2-glia-ablated mice could give a deeper insight in the 
heterogeneous reaction of the remaining and compensating NG2-glia. One drawback of this 
experiment, however, would be that the compensating NG2-glia are not intrinsically tagged 
with GFP – at least in this mouse line – and other labelling mechanisms in order to make them 
suitable for in vivo imaging would be required. 
Comparison of the bigger area of the lesion (up to 250µm distance from the lesion site) with 
the lesion core area (50µm distance from the lesion site) in Esco2fl mice gave further evidence 
of the importance and function of NG2-glia after injury (Figure 27). Within the core, the 
ablation of recombined NG2-glia was detected later (at 4dpl) compared with its surrounding 
(at 2dpl). At 14dpl, however, most NG2-glia were depleted in both defined areas of analysis. 
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These findings suggest that proliferation in the lesion core starts later, but at higher rates once 
initiated. Although also the non-recombined fraction of NG2-glia in the Esco2fl mice started to 
compensate by increased proliferation in the lesion core, the cell numbers never reached the 
same level as in the Esco2wt mice. However, while no increase could be detected, the cell 
numbers in the lesion core also did not decrease at any timepoint that was analyzed, indicating 
that the cells try to compensate for the loss. Deriving from the lesion core analysis in Esco2wt 
mice and from previous two-photon imaging studies, it is known that the stabilization of cell 
numbers in the Esco2fl mice did not only occur due to enhanced proliferation, but also through 
migration of NG2-glia after injury. Moreover, the peak of migration of NG2-glia directed to the 
lesion core was shown to appear earlier than the peak of proliferation. The observed decrease 
of NG2-glia in the bigger surrounding in this study underlines the described migration effect, 
as cells from the peri-lesion seem to migrate into the lesion core at early stages.  
Concluding these findings, the significantly reduced numbers of NG2-glia in the lesion site in 
Esco2fl mice derived from a fast cell death of recombined cells that cannot be compensated by 
non-recombined cells during the first 7dpl. This effect might even be enhanced by a reduced 
migration rate, as the respective cells were also ablated there and not enough migrating cells 
were available. 
4.2.2 INCREASE IN NG2-GLIA NUMBERS IN THE LESION CORE IS ESSENTIAL FOR WOUND CLOSURE  
So far, many studies addressed the NG2-glia dynamics after injury, both post-mortem and in 
vivo (Buffo et al. 2005; Simon et al. 2011; Hughes et al. 2013; Binamé et al. 2013; Susarla et 
al. 2014). Although NG2-glia reactivity has also been extensively analyzed in regard to 
neuronal regeneration failure (Levine et al. 2001; Bradbury et al. 2002; Galtrey and Fawcett 
2007; Busch et al. 2010; Xiao et al. 2014), only little is known about the cellular and functional 
importance in tissue reaction of this cell population. In this work, it was demonstrated for the 
first time that NG2-glia are fundamental for wound closure after injury. In Esco2fl mice lacking 
NG2-glia in the injury site, repair of the wound tissue is significantly delayed compared with 
mice that have normal NG2-glia numbers and reactivity (Figure 29). Although the required 
functionality of NG2-glia for wound closure can clearly be justified by the lack of cells in the 
lesion core, the underlying mechanisms remain unclear. NG2-glia seem to be important for 
physically filling the hole in the lesioned tissue and for initiating the formation of a scaffold for 
other cell types, e.g. fibroblasts, endothelial lineage cells etc., that enter into the injury site to 
repair the wound (Shechter and Schwartz 2013; Burda and Sofroniew 2014). Concomitantly, 
NG2-glia might actively secrete extracellular matrix factors as suggested by Garwood et al. 
(2004) to strengthen the tissue composition for better lesion connectivity and repair. 
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Besides NG2-glia, microglia/macrophages are known to fundamentally contribute to the early 
stages of inflammatory reaction and to long-term wound regeneration and closure (Davalos et 
al. 2005; Hines et al. 2009; Dibaj et al. 2010; David and Kroner 2011). Moreover, hypertrophic 
astrocytes are beneficial for strengthening the tissue integrity with their cellular processes and 
for creating a scaffold for other accumulating cells that compact and repair the injured tissue 
(Sofroniew 2009; Sofroniew and Vinters 2010). The astroglial scar forms an interconnected 
physical barrier that is important to separate and protect the non-lesioned brain parenchyma 
from the inflamed lesion core in order to prevent the spreading of tissue damage (Bush et al. 
1999; Faulkner et al. 2004; Voskuhl et al. 2009; Sofroniew and Vinters 2010). Hence, both the 
lack in number as well as the faulty regulated activation of microglia and astrocytes in the 
lesion of Esco2fl mice could hence have contributed in exacerbating the tissue damage and 
delaying the wound closure. However, as the astrocyte reaction was only reduced but not 
absent, the here observed effect was not as strong compared with the direct modulation of 
astrocytes (McGraw et al. 2001). Although a mild astrogliosis occurred in Esco2fl mice at 7dpl, 
only few signs of a physical barrier formation could be observed. This finding additionally 
explains the longer and more widespread accumulation of invasive immune cells in the lesion 
site. Reduced numbers of resident microglia could result in less phagocytic activity in the lesion, 
inducing a longer-lasting, stronger and further spreading tissue inflammation. This hypothesis 
is consistent with previous studies showing that excess debris inside a lesion as well as a 
reduced number of microglia after injury is blocking tissue repair and even exacerbating the 
lesion (Hines et al. 2009; Lalancette-Hébert et al. 2007; Ruckh et al. 2012).  
Besides the cellular components discussed so far, the extracellular matrix in the lesion site of 
Esco2fl mice should be additionally scrutinized. It is known that not only astrocytes, but also 
NG2-glia and other cell types in the lesioned brain express a variety of ECM proteins (mainly 
CSPGs) that negatively modulate the regenerative potential (McKeon et al. 1999; Yamaguchi 
2000; Garwood et al. 2004; Castro et al. 2005; Kwok et al. 2011; Ji and Tsirka 2012; Brown 
et al. 2012). A reduction of the growth-inhibitory EMC deposition could have effects on the 
long-term neuronal regenerative capacity in Esco2fl mice. Underlining this hypothesis, 
Rodriguez et al. (2014) recently reported about an improved regenerative neuronal potential 
in the spinal cord of mice with a reduced CSPG deposition following an inhibited activation of 
glial cell types after injury by reducing the NG2-glia reactivity. Although these factors have 
been reported to be detrimental to the neuronal regeneration in most cases, they are essential 
to strengthen and agglutinate the cavernous tissue after immune reaction. As the cellular 
reactivity and most probably also the intercellular signaling was disturbed in the injury site in 
Esco2fl mice, the secretion of ECM proteins could also be reduced. Consequently, the whole 
glial scar in the respective injured tissue would be less sticky, additionally contributing to the 
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delay in wound closure. At 14dpl, the tissue reaction in terms of cellular components 
normalized in the Esco2fl mice. However, it is not known if the disturbance of cellular reactivity 
during the early stages influences the general composition of the ECM also later on.  
In summary, this work clearly demonstrated the important role of increasing NG2-glia numbers 
inside the lesion core for wound closure that might, besides the physical appearance of cells 
include the scaffold formation for other components, as well as secretion of stabilizing factors. 
4.2.3 WOUND HEALING IS THE RESULT OF A NG2-GLIA ORCHESTRATED CELL-TO-CELL SIGNALING CASCADE  
Although NG2-glia were shown to be important, they cannot be accounted for the lesion repair 
alone. All the numerous cell types that are present in the lesion site are individually contributing 
to a proper tissue reaction and the following repair (Shechter and Schwartz 2013; Burda and 
Sofroniew 2014). In addition to the lack of NG2-glia in close proximity to and inside the lesion 
core of the Esco2fl mice, the reaction of both microglia/macrophages and astrocyte dynamics 
were significantly altered in the first days after the lesion when the strongest ablation effects 
were observed (Figure 31 and Figure 32). As the partial ablation of one single cell type already 
induced such a strong reactive disturbance of other cell types, a complex cell-to-cell signaling 
model is suggested for the concerted tissue reaction after TBI (Figure 35). The obtained data 
in this work furthermore strongly propose an orchestrating role of NG2-glia in this cell-to-cell 
signaling network regulating the role of both microglia and astrocytes. Microglia ablation after 
injury for example did not show such a deleterious effect on other cell populations (Gowing et 
al. 2006). As illustrated in the model, single cells and other tissue components are individually 
reacting to injury and some of their responses and released factors are vice versa strongly 
regulating the behavior of neighboring cells that also carry important roles in the whole 
process. So far, some studies addressed and discussed the signaling mechanisms of astrocytes 
and microglia, and their effect on tissue reaction and wound repair (John et al. 2003; Farina 
et al. 2007). The mechanisms that might influence NG2-glia reactions are also at the beginning 
to be explored (Arnett et al. 2001; Rhodes et al. 2006; Filipovic and Zecevic 2008; Su et al. 
2011; Clemente et al. 2013; Moyon et al. 2015a), while the role and the secreted factors of 
NG2-glia in this cell-to-cell signaling network are still unknown on the other hand. However, 
this model only includes the major cell types while many other factors, e.g. damaged neurons, 
fibroblasts, leukocytes, miRNAs etc., that play an additional role in cell-to-cell interactions have 
not been considered in the further discussion (John et al. 2003; Su et al. 2015). 
At 2dpl, the microglia/macrophage reaction in the Esco2fl mice was comparable to the wildtype 
controls (Figure 31). At this timepoint the microglial reaction was not expected to be highly 
altered, as the NG2-glia ablation was only mild, and the cellular brain function as well as cell-
to-cell signaling mechanisms should consequently not be disturbed. Moreover, resident 
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microglia and bone marrow-derived macrophages (BMDMs) are the first cells reacting 
immediately to injury, activated by factors directly derived from the blood (Shechter and 
Schwartz 2013). These immediate reaction was probably not altered in the NG2-depleted 
model. The astrocyte reaction in the NG2-glia-ablated mouse model was not analyzed at 2dpl, 
as astrocytes were shown to only react at later stages upon injury compared with other glial 
cell types (Buffo et al. 2005; Robel et al. 2011b; Bardehle et al. 2013). Therefore, no obvious 
differences in Esco2wt and Esco2fl mice were expected. Between 2dpl and 4dpl when the 
decrease of NG2-glia in the ablation model became more prominent, the Iba1+ microglia 
population could not be fully augmented in comparison with the Esco2wt mice. Hence, an 
accumulation of microglia/macrophages in the lesion core was missing. Preliminary analysis 
revealed that the proliferation rate in microglia was unaltered, therefore it can be assumed 
that migration deficits were resulting in a failure of microglia accumulation due to missing 
signals from the depleted NG2-glia. Similar to what could be observed in the microglia 
population at 4dpl, astrocytes in the Esco2fl mice failed to increase in numbers compared with 
Esco2wt mice (Figure 32), and with data from literature (Hampton et al. 2004; Sofroniew and 
Vinters 2010),. This deficiency in cell density became more obvious at 7dpl, when the NG2-
glia deficiency peaked. Microglia/macrophage numbers in the Esco2fl mice were on the other 
hand again similar to the wildtype controls at 7dpl, although at this timepoint, the NG2-glia 
deficit was still very distinct. One explanation could be that in order to achieve a proper 
microglia reaction, only a certain threshold of tissue reaction is required, and that this threshold 
was achieved at this timepoint despite the lacking NG2-glia numbers. Microglia might as well 
release factors that function in an autocrine feedback loop, therefore the population could 
have supported itself to recover. Additionally, NG2-glia-to-microglia signaling could only be 
required to elicit a special reaction e.g. migration, or reaction during a special time window. 
The mechanisms inducing the late-phase microglia reactions might be derived from 
somewhere else. Moreover there is the possibility that infiltrating BMDMs at this late reaction 
stage take over the function of resident microglia and unlike microglia, are not dependent on 
NG2-glia signaling. 
These findings of the altered glial response conforms to a previous study, where the authors 
blocked the NG2-glia reactivity after SCI and found a reduced microglial and astrocyte 
reactivity, while the proliferative capacity of these cells remained unaltered (Rodriguez et al. 
2014). However, the authors did not address the mechanism that could be relevant for the 
disturbed activation. Taking the suggested cell-to-cell signaling model into account, one could 
hypothesize that the lack of NG2-glia and a consequent lack of their released signaling factors 
leads to the failure in activating both microglia and astrocytes.  
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Figure 35: Cell-to-cell signaling mechanisms after acute brain injury. Cellular tissue reaction and 
subsequent wound healing following TBI displays a complicated cell-to-cell signaling network, including all kinds of 
resident brain cells, as well as invading cells from the periphery. Microglia are mainly activated by blood-derived 
signals and are known to regulate NG2-glia by secreted factors, astrocytes as well as the local tissue inflammation 
by a series of different factors. Astrocytes, that also carry receptors to be activated upon tissue damage, are 
additionally able to modify the local cellular tissue reaction via the secretion of cytokines and chemokines. Although 
NG2-glia are known to react to stimuli derived from different sources, their role in this signaling network still needs 
to be further explored. NG2-glia are suggested to play an orchestrating role in the regulation of tissue inflammation. 
Abbreviations: ATP: adenosine triphosphate; PRR: pattern-recognition receptor; TNF-α: tumor necrosis factor α; 
IL: interleukine; CCL2: chemokine (C-C motif) ligand 2; IGF-1: insulin-like growth factor 1; IFNγ: interferon γ; ROS: 
reactive oxygen species; NO: nitric oxide; MCP-1: monocyte chemoattractant protein 1; TGF-ß: transforming growth 
factor ß; CXCL10: chemokine (C-X-C motif) ligand 10; GM-CSF: granulocyte-macrophage colony-stimulating factor. 
 
This hypothesis is strengthened by different studies showing that microglia/macrophages and 
NG2-glia are able to influence each other by secretory mechanisms (Du Wu et al. 2002; Rhodes 
et al. 2006; Kang et al. 2013) (Figure 35). Late-stage responding astrocytes are also known 
to secrete a series of factors, e.g. granulocyte-macrophage colony stimulating factor (GM-
CSF), interleukine-6 (IL-6), and a number of chemokines from the CCL-family that elicit a 
reaction in microglia/macrophages (Farina et al. 2007).The obtained data furthermore suggest 
that astrocytes – in contrast to the microglia/macrophages – are more sensitive to, or 
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dependent on NG2-glia-derived signals in order to increase their cellular tissue reactivity, as 
their reactivity did not recover during the absence of NG2-glia. Although this work clearly 
demonstrated the dependency of astrocyte reactions on NG2-glia, several other studies already 
reported about important signaling mechanisms derived from other tissue-derived factors, 
including an autocrine astrocyte pathway via endothlin-1 (Figure 35, Gadea et al. 2008; 
Sofroniew 2009; Wang et al. 2015; Gyoneva and Ransohoff 2015). 
Despite the finding of reduced microglia numbers, the reason why especially at later timepoints 
a higher immune cell infiltration and a higher number of reactive microglia was observed could 
have several reasons: (I) BMDMs under wildtype conditions infiltrate the lesion site and 
subsequently undergo a fate-switch into M1 or M2 macrophages, making them 
indistinguishable from resident microglia. As this fate switch is highly dependent on the 
environment (Miron et al. 2013; Kumar et al. 2013), changes in the signaling cascade in the 
Esco2fl mice could disturb this fate switch, resulting in an accumulation of BMDMs in the lesion 
site. Such changes could either derive from the direct lack of NG2-glia or from the secondary 
decrease in the general cellular reactivity. (II) Moreover, tissue reaction after injury is a highly 
balanced interaction between pro- and anti-inflammatory signals, with the latter ones being 
especially important to late-stage reactions that reduce inflammation and initiate wound 
healing (Sofroniew 2015; Corps et al. 2015). Especially M2-polarized microglia were shown to 
regulate the anti-inflammatory injury reaction. However, NG2-glia certainly play an additional 
role in this context, as microarray analysis of reactive NG2-glia identified many signaling 
pathways involved in cell-to-cell signaling (Simon and Dimou unpublished data). (III) The 
apoptotic loss of numerous NG2-glia in the Esco2fl mice at already early stages further 
increased the tissue damage and accumulated debris. Therefore, the recruitment of blood-
derived immune cells is being augmented, as microglia/macrophages were shown to respond 
to outer stimuli (e.g. ATP) in a dose-dependent manner (Davalos et al. 2005; Koizumi et al. 
2007).  
In conclusion, the reduction of cell numbers in the lesion site in Esco2fl mice suggests that 
NG2-glia play a crucial role in the orchestration of cell-to-cell signaling and celluar reaction of 
other resident cell types following TBI. 
 
4.3 TRANSLATIONAL APPROACHES AND CLINICAL IMPLICATIONS  
Most of the studies deepening the general understanding of NG2-glia either in health or in 
disease were carried out using rodents, while the access to human tissue and therefore the 
knowledge of the human counterparts remains vague. Although these cells have already been 
discovered and used for tissue culture a long time ago (Armstrong et al. 1992; Gogate et al. 
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1994; Chang et al. 2000), it took several years to identify that adult human NG2-glia also carry 
the uniqueness of being proliferative in cortical regions outside the neurogenic niches (Geha 
et al. 2010; Rhee et al. 2009). Along the same line, Yeung et al. (2014) just recently reported 
that in adult human cortices there is a certain amount (although very low) of oligodendrocyte 
as well as myelin turnover. Considering these findings, there is evidence that some more well 
described rodent NG2-glia characteristics can be translated, and potentially used for repair 
mechanisms in humans. As multiple sclerosis is a major disease burden in young adults (Murray 
2015), remyelination out of an either brain resident or transplanted NG2-glia pool is one of the 
main translational goals to be achieved in medical research; already more or less successful 
(Gupta et al. 2012). However, this work emphasized for the first time, that the deep 
mechanistic understanding of NG2-glia is also in many other aspects indispensable for future 
clinical purposes. 
NG2-glia proliferation, differentiation and subsequent myelin production are rapidly declining 
during the process of aging (Lasiene et al. 2009; Psachoulia et al. 2009; Clarke et al. 2012; 
Young et al. 2013), and so is the white matter volume and the therewith associated cognitive 
abilities in humans (Bartzokis et al. 2001; Hasan et al. 2008; Zahr et al. 2009). There are 
speculations that the decline in NG2-glia proliferation and differentiation is the reason for the 
progressive loss of cognitive functions. Furthermore the work presented in this study 
demonstrated that a disturbance of the oligodendrocyte lineage equilibrium even during the 
young adulthood has a high impact on the maintenance of both spatial cognitive and motor 
abilities. Understanding the fundamental mechanisms driving both proliferation as well as 
differentiation of NG2-glia and circumventing the age-related decline of these characteristics 
in humans, would be one step forward in providing a cure for our aging society. 
After injury, the situation of gaining benefits from understanding NG2-glia is similarly 
promising. Addressing neuronal loss after TBI or SCI and the causative lack of functional 
recovery is a main focus of clinical research. Several approaches promoting recovery for 
neuronal repair were already extensively used, including transplantation of stem cells (Lu et 
al. 2014), as well as in vivo reprogramming of glial cells into functional neurons (Grande et al. 
2013; Heinrich et al. 2014). However, this work clearly demonstrated the valuable impact on 
NG2-glia in the repair mechanisms after injury. Triggering them towards a specific reaction in 
early stages after injury by externally applying stimulating cues could be exploited for the 
progress in the recovery of TBI in humans. 
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5 MATERIALS 
5.1 CHEMICALS 
0,9% NaCl solution (Saline)      Braun 
2-Propanol (Isopropanol)      Roth 
4′,6-diamidino-2-phenylindole dilactate (DAPI)  Invitrogen 
5-Bromo-2′-Deoxy-Uridine (BrdU)    Sigma 
Acetone       Roth 
Agarose        Serva 
Araldit Kit        Fluka 
Bovine serum albumin     Sigma 
Bromphenol blue       Sigma 
Calcium chloride dihydrate     Sigma 
Citric acid monohydrate     Roth 
Corn oil        Sigma 
Dextran-fluorescein      LifeTechologies 
Dimethylarsinic acid sodium salt trihydrate   Merck 
di-Sodium hydrogen phosphate dihydrate   Merck 
dNTPs        PeqLab 
Ethanol 70 %        Roth 
Ethanol p.a.        Roth 
Ethidiumbromide       Roth 
Ethylene glycol       Sigma 
Ethylenediamine-tetraacetic acid (EDTA)   Sigma   
Formaldehyde (Formol)      Roth 
Formamide        Roth 
Glacial acetic acid      Roth 
Glutaraldehyde (electron microscopy grade) 25 %  Serva 
Glycerine       Sigma 
Glycerole        Sigma 
Glycine        Sigma 
Goat Serum       Gibco 
In-situ cell death detection kit    Roche 
Lead citrate       Sigma 
Mounting solution (AquaPolymount)    Polysciences 
Osmium tetroxide solution 4 %     Sigma 
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Paraformaldehyd       Sigma 
Potassium chloride       Sigma 
Potassium hydroxide       Sigma 
Proteinkinase K       Roth 
Q-solution        Qiagen 
Sodium acetate trihydrate     Sigma 
Sodium bicarbonate       Sigma 
Sodium carbonate       Fluka 
Sodium chloride       Sigma 
Sodium dodecyl sulfate     Roth 
Sodium hydroxide       Fluka 
Sodium hydroxide pellets      Sigma 
Sodium nitrite       Fluka 
Sodium phosphate       Sigma 
Sucrose        Merck 
Sudan Black B       Sigma 
Tamoxifen        Sigma 
Taq Polymerase      NEB/ self-made 
TRISbase       Sigma 
TRISHCL       Sigma 
Triton X-100        Sigma 
Tween20        Sigma 
5.2 DRUGS 
Atipamezol       Vetoquinol 
Carprofen (Rimadyl)      Pfizer 
Fentanyl       Sandoz 
Flumazenil       Hexal 
Ketamin       Pfitzer 
Medetomidin       Vetoquinol 
Naloxon       Chemos 
Xylazinhydrochlorid (Rompun) 2%     Bayer 
Xylocain Pumpspray      AstraZeneca 
5.3 CONSUMABLES 
24-well plates       Sarstedt 
48-well plates       Sarsted 
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Coverslips       Roth 
Driller        Foredom 
Eye cream       Bebanthen 
Falcon tubes (15ml, 50ml)     Greiner 
Filter tips       Sarstedt 
Insulin syringes U-100     BD Micro Fine (PZN: 324870) 
Microscope slides Superfrost     Thermo Scientific 
Microscope slides      Roth 
Needles       Braun 
Nescofilm       Nescofilm 
Parafilm       Parafilm 
Operation instruments     FST 
Pipet tips       Sarstedt 
Pipets        Gilson 
Reaction tubes (0.5ml, 1.5ml, 2ml, 5ml)   Eppendorf 
Reaction tubes for PCR     Eppendorf 
Rotilabo® cotton buds     Roth 
Serological pipets (5ml, 10ml, 15ml)    Sarstedt 
Sugi sponge strips rectangular/triangular   Kettenbach 
Surgical blades      Schreiber Instrumente 
Suture        Ethicon 
Syringe (1ml)       Braun 
Transfer pipets      Sarstedt 
V-LanceTM Knife, 19 Gauge     Alco © Surgical 
5.4 SOFTWARE 
Any-maze       Stoelting 
Fiji/ImageJ       Wayne Rasband National Institutes 
        of Health 
GraphPad Prism 5      GraphPad Software, Inc. 
VLC Media Player 2.1.3 Rincewind    Free Software Foundation Inc. 
Zen 2008       Zeiss 
Zen 2011       Zeiss 
5.5 TECHNICAL EQUIPMENT      
Cryostate       Leica 
Digital video camera Camileo X200    Toshiba 
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Geldoc™ XR       BIO-RAD 
Microscope Imager.M2     Zeiss 
Microscope LSM700      Zeiss 
Microscope Observer.Z1     Zeiss 
Microscope Leica MZ6     Leica 
Perfusion pump      Gilson 
pH meter WTW      inoLab 
Stereotactic apparatus     Stoelting 
Thermocycler 3000      Biometra 
Thermomixer comfort     Eppendorf 
Thermoshaker       Gerhardt 
Vortex-Genie       Bender & Hobein AG 
Water bath       Haake 
5.6 BUFFERS AND SOLUTIONS 
5.6.1 BUFFERS FOR DNA EXTRACTION AND GENOTYPING 
10mM Tris-HCL 
 1.211g  TRISbase 
 Ad 1l H2O, adjust to pH8.5 
Lysis Buffer 
 1mM  NaCl 
 5mM  EDTA    
 0.2%  SDS 
 0.2M  NaCl 
10mg/ml  Proteinase K (freshly added) 
Ad 1l H2Odd 
10x PCR buffer 
 500mM Potassium chloride 
 100mM TRISHCl 
 In H2O, adjust to pH8.7 
50x TAE buffer 
242g  TRISBase 
37.2g  Disodium EDTA 
57.1ml  Glacial acetic acid 
Ad 1l H2Odd 
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6x Loading buffer 
 10mM  TRISHCl (pH7.6) 
 0.03%  Bromphenol blue 
 0.03%  Xylencyanol 
 60%  Glycerin 
 60mM  EDTA 
 In H2Odd 
5.6.2 BUFFERS FOR ANIMAL TISSUE PREPARATION 
20% Paraformaldehyde (stock solution) 
 134g  Di-sodium-hydrogenphosphat 
 400g  PFA powder 
 10ml  Sodium hydroxide 
 Ad 1600ml H2O, pass through filter paper, adjust to pH7.4 
4% PFA 
 100ml  20% PFA 
 400ml  H2O 
10x Phosphate buffered saline (PBS) 
 73.66g  Di-sodium-hydrogenphosphat 
 10g  Potassium-dihydrogenphosphate 
 400g  Sodium chloride 
 10g  Potassium chloride 
 Ad 5l H2O, adjust to pH7.4  
1x PBS 
 100ml  10x PBS 
 800ml  H2O 
 Readjust pH7.4 
Cryopotection solution 
 30%  Sucrose 
 In 1x PBS 
5.6.3 BUFFERS FOR IMMUNOHISTOCHEMISTRY 
Blocking solution 
 10%  Goat serum 
 0.5%  TritonX 
 In 1x PBS 
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Citrate buffer 
 10mM  Citrate 
 0.05%  Tween20 
 In H2Odd, adjust to pH6.0 
10x Phosphate buffer 
 65g  Sodiumdihydrogenphosphate 
 15g  Sodium hydroxide 
 Ad 400ml H2Odd, adjust to pH7.2-7.4 
Storing solution 
 150ml  Glycerol 
 150ml  Ethylen glycol 
 50ml  10x Phosphate buffer 
 Ad 500ml H2Odd  
5.6.4 BUFFERS FOR IN SITU CELL DEATH DETECTION 
Permeabilisation solution 
 0.1%  TritonX 
 0.1%  Sodium citrate 
 In 1x PBS, always prepare freshly 
DNaseI solution 
 50mM  TRISHCl 
 1mg/ml BSA 
 300U  DNaseI 
 In H2Odd, adjust to pH7.5 
5.6.5 BUFFERS FOR CRESYLVIOLET STAINING 
0.1% Cresylviolet staining solution 
 300mg  Cresylviolet 
 1.63g  Sodium acetate 
 2.9ml  Glacial acetic acid 
 Ad 300ml H2Odd, stir for 30min at 60°C and filter 
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5.6.6 BUFFERS FOR SUDAN BLACK STAINING 
Sudan Black staining solution 
 5 spatula tips Sudan Black B 
 In 70% EtOH, stir properly and filter  
5.6.7 BUFFERS FOR ELECTRON MICROSCOPY 
0.2M Cacodylat buffer 
21.4g   Dimethylarsinic acid sodium salt trihydrate  
0.22g   Calcium chloride dehydrate 
Ad 500ml H2Odd, adjust to pH7.2 
Karnovski fixative 
2.5%   Glutaraldehyde 
2%  Paraformaldehyde (PFA) 
0.1M  Cacodylat buffer 
Storing solution 
4%  PFA 
2.5%  Sucrose 
In 0.1M Cacodylat buffer 
Washing buffer 
2%  Sucrose 
In 0.1M Cacodylat buffer 
Osmication solution 
2%  Osmium tetroxide solution 
0.002% Calcium chloride 
2%  Sucrose 
In 0.2M Cacodylat buffer 
Lead citrate buffer 
1.33g  Lead citrate 
1.76g  Sodium citrate 
Ad 30ml H2O (EM purity), dissolve with 8ml NaOH and fill up to 50ml with H2O (EM 
 purity) 
Uranyl acetate 
 Spatula tip Uranyl acetate 
 Ad 1ml 70% MeOH, stir under light exclusion and centrifuge 10min at 6000rpm 
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5.6.8 SOLUTIONS FOR DRUG AND DIE APPLICATIONS 
Rimadyl stock solution 
 50mg/ml Carprofen (Rimadyl) 
 In NaCl (0.9%) 
Ketamin/Rompun anesthesia solution 
 2.5ml  NaCl (0.9mg/ml) 
 1ml  Ketamin 
 0.25ml  Rivapoun 
MMF (Sleep) mix 
 0.25ml  Fentanylcitrat 
 0.5ml  Midazolam 
 0.25ml  Medetomidin 
 4ml  NaCl (0.9%) 
Awake mix 
 1.5ml  Naloxon 
 2.5ml  Flumazenil 
 0.25ml  Atipamezol 
 0.75ml  NaCl (0.9%) 
BrdU drinking water 
 1mg  BrdU 
 10g  Sucrose 
 Ad 1l H2O (tap water) and stir 30min under light protection 
Tamoxifen solution 
 40mg  Tamoxifen 
 100µl  EtOH p.a. 
 Ad 1ml corn oil and shake for 3hrs at 37°C 
Dextran-fluorescein solution 
 5mg  Dextran-fluorescein 
 1ml NaCl (0.9%) 
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6 METHODS 
6.1 ANIMALS 
6.1.1 MOUSE LINES 
6.1.1.1 SOX10ICREERT2XCAG-EGFPXESCO2FL/FL 
This mouse line was a crossing product of three different mouse lines. The Sox10iCreERT2 line 
is an inducible BAC (Bacterial artificial chromosome) transgenic mouse-line. The BAC with the 
improved Cre-recombinase (iCre) fused to the modified human estrogen receptor (ERT2) under 
the Sox10 promoter was randomly inserted into the mouse genome, with 2.2 copies per cell 
(Simon et al. 2012). The line was crossed with a green fluorescent protein (GFP) reporter line, 
to visualize the recombination rate (Nakamura 2006). 
The Esco2fl/fl line is an inducible conditional knockout mouse working with the Cre-LoxP system 
(elaborately described in chapter 1.6). Parts of the coding sequence including the start codon 
of the cell cycle protein Esco2 was flanked with LoxP sites and are therefore cut when the iCre 
is active. The mouse line had a pure C57BL/6J background. The Sox10 and the eGFP allele 
were bred homozygous whereas the Esco2 locus was bred heterozygous in order to receive 
both heterozygous wildtype and knockout mice in the same litter. 
In this work, the term Esco2wt refers to the pure Esco2wt/wt genotype, whereas the term Esco2fl 
refers to both the mixed Esco2wt/fl as well as the pure Esco2fl/fl alleles. This two genotypes were 
mixed, because both the homozygous and the heterozygous animals showed the same cellular 
behavior, and were therefore pooled. 
6.1.1.2 NG2CREERT2XCAG-EGFPXESCOFL/FL 
This mouse line is also a crossing product of three different mouse lines. The NG2CreERT2 is 
an inducible knockin mouse, where the open reading frame of the CreERT2 was inserted into 
the endogenous NG2 locus (Huang et al. 2014b). This mouse line was crossed with the CAG-
eGFP and the Esco2fl/fl as described in 6.1.1.1. To avoid the loss of the NG2 proteoglycan, the 
NG2 locus was bred heterozygous, the Esco2 locus was bred heterozygous in order to receive 
both heterozygous wildtype and knockout mice in the same litter. The mouse line had a pure 
C57BL/6J background. 
6.1.2 GENOTYPING 
6.1.2.1 DNA ISOLATION 
Genomic DNA was isolated using small tail or ear biopsies that were lysed in 500µl lysis buffer 
at 55°C over night (o.n.) in the shaker and afterwards centrifuged for 5 minutes (min) at 
10000 rounds per minute (rpm) at room temperature (RT). The supernatant was transferred 
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into a new eppendorf tube, the DNA was precipitated with 500µl isopropanol for 5min and 
pelleted by 10min centrifugation at 10000rpm. The supernatant was removed and the DNA 
pellet dried at RT. Afterwards the DNA was dissolved in 200µl 10mM Tris-HCL pH8 at 55°C for 
2hrs in the shaker and kept at 4°C until further usage. 
6.1.2.2 PCR 
In order to define the genotype of the mice for a specific locus, a gene specific polymerase 
chain reaction (PCR) was performed, using the mastermix reactions displayed in Table 3. 
Primer sequences of the according genes are shown in Table 4. For the NG2CreERT2 PCR, two 
preparations were needed: one mastermix containing the forward and a reverse mutant 
primer, another one containing the forward and the reverse wildtype primer. After running the 
gene specific PCR program (cf. Table 5), samples were enriched with 10x loading buffer, 
separated on a 2% agarose gel and visualized. 
 
Table 3: Mastermix for genotyping PCR. 
Substance Volume [µl]
H2O 11µl
Buffer A 2.5µl
MgCl2 2.5µl
Betaine solution 5µl
dNTPs 0.5µl
Forward primer (100mM) 0.5µl
Reverse primer (100mM) 0.5µl
Taq polymerase 0.5µl
DNA 2µl
Total volume 25µl
 
Table 4: Primer sequences for genotyping PCR. 
Gene locus Direction Primer sequence Band size
Sox10iCreERT2 forward 5’-AAACACCCACACCTAGAGAC-3’ 452bp
 reverse 5’-ACCATTTCCTGTTGTTCAGC-3’
NG2CreERT2 forward 5’-GGCAAACCCAGAGCCCTGCC-3’ WT: 557bp
 reverse (WT) 5’-GCTGGAGCTGACAGCGGGTG-3’ Cre: 829bp
 reverse (Cre) 5’-GCCCGGACCGACGATGAAGC-3’  
CAG-eGFP forward 5’-CTG CTA ACC ATG TTC ATG CC-3’ 350bp
 reverse 5’-GGT ACA TTG AGC AAC TGA CTG-3’
Esco2 forward 5’-ATCTGGGTCCTCATTCTGCACAGC-3’ WT: 279bp
FL: 347bp  reverse 5’-GTGCACATACTTATTGACAGGTGG-3’
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Table 5: PCR cycle programs for genotyping. 
6.1.3 TAMOXIFEN ADMINISTRATION 
Tamoxifen was diluted in corn oil and 10% EtOH p.a. with a final concentration of 40mg/ml 
and dissolved by shaking at 37°C for a minimum of 3hrs. 250µl of the tamoxifen solution was 
applied orally to adult mice (8-10 weeks, ~25g bodyweight) with a gavage needle every second 
day for a total of three times (10mg or 400mg/kg bodyweight, total of 30mg). For mice with 
less body weight accordingly less of the tamoxifen solution was applied. 
6.1.4 BRDU ADMINISTRATION 
In order to achieve long-term labelling of dividing cells, the DNA base analogue 5-Bromo-2´-
Deoxy-Uridine (BrdU) was administered via the drinking water. BrdU was dissolved at a 
concentration of 1mg/ml with addition of 1% sucrose under light protected stirring for 30min 
at RT. The BrdU solution could be kept in the fridge for 1 week and was refreshed in the 
drinking bottles every 3rd day. 
6.1.5 BEHAVIORAL ASSESSMENT 
Standardized behavioral tests were performed to assess the motor phenotype of adult mice. 
Prior to the data analysis, adult mice (8-12 weeks) were trained for 2 weeks every second day 
to perform the behavioral tests. During the first week of training, mice received tamoxifen 
according to the normal protocol described above. After the training period motor behavior 
was assessed on a weekly basis until the mice were sacrificed at the end of the experiment. 
Tests were monitored by a digital video camera and afterwards analyzed in slow motion mode 
in a blinded manner. Statistical analysis of the behavioral experiments was done with the 
GraphPad Prism 5 software. As the same mice were analyzed multiple times, the repeated-
measures ANOVA was used to determine significance. Significant differences were indicated 
with * for p<0.05, ** for p<0.01 or *** for p<0.001. 
6.1.5.1 GRID WALK 
Mice were placed in an arena (60x40x18cm) with a grid ground (1cm mash size) elevated 
50cm from the ground and could move freely for 2.5min. Total step and misstep numbers 
Sox10iCreERT2 NG2CreERT2 GFPII-reporter Esco2 
Temp. 
[°C] 
Time Temp. 
[°C] 
Time Temp. 
[°C] 
Time Temp. 
[°C] 
Time
94 3min 94 3min 94 5min 94 3min 
94 30sec 94 30sec 94 30sec 94 30sec
52 30sec 26x 64 30sec 30x 55 30sec 29x 60 30sec 26x
72 1min 72 45sec 72 1min 72 1min 
72 10min 72 2min 72 10min 72 10min
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were counted and analyzed. A misstep was counted when the stepping foot slipped through 
the grid. 
6.1.5.2 BEAM CROSSING 
Mice had to cross a round wooden beam of 1cm diameter and 70cm in length elevated 20cm 
from the ground. Mice had to fully cross the beam three times for a successful score (100%). 
When the mouse fell down, it was rated with 0%. 
6.1.5.3 HORIZONTAL LADDER  
Mice had to cross a 1m horizontal ladder with different step intervals (1-2cm spacing) elevated 
50cm from the ground. In order to prevent the mice from learning, the step pattern was 
changed weekly. Total step and misstep numbers were counted and analyzed. 
6.1.5.4 OPEN FIELD 
Mice could run free in a rectangular open filed arena (59.5x37x19cm) that was subdivided into 
12 equal rectangles (15x15cm) for 4min. The number of crossed fields over the whole period 
was counted. 
6.1.5.5 NOVEL OBJECT RECOGNITION TEST 
For the Novel Object Recognition (NOR) test, mice were habituated to the open field arena 
and the environment for two consecutive days for 5min each. The following day, two similar 
objects were placed in the arena and during the 5min habituation period, the interaction time 
of the mice with each object was analyzed. After a 30min interval, one object was replaced by 
an object that was similar in size but different in shape and colour. During the 5min acquisition 
period, the interaction time of mice with the object as well as the total distance of travelling 
was analyzed. The interaction index was calculated by:  
interaction index= interaction new objecttotal interaction time x100. 
6.1.6 ANESTHESIA 
Prior to perfusion or surgery, mice were anesthetized with either Ketamin/Rompune or 
Medetomidin/Midazolam/Fentanyl (MMF). Before any further processes, mice were tested for 
the complete lack of reflexes at the hind-paws or the upper tail. 
6.1.6.1 KETAMINE/ROMPUNE 
Ketamine/Rompune anesthesia was used for perfusion of the mice (see section 6.1.8). 
Therefore 1ml ketamin (10%) and 0.25ml xylazine hydrochloride (2%) and was mixed with 
2.5ml saline (0.9%). Adult mice with an average weight of 25g received an intraperitoneal 
(i.p.) injection of 350µl of the anesthetic what was considered to be a lethal overdose. 
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6.1.6.2 MMF 
Medetomidin/Midazolam/Fentanyl (MMF) anesthesia was used to anesthetize mice for 
surgeries, as previously reported in Sirko et al. 2013. The solution that was i.p. injected 
contained 0.5mg/kg body weight Medetomidin, 5mg/kg body weight Midazolam and 
0.05mg/kg body weight Fentanyl. The injection volume (in µl) was calculated by the body 
weight (in g) x 10 + 20µl excess. As the anesthesia needs to be antagonized, the same volume 
of an antisedate was i.p. injected to wake the animals up containing 2.5mg/kg body weight 
Atipamezol, 0.5mg/kg body weight Flumazenil and 1.2mg/kg body weight Naloxone. 
6.1.7 MODEL OF STAB WOUND INJURY 
Surgeries were performed in accordance to the policies of the state of Bavaria under the license 
numbers 55.2-1-54-2531-144-07 (old) and 55.2-1-54-2532-171-11 (new). 
The stab wound injury is a mouse model for an acute traumatic brain injury. To perform a stab 
wound adult mice (2-3 months old) were deeply anesthetized with MMF (see chapter 6.1.6.2) 
and the fur was removed from the scull. During the anesthesia the eyes of the mice were 
protected with a special eye crème. For the operation, mice were placed and fixed in a 
stereotactic apparatus, the skin was cut open longitudinally and completely detached from the 
scull. A unilateral small craniotomy (around 2mm in diameter) was performed in the scull at 
the somatosensory cortex (rostral to the bregma) with a dental driller, without damaging the 
meninges. The cortical GM was longitudinally cut with a 19 gauge V-LanceTM knife. The cut 
was about 1.5mm in length and 0.6mm in depth to exclude an injury of the WM. After the 
surgery the skin lesion was stitched and the animals were woken up from the anesthesia with 
the antisedate. For pain prevention, the mice received Carprofen (Rimadyl) (4mg/kg body 
weight) 30min prior to and 24hrs after the surgery.  
6.1.8 TRANSCARDIAL PERFUSION 
Mice received a lethal dose of ketamine/rompune intraperitoneal (i.p) (see section 6.1.6). 
Before the clinical death, the thorax of the mice was opened and a needle was inserted into 
the right ventricle. To open the blood circulation, the left atrium was opened. After a 5min 
washout of the blood with PBS, mice were perfused for 23min with 4% PFA. After careful 
preparation of the brains they were postfixed for around 20min in 4% PFA and afterwards 
cryoprotected in 30% sucrose (in PBS).  
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6.2 IMMUNOHISTOCHEMISTRY 
6.2.1 TISSUE COLLECTION AND SECTIONING 
6.2.1.1 BRAINS 
After the transcardial perfusion (see chapter 6.1.8) brains were dissected, postfixed for 20min 
in 4% PFA and cryoprotected in 30% sucrose. For immunohistochemistry whole brains were 
sectioned (either coronal or sagittal) as 30µm free floating sections at the cryostate. Sections 
were either directly stained or kept until further usage in storing solution at -20°C. 
6.2.1.2 SCIATIC NERVES 
After the transcardial perfusion (see chapter 6.1.8) sciatic nerves from both legs were 
dissected, postfixed for 10min in 4% PFA and cryoprotected in 30% sucrose. Sciatic nerves 
were cut longitudinally in sections of 20µm thickness and directly mounted on superfrost glass 
slides. For teased fiber preparation, 0.5cm sciatic nerve samples were teased with forceps and 
directly mounted on superfrost glass slides. Sections and fibers were stored at -20°C until 
further processing. 
6.2.1.3 SKELETAL MUSCLES 
After the transcardial perfusion (see chapter 6.1.8) different skeletal muscles were dissected, 
directly cryoprotected in 30% sucrose. Muscles pairs from both body sides were cut together 
longitudinally in sections of 40µm thickness at the cryostate and directly mounted on superfrost 
glass slides. Sections were stored at -20°C until further processing. 
6.2.2 IMMUNOHISTOCHEMICAL STAININGS 
Prior to antibody incubation, sections were blocked for 30min in blocking solution. Primary 
antibodies (for details and final concentrations see Table 6) were incubated over night at 4°C 
in blocking solution on a shaker. Afterwards sections were washed 3 times in 1x PBS. 
Secondary antibodies (see Table 7 7) directed against the host of the primary antibody were 
all diluted 1:500 in blocking solution and incubated for 2hrs at RT on the shaker. 5min before 
the end of the incubation time, sections were counterstained with DAPI (1:1000). Sections 
were properly washed in 1x PBS, mounted on glass slides, dried at RT and embedded with 
Aqua-Polymount. 
In order to allow the antibody directed against BrdU to enter the nucleus, a special treatment 
prior to the staining was necessary. Sections were incubated for 20min in 0.01M citrate buffer 
(pH6, 0.05% Tween20) at 96°C, washed with 1x PBS and 10min fixed in 4%PFA. Secondary 
antibody staining was performed according to the protocol described above. 
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Table 6: List of primary antibodies. 
Recognized antigen Host Dilution Company
AN2 Rat 1:50 Prof. Trotter (University of Mainz) 
BrdU Rat IgG2a 1:100 Biozol (OBT0030)
CASPR clone K65/35 Mouse IgG1 1:100 UC Davis/NIH NeuroMab Facility (75-001)
CC1 (APC) Mouse IgG2b 1:100 Calbiochem (OP80)
CD45 Rat IgG2b 1:500 BD Pharmingen (550539) 
GFAP Mouse IgG1 1:400 Sigma-Aldrich (G3893)
GFAP Rabbit 1:400 Sigma-Aldrich (G9269)
GFP Chicken 1:1000 Aves Lab (GFP-1020)
Iba1 Rabbit 1:500 Wako (019-19741)
Ki67 Rabbit 1:100 Thermo Fischer (14-5698-82) 
Ki67 Rat 1:250 eBioscience (RM-9106-S) 
Kv1.2 clone K14/16 Mouse IgG2b 1:100 UC Davis/NIH NeuroMab Facility 75-008 
NeuN Mouse IgG1 1:100 Millipore (MAB337)
NFH Rabbit 1:500 Sigma-Aldrich (N4142)
NG2 Rabbit 1:500 Millipore (AB5320)
S100ß Mouse 1:300 Sigma-Aldrich (S2532)
S100 Rabbit 1:300 Sigma-Aldrich (S2644)
α-Bungarotoxin A594 
conjugated 
Bungarus 
multicictus 
1:1000 Invitrogen (B13423)
  
 
Table 7: List of secondary antibodies. 
Antibody Host Label Dilution Company
Anti-chicken Goat Alexa488 1:500 Invitrogen (A11039) 
Anti-rat Goat Cy3 1:500 Dianova (112-165-167) 
 Goat Alexa647 1:500 Invitrogen (A21247) 
Anti-rabbit Goat Alexa647 1:500 Dianova (111-605-144) 
 Goat Alexa649 1:500 Dianova (111-495-144) 
 Donkey Cy5 1:500 Dianova (711-175-152) 
 Donkey Cy3 1:500 Dianova (711-165-152) 
Anti-mouse Goat Alexa647 1:500 Dianova (115-605-006) 
 Goat Cy3 1:500 Dianova (115-165-166) 
Anti-mouse IgG2b Goat Alexa647 1:500 Invitrogen (A21241) 
 
6.2.3 QUANTIFICATIONS AND STATISTICAL ANALYSIS 
For the immunohistochemical analysis, Z-stack images of 12-10µm were collected with a Zeiss 
confocal microscope system (LSM710) with the 40x objective. The quantitative analysis was 
done afterwards using the Fiji or ImageJ cell counter plugin on collapsed stacks. Total cell 
numbers of single stacks were counted and afterwards calculated in cells/mm2. Double-labeling 
of cells was verified by switching between different channels in the software. For the 
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quantification, a total of 9 Z-stacks (3 stacks from 3 different sections each) were analyzed 
per mouse. Group sizes of n≥3 were used, reflecting the standard of other work published in 
this field. All data (if not explicitly stated) were displayed as mean±standard error of the mean 
(sem). Statistical analysis was performed with the GraphPad Prism 5 software. As all the cell 
numbers and other types of quantifications showed a Gaussian distribution, significant 
differences were determined using the unpaired Student’s t-test for two or the One-way 
ANOVA for more than two groups. Significant differences were indicated with * for p<0.05, ** 
for p<0.01 or *** for p<0.001. 
 
6.3 TUNEL STAINING 
To visualize apoptotic cells in brain section a terminal deoxynucleotidyl transferase dUTP nick 
end labeling (TUNEL) staining was performed, using an in situ cell death detection kit (Roche). 
Therefore cells were fixed in 4% PFA, washed properly in 1x PBS and incubated for 2min on 
ice in permeabilisation solution. After a brief wash a positive control was incubated for 10min 
at RT in DNaseI solution and properly washed in 1x PBS. Sections were then incubated for 
60min at 37°C in label and enzyme solution according to the manufacturer’s protocol (solutions 
provided with the kit). A negative control was incubated without the enzyme solution. After 
washing the sections immunostainings for co-labeling of TUNEL+ cells was performed as 
described in chapter 6.2.2. 
 
6.4 CRESYLVIOLET STAINING 
Free floating sections were mounted on superfrost slides and dried properly at RT. Slides were 
then hydrated in a decreasing ethanol row (100%, 70%, 50%, 3min each) and then washed 
for 3min in H2O. The staining was performed for 20min in cresylviolet staining solution at RT 
and afterwards washed for 3min in H2O. After the staining, sections were dehydrated in an 
increasing alcohol row (50%, 70%, 100%, 3min each), for 3min in 2-propanol and finally for 
3min in xylol. After the sections were dried, they were embedded in DCX mounting medium. 
The staining was visualized under a brightfield microscope. 
 
6.5 MYELIN VISUALIZATION 
6.5.1 SUDAN BLACK STAINING 
Free floating sections were mounted on superfrost slides and properly dried. Slides were 
incubated for 10min in Sudan Black staining solution and washed briefly in H2O. The staining 
was then differentiated in 70% EtOH, washed in H2O again and mounted in Aqua-Polymount. 
The myelin staining was then visualized with the 25x objective of a Zeiss bright field 
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microscope. The intensity of the gray value was calculated using a Fiji plugin. For each animal 
12 fields from six different sections with the same area were analyzed and the average 
displayed. 
6.5.2 ELECTRON MICROSCOPY 
6.5.2.1 TISSUE PREPARATION 
Animals were deeply anesthetized for perfusion (see chapter 6.1.6.1) and perfused with the 
Karnovski fixative. Compared to the normal perfusion, these mice were perfused with higher 
pressure, using around 50ml of the fixative. Brains were dissected and postfixed for 3hrs at 
4°C and then transferred into storing solution, where they were incubated o.n. or kept at 4°C 
until further processing. Prior to cutting, the brains were washed in washing solution for 4-
5hrs, and the somatosensory cortex was cut into 500µm sections at the vibratome. Small 
pieces of the WM where cut out of the area of interest with a razor blade and underwent 
osmication. This was done by incubating the tissue for 2hrs on a precooled metal plate (-20°C) 
under light exclusion in the osmication solution. This step was needed to stabilize lipids that 
are the main components of myelin. Afterwards the sections were carefully washed in washing 
solution o.n. at 4°C followed by a dehydration in a graded alcohol row for 20min each (70%, 
80%, 90%, 96%, 100% and 100%) and a 30min incubation in propylenoxide in a glass vial. 
Finally, the sections were incubated o.n. at 4°C in a 1:1 propylenoxide:araldite mixture. 
Sections were embedded in molds using an araldite epoxy embedding kit (according to the 
manufacturing protocol) and polymerization was achieved by incubation for 2d at 60°C. In the 
first 12hrs, the orientation of the embedded tissue was checked and re-oriented if necessary. 
6.5.2.2 ULTRATOME SECTIONING 
The embedded tissue blocks were first trimmed with a razor blade, and afterwards semi-thin 
cross-sections of the WM were cut and stained for 1min with toluol blue to analyze the cutting 
plane under the light microscope. Ultrathin sections were cut between 80-90nm thickness and 
as many as possible were placed on a grid and properly dried on a filter paper. 
6.5.2.3 CONTRASTING 
Ultrathin sections on the grid were incubated on a drop of 4% uranyl acetate for 30min and 
washed first in 70% MeOH, then in 35% MeOH and afterwards twice in H2O. After drying the 
sections they were incubated for 5min on a drop a lead citrate solution and finally washed in 
H2O. 
6.5.2.4 PICTURE ACQUISITION AND ANALYSIS OF MYELIN ABBERATIONS 
Pictures of different magnifications were randomly taken using a transmission electron 
microscope (TEM) Libra 120 system from Zeiss. Pictures were analyzed in a blinded manner 
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by two independent persons (Dr. Leda Dimou and myself) for myelin abberations. Myelin 
abberations included: Myelin outfoldings, vacuolization/degeneration of myelinated axons, 
myelination of multiple axons and other myelin abberations. 
 
6.6 BBB CLOSURE ANALYSIS 
At the day of analysis, mice were deeply anesthetized and around 100µl of a 3000Da dextran-
fluorescein (5mg/ml) was injected into the tail vein. After 30min brains were collected and 
immediately frozen on dry ice. Brains were cut in sections of 20µm and thoroughly dried. 
Afterwards the sections were briefly washed in 1x PBS and fixed for 20min in 4% PFA. After 
washing them properly in 1x PBS, sections were dried and mounted with Aqua Polymount. 
Leakage of the fluorescent dye into the brain parenchyma was analyzed with the 20x objective 
of a Zeiss epifluorescent microscope. Contralateral non-lesioned hemispheres served as a 
negative control. 
 
6.7 DETERMINATION OF THE LESION SIZE 
Pictures of the lesioned area were acquired with the 10x objective of a Zeiss epifluorescent 
microscope using the DAPI channel. The lesion size was determined by measuring the DAPI-
free area with a plugin in the Fiji software. For each animal >7 sections were analyzed and 
the biggest lesion that could be found was used for the quantification. 
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9 APPENDIX 
9.1 SUPPLEMENTARY TABLES 
9.1.1 SUPPLEMENTARY TABLES FOR NG2-GLIA ABLATION IN THE HEALTHY BRAIN 
Table 8: Absolute numbers of GFP+cells in Escowt and Escofl mice in the cerebral GM and WM at 
different timepoints after induction. 
 
GM [cells/mm²] WM [cells/mm²]
1wpi 16wpi 1wpi 16wpi
Esco2wt 
615.3 
± 
12.7 
698.7 
± 
15.1 
1985 
± 
18 
2219 
± 
17 
Esco2fl 
606.5 
± 
3.7 
511.9 
± 
141.6 
2005 
± 
21 
1686 
± 
114 
 
Table 9: Absolute numbers of recombined (GFP+) NG2-glia in Escowt and Escofl mice in the cerebral 
GM and WM at different timepoints after induction. 
 
GM [cells/mm²] WM [cells/mm²] 
1wpi 6wpi 11wpi 16wpi 1wpi 6wpi 11wpi 16wpi
Esco2wt 
174.0 
± 
3.0 
180.7 
± 
1.4 
140.6 
± 
2.1 
151.3 
± 
6.2 
197.3 
± 
14.6 
140.1 
± 
13.2 
114.4 
± 
17.6 
113.4 
± 
7.9 
Esco2fl 
165.3 
± 
5.4 
142.4 
± 
2.3 
81.6 
± 
2.6 
88.5 
± 
7.1 
182.6 
± 
8.7 
93.2 
± 
3.0 
42.4 
± 
3.6 
26.1 
± 
13.0 
 
Table 10: Absolute numbers of total (GFP+ and GFP-) NG2-glia in Escowt and Escofl mice in the cerebral 
GM and WM at different timepoints after induction. 
 
GM [cells/mm²] WM [cells/mm²] 
1wpi 6wpi 11wpi 16wpi 1wpi 6wpi 11wpi 16wpi
Esco2wt 
228.8 
± 
3.1 
246.6 
± 
1.2 
225.9 
± 
2.0 
248.5 
± 
1.1 
232.2 
± 
16.1 
254.8 
± 
7.8 
243.5 
± 
6.4 
206.4 
± 
2.9 
Esco2fl 
221.4 
± 
6.0 
241.6 
± 
0.7 
232.8 
± 
4.5 
244.2 
± 
3.2 
219.1 
± 
5.8 
251.9 
± 
17.0 
239.8 
± 
10.3 
232.9 
± 
18.6 
 
Table 11: Forelimb missteps of Esco2wt and Esco2fl mice in the grid walk experiment at different 
timepoints after induction. 
 
3wpi
[%] 
6wpi
[%] 
11wpi
[%] 
15wpi
[%] 
29wpi 
[%] 
Esco2wt 
1.8 
± 
0.1 
2.3 
± 
0.1 
2.4 
± 
0.3 
2.6 
± 
0.2 
3.6 
± 
0.4 
Esco2fl 
1.7 
± 
0.2 
5.6 
± 
0.6 
8.8 
± 
0.3 
9.5 
± 
0.9 
13.6 
± 
0.6 
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Table 12: Hindlimb missteps of Esco2wt and Esco2fl mice in the grid walk experiment at different 
timepoints after induction.  
 
3wpi
[%] 
6wpi
[%] 
11wpi
[%] 
15wpi
[%] 
29wpi 
[%] 
Esco2wt 
0.2 
± 
0.1 
0.9 
± 
0.2 
3.4 
± 
0.4 
3.8 
± 
0.5 
6.1 
± 
0.5 
Esco2fl 
0.4 
± 
0.2 
0.5 
± 
0.2 
0.9 
± 
0.2 
0.6 
± 
0.3 
1.8 
± 
0.1 
 
Table 13: Time of Esco2wt and Esco2fl mice spent on an accelerating rotarod. Time is displayed in seconds 
[s]. Data are presented as mean±sem. 
 
5wpi 
[ms] 
6wpi
[ms] 
7wpi
[ms] 
8wpi
[ms] 
9wpi
[ms] 
11wpi 
[ms] 
12wpi 
[ms] 
Esco2wt 
214.3 
± 
26.6 
209.0 
± 
8.2 
187.7 
± 
19.7 
249.7 
± 
21.8 
263.0 
± 
14.6 
279.7 
± 
24.2 
261.0 
± 
18.0 
Esco2fl 
130.3 
± 
13.1 
136.3 
± 
24.9 
151.3 
± 
53.2 
171.7 
± 
37.6 
179.7 
± 
24.2 
185.7 
± 
11.5 
176.0 
± 
21.1 
 
Table 14: Absolute numbers of recombined (GFP+) NG2-glia in NG2-Escowt and NG2-Escofl mice in the 
cerebral GM and WM at different timepoints after induction. 
 
GM [cells/mm²] WM [cells/mm²]
1wpi 1ypi 1wpi 6wpi
NG2-Esco2wt 
100.8 
± 
2.4 - 
113.6 
± 
5.0 - 
NG2-Esco2fl 
94.7 
± 
6.3 
46.7 
± 
5.9 
109.9 
± 
6.7 
21.0 
± 
6.1 
 
Table 15: Absolute numbers of total (GFP+ and GFP-) NG2-glia in NG2-Escowt and NG2-Escofl mice in 
the cerebral GM and WM at different timepoints after induction. 
 
GM [cells/mm²] WM [cells/mm²]
1wpi 1ypi 1wpi 6wpi
NG2-Esco2wt 
215.4 
± 
2.9 - 
231.0 
± 
6.7 - 
NG2-Esco2fl 
233.2 
± 
3.4 
220.0 
± 
1.2 
242.2 
± 
9.3 
206.8 
± 
5.1 
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Table 16: Forelimb missteps of NG2-Esco2fl mice in the grid walk experiment at different timepoints 
after induction. 
 
3wpi 
[%] 
15wpi
[%] 
32wpi
[%] 
40wpi
[%] 
50wpi 
[%] 
NG2-Esco2fl 
2.2 
± 
0.2 
3.2 
± 
0.1 
5.5 
± 
0.6 
7.7 
± 
0.7 
8.4 
± 
0.6 
 
Table 17: Forelimb missteps of NG2-control mice in the grid walk experiment at different timepoints 
after induction. 
 
3wpi
[%] 
8wpi
[%] 
15wpi
[%] 
NG2-control 
2.5 
± 
0.3 
2.4 
± 
0.2 
2.6 
± 
0.5 
 
Table 18: Latencies of conduction velocities in Escowt and Escofl mice. Latencies from the stimulating to 
the recording electrodes are displayed in milliseconds [ms]. Data are presented as mean±sem. 
 
S1 
[ms] 
S2 
[ms] 
S3 
[ms] 
S4
[ms] 
S5
[ms] 
S6
[ms] 
S7
[ms] 
S8
[ms] 
S9 
[ms] 
S10 
[ms] 
S11
[ms] 
Escowt 
1.468 
± 
0.03 
1.415 
± 
0.03 
1.473 
± 
0.04 
1.443 
± 
0.01 
1.443 
± 
0.006 
1.445 
± 
0.01 
1.44 
± 
0.01 
1.435 
± 
0.01 
1.44 
± 
0.01 
1.430 
± 
0.005 
1.433 
± 
0.1 
Escofl 
1.305 
± 
0.05 
1.415 
± 
0.06 
1.485 
± 
0.03 
1.408 
± 
0.03 
1.453 
± 
0.01 
1.528 
± 
0.05 
1.543 
± 
0.05 
1.675 
± 
0.1 
1.643 
± 
0.1 
1.688 
± 
0.1 
1.740 
± 
0.1 
 
9.1.2 SUPPLEMENTARY TABLES FOR NG2-GLIA ABLATION IN THE INJURED BRAIN 
Table 19: Absolute numbers of GFP+ cells in Escowt and Escofl mice in close proximity to the lesion site 
at different timepoints after the lesion. 
 
control 
[cells/mm²] 
2dpl
[cells/mm²]
4dpl
[cells/mm²]
7dpl
[cells/mm²] 
14dpl 
[cells/mm²]
Esco2wt 
615.3 
± 
12.7 
677.4 
± 
8.9 
836.1 
± 
27.3 
869.1 
± 
9.1 
598.5 
± 
13.1 
Esco2fl 
606.5 
± 
3.7 
616.2 
± 
26.3 
597.9 
± 
17.1 
373.1 
± 
23.0 
299.5 
± 
47.9 
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Table 20: Absolute numbers of recombined (GFP+) NG2-glia in Escowt and Escofl mice in close 
proximity to the lesion site at different timepoints after the lesion. 
 
control 
[cells/mm²] 
2dpl
[cells/mm²]
4dpl
[cells/mm²]
7dpl
[cells/mm²] 
14dpl 
[cells/mm²]
Esco2wt 
197.3 
± 
9.9 
151.5 
± 
2.4 
150.0 
± 
2.0 
205.4 
± 
8.7 
192.0 
± 
8.0 
Esco2fl 
182.6 
± 
8.8 
112.2 
± 
1.1 
74.1 
± 
2.6 
60.73 
± 
5.0 
12.9 
± 
3.6 
 
Table 21: Absolute numbers total (GFP+ and GFP-) NG2-glia in Escowt and Escofl mice in the bigger 
surrounding of the lesion site at different timepoints after the lesion. 
 
control 
[cells/mm²] 
2dpl
[cells/mm²]
4dpl
[cells/mm²]
7dpl
[cells/mm²] 
14dpl 
[cells/mm²]
Esco2wt 
232.2 
± 
16.1 
203.2 
± 
4.0 
213.2 
± 
4.2 
317.1 
± 
7.3 
311.4 
± 
2.4 
Esco2fl 
219.1 
± 
5.8 
168.3 
± 
1.1 
146.1 
± 
3.1 
207.7 
± 
2.3 
270.0 
± 
1.3 
 
Table 22: Absolute numbers of recombined (GFP+) NG2-glia in Escowt and Escofl mice in the lesion 
core at different timepoints after the lesion. 
 
control 
[cells/mm²] 
2dpl
[cells/mm²]
4dpl
[cells/mm²]
7dpl
[cells/mm²] 
14dpl 
[cells/mm²]
Esco2wt 
177.8 
± 
7.8 
224.0 
± 
8.2 
449.8 
± 
12.8 
284.4 
± 
17.0 
211.6 
± 
4.8 
Esco2fl 
177.0 
± 
1.8 
190.2 
± 
4.7 
133.3 
± 
10.7 
67.6 
± 
3.6 
16.0 
± 
6.2 
 
Table 23: Absolute numbers total (GFP+ and GFP-) NG2-glia in Escowt and Escofl mice in the lesion 
core at different timepoints after the lesion. 
 
control 
[cells/mm²] 
2dpl
[cells/mm²]
4dpl
[cells/mm²]
7dpl
[cells/mm²] 
14dpl 
[cells/mm²]
Esco2wt 
227.6 
± 
4.7 
300.4 
± 
4.7 
616.9 
± 
12.4 
455.1 
± 
26.6 
332.4 
± 
7.8 
Esco2fl 
232.9 
± 
6.4 
270.2 
± 
7.8 
275.6 
± 
19.8 
240.0 
± 
11.1 
298.7 
± 
12.3 
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Table 24: Absolute numbers of Iba1+ microglia in Escowt and Escofl mice in the bigger surrounding of 
the lesion site at different timepoints after the lesion. 
 
control
[cells/mm²]
2dpl
[cells/mm²]
4dpl
[cells/mm²]
7dpl 
[cells/mm²] 
Esco2wt 
329.8 
± 
2.1 
604.7 
± 
51.9 
1285 
± 
75.8 
951.4 
± 
4.5 
Esco2fl 
339.6 
± 
4.7 
518.9 
± 
24.5 
977.1 
± 
29.6 
876.7 
± 
53.3 
 
Table 25: Absolute numbers of Iba1+CD45+ activated microglia in Escowt and Escofl mice in the bigger 
surrounding of the lesion site at different timepoints after the lesion. 
 
control
[cells/mm²]
2dpl
[cells/mm²]
4dpl
[cells/mm²]
7dpl 
[cells/mm²] 
Esco2wt 
8.9 
± 
2.3 
184.4 
± 
10.2 
86.0 
± 
39 
35.5 
± 
5.4 
Esco2fl 
6.2 
± 
1.8 
131.2 
± 
17.3 
297.0 
± 
68.5 
241.2 
± 
9.4 
 
Table 26: Absolute numbers of CD45+ invading macrophages in Escowt and Escofl mice in the bigger 
surrounding of the lesion site at different timepoints after the lesion. 
 
control
[cells/mm²]
2dpl
[cells/mm²]
4dpl
[cells/mm²]
7dpl 
[cells/mm²] 
Esco2wt 
5.3 
± 
1.5 
159.2 
± 
25.2 
183.5 
± 
1.5 
54.1 
± 
5.8 
Esco2fl 
7.1 
± 
4.4 
169.3 
± 
8.9 
438.0 
± 
57.7 
281.1 
± 
39.5 
 
Table 27: Absolute numbers of the total astrocyte (S100ß+) and the reactive astrocyte 
(S100ß+GFAP+) population in Escowt and Escofl mice in the bigger surrounding of the lesion site at 
different timepoints after the lesion. 
 Esco2wt Esco2fl 
 S100ß+
[cells/mm2] 
S100ß+GFAP+
[cells/mm2] 
S100ß+ 
[cells7mm²] 
S100ß+GFAP+
[cells/mm²] 
control 
462.8 
± 
3.1 
113.5 
± 
33.1 
449.5 
± 
16.2 
78.9 
± 
14.2 
4dpl 
512.7 
± 
17.1 
418.5 
± 
20.5 
381. 
± 
7.0 
220.8 
± 
12.8 
7dpl 
739.2 
± 
11.8 
660.7 
± 
5.9 
594.6 
± 
7.9 
458.1 
± 
10.2 
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9.2 ABBREVIATIONS 
AEP  Anterior entopeduncular region 
AMPA  α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
APC (CC1)  Adenomatosis polyposis coli 
APP  Amyloid precursor protein 
AraC   Cytosine-D-arabinofuranoside 
ATP   Adenosine triphosphate 
BAC   Bacterial artificial chromosome 
BBB   Blood brain barrier 
BMDM  Bone marrow-derived macrophage 
BMP   Bone morphogenic protein 
BrdU   5’-bromo-desoxyuridine 
CASPR  Contactin-associated protein 
Kv1.2  Potassium voltage-gated channel subfamily A member 2 
CC1   See APC 
CCI  Controlled cortical impact 
CCL2  Chemokine (C-C motif) ligand 2 
CD45   Cluster of differentiation 45 
CD68  Cluster of differentiation 45, microsialin 
CGE  Caudal ganglionic eminence 
CNPase 2’,3’-cyclic nucleotide 3’-phosphodiesterase 
CNS   Central nervous system 
CSPG  Chondroitin sulfate proteoglycan 
d   Day 
DAPI   4’,6’-diamidino-2-phenylindole 
dpi   Days post induction 
dpl   Days post lesion 
DNA  Desoxyribonucleic acid 
DT  Diphteria toxin 
E  Embryonic day 
EAE  Experimental autoimmune encephalitis 
ECM  Extracellular matrix 
EdU  5’-ethinyl-desoxyuridine 
e.g.   Exempli gratia 
EM  Electron micoscropy 
ER   Estrogen receptor 
Esco2  Establishment of cohesion 1 homolog 2 
FA  Fractional anisotropy 
fMRI  Functional magnetic resonance imaging 
g   Gram 
GABA  Gamma-aminobutyric acid 
GFAP   Glial fibrillary acidic protein 
GFP   Green fluorescent protein 
GM   Gray matter 
Gp   Guinea pig 
GPR17  G-protein coupled receptor 17 
GSTπ   Glutathione-S-transferase π 
hrs   Hours 
Iba1   Induction of brown adipocytes 1 
iCreERT2 Improved Cre recombinase fused to a truncated estrogen receptor 
IL  Interleukine 
INFγ  Interferone gamma 
iNOS  Inducible nitric oxide synthase 
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i.p.  intraperitoneal 
kg   Kilogram 
LCA  Leucocyte common antigen 
LGE  Lateral ganglionic eminence 
LoxP  Locus of crossover phage 
LTP  Long-term potentiation 
M   Molar 
m   Mouse 
MAG   Myelin-associated glycoprotein 
Mash1  Mammalian achaete scute homolog-1 
MBP   Myelin basic protein 
mg   Milligram 
MGE  Medial ganglionic eminence 
min   Minute 
mm   Millimeter 
MMF  Medetomidin/Midazolam/Fentanyl 
MS   Multiple sclerosis 
NeuN   Neuronal nuclear antigen 
NG2   Neuron-glia antigen 2 
NMDA  N-methyl-D-aspartate 
NMJ  Neuromuscular junction 
NOR  Novel object recognition 
NSC  Neural stem cell 
NTN1  Netrin 1 
OHT  4’-hydroxy-tamoxifen 
o.n.  Over night 
OLIG2   Oligodendrocyte transcription factor 2 
OPC   Oligodendrocyte progenitor cell 
Pax6  Paired box 6 
PCR  Polymerase chain reaction 
PDGFRα  Platelet-derived growth factor α receptor 
PFA   Paraformaldehyde 
Plp  Proteolipid protein 
pMN  Precursor motorneuron 
PNS   Peripheral nervous system 
PTEN  Phosphatase and tensin homolog 
PTGDS  Prostaglandin D2 Synthase 
Rb   Rabbit 
rpm  Rounds per minute 
Rt   Rat 
RT  Room temperature 
s.c.   Subcutan 
S100β   S100 calcium binding protein β 
SEM   Standard error of the mean 
SCI  Spinal cord inury 
SHH  Sonic Hedgehoc 
Sox   SRY (sex determining region Y)-related high mobility group box protein 
SVZ  Subventricular zone 
SWI  Stab wound injury 
TAM   Tamoxifen 
TAP  Transient amplifying progenitor 
TBI  Traumatic brain injury 
TIMP 1 Tissue inhibitor of metalloproteinase 1 
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TGFα  Transforming growth factor α 
TNFα  Tumor necrosis factor α 
VEGF  Vascular endothelial growth factor 
WM   White matter 
Wt   Wildtype 
wpi  Weeks post induction 
wpl  Weeks post lesion 
μm   Micrometer 
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